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CORRESPONDENCE
Contributions to the Correspondence section are welcomed. 
They should be typewritten and double spaced.
The Cost of Arthroscopy
To the editors. —The letters of Profitt and 
Giachino and of Sullivan in the Septem­
ber 1986 issue of the Journal (page 301) 
both deserve comment.
Simple arithmetic indicates that Profitt 
and Giachino are doing about 10 
arthroscopic examinations per week — a 
considerable number. Have they given 
any thought to “ containing” the cost of 
investigating knee symptoms by reducing 
the number of arthroscopies?
I agree with Dr. Sullivan about the exis­
tence of enthesopathy — more commonly 
known as “ tendon-bone junction syn­
drome” — but it can be diagnosed 
without arthroscopy. Indeed, the bone- 
tendon interface at the lower pole of the 
patella cannot be seen from inside the 
joint as it is covered with synovium and 
the retropatellar fat pad.
I think far too many arthroscopic 
examinations are being done and that this
leads to unwarranted surgical procedures, 
particularly now that instruments for 
arthroscopic surgery are widely available.
W .R. H arris, m d , frcsc
Ste. E.N. 1-234,
Toronto General Hospital, 
200 Elizabeth St.,
Toronto, Ont.
M5G 2C4
The Need to Use the Huber-point 
Needle in the Port-A-Cath 
Implantable Device
To the editors.—The Port-A-Cath (Phar­
macia [Canada] Inc., Dorval, PQ) is a 
totally implantable drug delivery system, 
with a stainless steel port connected to a 
silicone catheter, which is implanted into 
a vein. The reservoir is entered through
a self-sealing silicone rubber septum 
which, according to the manufacturer’s 
manual, will accept 2000 punctures, using 
an atraumatic 22-gauge Huber-point nee­
dle, without leakage. The manufacturer’s 
recommendation is not to use regular nee­
dles, such as a 22-gauge Yale hypodermic 
needle, for fear of damaging the septum.
Since March 1984 we have implanted 
over 75 Port-A-Cath devices at the Royal 
Victoria Hospital in Montreal, using 
mainly the Huber-point needle to gain 
access to the venous system. Occasionally, 
we ran short of Huber-point needles, 
making access through the Port-A-Cath 
impossible.
In view of the lack of information in 
the medical literature on the use of dis­
posable Yale hypodermic needles through 
the Port-A-Cath septum, we decided to 
test and compare leakage from the sep­
tum using both types of needle.
continued on page 99
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A Report on Clinical Trials 
of NU GAUZE* Sponges including in vitro 
and in vivo comparisons 
with conventional cotton gauze sponges
In this study by Dr. Dale C. Birdsell, Chief of Plastic 
Surgery at Calgary’s Foothills Hospital, and his associate 
Dr. John S.D. Davidson, also of Foothills Hospital, 
conventional cotton gauze sponges were compared with 
NU GAUZE* rayon sponges.
In the field of medicine, the most newsworthy items are 
usually new surgical procedures or medications. Little 
attention is given to advances made in the everyday ‘tools 
of the trade', so to speak, such as instruments, sutures, 
dressings and sponges. As Dr Birdsell says in his study, 
“One could take the view that the cotton gauze sponges 
presently used (in use for more than 50 years) are 
perfectly adequate and no changes are required. This 
would be wrong. Firstly, they may be adequate, but they 
are not perfect.” Dr. Birdsell then gives a very appropriate 
comparison of our attitudes towards our ‘tools of the trade’, 
“If surgeons 20 years ago had not taken a progressive 
attitude concerning new suture materials, we would 
probably still be using silk and cotton sutures. Is it possible 
that the presently used cotton gauze sponge will someday 
be considered in the same category with silk and cotton 
sutures?”
Considering the work that the sponge is called upon 
to do, everything from prepping to dressing wounds, it 
should do these tasks with maximum efficiency and 
minimal possible deleterious side effects. A lot has been 
written about effects of lint in wounds and about maceration 
under wet dressings. Dr. Birdsell investigated linting and 
absorption, both in vitro and in clinical trials, comparing 
NU GAUZE* sponges and cotton gauze sponges.
The results of these clinical investigations showed that 
NU GAUZE* sponges fared considerably better than 
cotton gauze sponges.
ABSORPTION CAPACITY (in mL of citrated blood) 
OF NU GAUZE* SPONGES COMPARED TO 8 
AND 12 PLY COTTON GAUZE SPONGES
Trial # NU G A U ZE *
C otton
gauze D ifference
Cotton
gauze D ifference
s  p ly 12 ply
1 17 11 6 14 3
2 16 11 5 14 2
3 17.5 11 6 .5 14 3.5
4 18 11 7 13 5
5 17 11 6.5 13.5 4
Average 17.2 11 6.2 (56 .4% ) 13.7 3 .5  (25 .5% )
“The total absorption capacity of the NU GAUZE* sponge 
exceeded that of the 8 ply and 12 ply cotton gauze 
sponges by approximately 56% and 26% respectively. 
Furthermore, subsaturation amounts of blood were always 
more completely absorbed by the NU GAUZE* sponges 
in both the laboratory and clinical settings. In the latter 
case, donor sites were left drier and hence more 
amenable to easy and efficient dressing of the wound. As 
well, removal of the NU GAUZE* sponge from the wound 
was consistently associated with less disruption of the 
exposed and friable dermal capillary bed. Less disruption 
and thus less bleeding contributed to the efficiency of 
dealing with the donor site wound.
In vitro studies show quite conclusively that NU GAUZE* 
sponges contain less free lint than conventional cotton 
gauze sponges. Free lint in surgical wounds poses a real 
threat from the standpoint of inciting foreign reactions. 
Such reactions could enhance scar formation that may 
jeopardize the final outcome in plastic surgical procedures 
ranging in scope from cosmetic surgery to tendon and 
peripheral nerve surgery. Further, any retention of lint 
(a foreign body) could increase the likelihood of bacterial 
contamination progressing to infection.”
Concerning the handling properties of NU GAUZE* 
sponges, both investigators found the enhanced resiliency 
of the NU GAUZE* sponges to be a positive feature when 
packing closed spaces or applying dry pressure dressings.
As Drs. Birdsell and Davidson summarized, “From these 
investigations, the NU GAUZE* sponges display features 
that make them comparable to, and in many aspects 
superior to conventional cotton gauze sponges. We found 
NU GAUZE* to have better absorption, while being less 
linting, less wound disruptive and more resilient than 
ordinary cotton gauze sponges. This makes NU GAUZE* 
a more rational choice for an all-purpose, absorbent 
sponge for dressing and wound care.”
NU GAUZE* Sponges are available from Johnson 
& Johnson Inc.
For a copy of the complete clinical report, contact the 
Patient Care Division, Johnson & Johnson Inc., Montreal, 
Quebec H1V2E4.
‘ Trademark of JOHNSON & JOHNSON
SURGEONS’ UPDATE
What's new in surgery is the subject of this column. The short items are designed to let readers know 
who's doing what and why. Surgeons are interested in what other surgeons are doing in 
research, education, practice and administration. Surgery is a vibrant specialty, and, as 
its practitioners, you must be the source as well as the readers of this column.
Determining and Rationalizing 
the Supply of Physicians
The Royal College of Physicians and Sur­
geons of Canada and the Canadian Med­
ical Association are working together to 
determine how many specialists are 
needed now and in the future. Their first 
step is to find out how many physicians 
are currently practising in the 39 special­
ties, relying mainly on data collected by 
CMA’s “ physician manpower question­
naire” sent out in 1982, and they are 
validating the information.
Coordinating the operation is James A. 
Low, FRCSC, who chairs the manpower 
committee of the Royal College; he is sup­
ported by staff in the CMA Department 
of Economics who expect the job to be 
complete about December 1987. Also, 
each medical and surgical specialty has a 
working group to share the task of con­
tacting hospitals across the country. Once 
the information has been updated, the 
groups will be drafting statements about 
the current numbers in the specialty and 
the “ ideal” number as a proportion of 
the population.
For example, the Canadian Association 
of General Surgeons’ manpower and eco­
nomics committee undertook the task for 
general surgery. The committee, chaired 
by Frank Turner, FACS, FRCSC, in 
Kelowna, BC, had completed the legwork 
at the end of January.
Said Turner, “ We split the task up by 
province; in Prince Edward Island, the 
job was not so bad — of the 11 surgeons 
on the list, 6 were in practice. In Ontario 
where we found 560 surgeons, the task 
was done in two ways because Ontario 
already had a list. We compared the 
names on the two lists and then called col­
leagues to verify information not appear­
ing on both lists.
“ The figures indicate that of 2683
Contributions to this column are welcome. 
Please send your material to: Mrs. Amy 
Chouinard, Canadian Journal o f Surgery, PO 
Box 8650, Ottawa, Ont. K1G 0G8.
surgeons listed on CMA’s data bank as 
full-time general surgeons only 1517 
(56.5%) are in fact practising general 
surgery full time. Quite a number have 
retired, several have died, and others have 
moved into other branches of medicine 
or into administration. This figure seems 
to apply right across the country, which 
means that government forecasts have 
been based on incorrect data, and it 
explains why we as an association have 
always been hearing about 2000 general 
surgeons but could only get about 1200 
members.
“ In some parts of the country, physi­
cians, although not certificated, are prac­
tising general surgery, but most are senior 
doctors in remote communities who have 
done it for years and are quite competent.
“ To get a handle on the needs for the 
future, we have been approaching com­
munities and finding out whether they 
have enough or too many general sur­
geons” , but the group is still wrestling 
with the problem of determining an 
appropriate ratio for general surgeons to 
population.
Turner commented: “We may find that 
in a large community one general surgeon 
can serve 17 000 people whereas a com­
munity of 10 000 also needs at least one 
surgeon.”
Said N. Tait McPhedran, FACS, 
FRCSC, of Calgary, who has been work­
ing with Turner, “ We’ve known for at 
least 10 years that general surgeons are 
one of the groups getting older. It was one 
of the first specialties to fill after the War, 
and general surgeons are retiring as 
predicted very quickly. We are going to 
see a major shortage within the next 5 to 
10 years.
“ Training takes a minimum 4 years so 
there’s no turn on, turn off mechanism. 
We have attempted to interest university 
people and government in providing more 
slots for training, but so far our requests 
have fallen on deaf ears.”
The federal/provincial advisory com­
mittee on health manpower forecast a 
shortage of 994 in the surgical specialties 
and 389 in laboratory specialties by the 
year 2000. The same report, founded 
mainly on information from Southam 
Medical Data Base and released early in 
1985, asserted that a surplus of general 
practitioners and medical specialists 
existed in 1980 and that it would grow to 
4870 and 2495, respectively, by the year 
2000. However, CMA and the Royal Col­
lege believe that the forecast was inac­
curate for several reasons, not the least 
of which was an underestimate of death 
and retirement of physicians in the next 
four decades. Also the government com­
mittee, which did not include any physi­
cians, projected a decline in emigration 
rates.
Figures about the ages of physicians 
suggest that annually 600 physicians will 
retire or die during the years 1986 to 1990 
and the numbers will rise to 1550 each 
year during the period 2010 to 2020. 
According to the Royal College and 
CMA, this finding and the current 
emigration rates indicate an overall short­
fall of 1754 physicians in the year 2000 
even if the government’s physician-to- 
population ratios are correct.
Two specialty groups — laboratory 
medicine and neurology — undertook 
validation as a pilot project last summer. 
Both called for growth not cutbacks in 
residencies. For example, the committee 
for laboratory medicine recommended 
increases such that the ratio, which is cur­
rently one specialist to 19 764 people, 
would be one to between 15 659 and 17 
307. The committee based its recommen­
dation on numbers of vacant positions 
currently funded in hospitals across the 
country and estimates by laboratory 
directors about positions needed to pro­
vide standard services.
Both McPhedran and Turner agreed 
that few specialty groups are likely to ask 
for a cut in residency positions, but, said 
McPhedran, “ There are some that are 
obviously overfilled — if you look at it 
objectively — pediatrics, family practice 
and medical specialties.”
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The groundwork for validation of data 
about medical specialists and family phy­
sicians has been laid. Emergency physi­
cians have already completed the task. 
Said Jan Ahuja, FRCPC, “ We were for­
tunate in that we as a group (the Cana­
dian Association of Emergency Physi­
cians) had undertaken in the summertime 
a study on our own. We used the same 
five people in the geographic areas and 
they had subcommittees phoning every 
hospital in Canada.
“ For the Ottawa area, I participated in 
the original survey and I spent about 10 
hours on the phone; I’m quite sure that 
literally hundreds of man hours went into 
this. We contacted department heads and 
sent them a questionnaire.”
Like general surgeons, the emergency 
physicians found the data were not relia­
ble: “ We found many people who were 
listed as emergency physicians but did not 
have certification from the Royal College 
or from the College of Family Physicians 
of Canada.” The implication is that more 
such specialists are needed so the focus 
is to find out not only who has formal 
qualifications to practise a specialty but 
who is actually practising, that is, spend­
ing about 70% of his or her time work­
ing in the specialty.
In the next issue of the Journal the 
question of mandatory retirement will be 
discussed.
Work Under Way 
on New Heart Facilities for VGH
A project estimated at $2.7 million will 
give the Vancouver General Hospital six 
new operating rooms and 62 new beds — 
18 for cardiac intensive care and 44 for 
patients who have had heart operations.
Costs of the project will be shared on 
a 60 to 40 basis by the provincial govern­
ment and the Greater Vancouver 
Regional Hospital District. Completion 
is expected in autumn 1987.
Defence Association Wants 
More Surgeons Ready for Service
The Canadian Forces Medical Services 
need more surgeons who are familiar with 
the military and who can respond in an 
emergency, said representatives at the 
annual conference of defence associa­
tions, held in Ottawa in January.
A.V. Grasset, MCFP, president of the 
Defence Medical Association, outlined 
concerns to CJS: “ We discussed the lack 
of medical specialists, specifically trauma 
surgeons, orthopedic specialists and 
anesthetists, for the armed forces to 
respond in case of a crisis.
“ There are barely enough in the Cana­
dian forces for peacetime conditions. If 
there were an overseas crisis or one in 
Canada, such as a 747 going down in the 
Arctic, the Canadian forces with its 
potential transport, mobility and exper­
tise could be called upon to help and 
should be able to supply sufficient medi­
cal care. If there were sudden hostilities 
in Europe, the NATO forces would 
require 24 surgical teams immediately. 
About seven could be provided by allies 
on the spot but the Canadian Forces Med­
ical Services would have to provide 17 
teams of surgeons, anesthetists and sur­
gical assistants.
“ At the moment, the total number of 
trained surgical specialists on strength is 
13; the total number of anesthetists on 
strength is 6. One possibility is to invite 
names on a list to supplement the 
reserves; the group could be given some 
basic training at times convenient to 
them. In other words we could ask for 
volunteers to be ready for emergencies; 
they would be given some incentive and 
orientation and would be available in 
emergencies. We are asking the govern­
ment for such a program, which would 
be in addition to the medical reserves. The 
reserves provide regular part-time 
experience in the military and also badly 
need health professionals of all sorts.”
Amy Chouinard
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REVIEW ARTICLE
A . M i n i a c i , m d ; C .H . R o r a b e c k , m d , FRCSC, FACS*
Tibialis Anterior Muscle Hernia: a Rationale for Treatment
Tibialis anterior muscle hernia is an 
orthopedic problem that should be dealt 
with carefully since the potential compli­
cations of treatment are serious. The 
literature is reviewed to provide a better 
understanding of the natural history, inci­
dence, classification and treatment of 
muscle hernias.
Guidelines are proposed for a rational 
treatment plan for tibialis anterior muscle 
hernias. Asymptomatic hernias need no 
treatment. Longitudinal fasciotomies are 
recommended as the treatment of choice 
in symptomatic tibialis anterior muscle 
hernias that are refractory to conserva­
tive treatment.
La hernie du muscle jambier anterieur est 
un probleme orthopedique qui doit etre 
aborde avec precaution car les complica­
tions du traitement peuvent etre serieu- 
ses. On a fait I'Stude des publications 
sur le sujet afin d'en ressortir une meil- 
leure connaissance de I'histoire naturelle 
de la hernie musculaire, de son inci­
dence. sa classification et son trai­
tement.
On sugg&re une marche a suivre visant 
a offrir un plan de traitement logique des 
hernies du muscle jambier anterieur. Les 
hernies asymptomatiques ne necessitent 
aucun traitement. Une fasciotomie longi- 
tudinale est recommandee comme traite­
ment de premier choix dans les cas de 
hernies musculaires qui rgsistent a un 
traitement conservateur.
From the Division o f Orthopedic Surgery, 
Department o f  Surgery, University Hospi­
tal, University o f  Western Ontario, Lon­
don, Ont.
*Chief, Division o f  Orthopedic Surgery, 
University Hospital
Accepted fo r  publication Nov. 6, 1986
Reprint requests to: Dr. C.H. Rorabeck, 
University Hospital, University o f  Western 
Ontario, PO Box 5339, Station A , London, 
Ont. N6A 5A5
Herniation of the tibialis anterior muscle 
is generally asymptomatic and a relatively 
minor orthopedic problem, but if not 
treated with the utmost care it can have 
serious consequences. There is a group of 
patients who will seek medical attention 
because they experience symptoms or are 
concerned with the cosmetic appearance 
of the leg. Therefore, a thorough under­
standing of the natural history of muscle 
hernia and an appreciation of potential 
complications arising from proposed 
treatment are necessary for a rational 
approach to management.
History
Muscle hernias are not rare but have 
received little attention in the medical 
literature, even though the earliest pub­
lished report was by Richet in 1855.*-2 A 
number of other reports followed3 and 
in 1929 Ihde1 published the first compre­
hensive review of the literature. In addi­
tion he provided a system of classifica­
tion for muscle hernia and reported 12 
cases in the leg and 1 in the thigh, all 
occurring in military personnel. Through
to the late 1940s most of the reports were 
provided by military physicians, describ­
ing their personal experiences with diag­
nosis and management of muscle hernias 
in military recruits.4-9 Since then there 
has been a relative paucity of published 
information on the subject. Authors have 
outlined modes of treatment that vary 
from simple closure of fascial 
defects5,7'10 to patch repair with fascial 
grafts,5,11'12 most reporting good func­
tional and cosmetic results. Recently, seri­
ous complications have been reported 
after treatment of muscle hernias.13,14 
Wolfort and colleagues14 described two 
cases of anterior tibial compartment syn­
drome (Fig. 1) after hernia repair.
The purpose of this paper is to propose 
guidelines for the management of mus­
cle hernias, that, if followed, should 
reduce the risk of this complication.
Incidence
Opinions vary as to the true incidence 
of muscle hernia. Ihde1 reported the con­
dition as rare, because there were few 
reports of muscle hernia at that time.
FIG. 1—Compartment syndrome, serious complication of repair of tibialis anterior mus­
cle hernia.
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Other authors have now concluded that 
the condition is more common.715 
McMaster in 19437 reviewed 1800 hospi­
tal admissions to an orthopedic hospital 
for marines and found 21 men with 38 
muscle hernias. Only two reports in the 
literature of muscle hernia occurred in 
women, but since most of these reports 
are of military personnel this may not 
reflect the true incidence of muscle her­
nias in the general population. Obermaier 
and Wilson15 reported their experience 
with muscle hernia and postulated that its 
incidence in the general population is 
underestimated since most cases are 
asymptomatic and the patients do not 
seek medical attention. They also noted 
that in a large number of patients the ini­
tial diagnosis was incorrect and patients 
were not considered for surgery. There 
does not seem to be any specific tendency 
towards race or geographic location. 
Most patients are young men between 18 
and 40 years of age.
Etiology and Classification
The preponderance of healthy, active, 
young men with this disorder suggests 
that heavy muscular activity may predi­
spose to muscle hernia. The tibialis 
anterior muscle is the one most often 
affected, but hernias have been reported 
in other muscles in both upper and lower 
extremities.14 The simplest and most use­
ful classification was proposed by Ihde,1 
who divided muscle hernias into two 
groups: constitutional and traumatic. 
Constitutional hernias result from a con­
genital defect in the muscle fascia that 
enlarges, permitting a muscle hernia. This 
theory has been supported by various 
authors.7,15 Although Ihde only noted 
single hernial defects, later reports6 sug­
gested that constitutional hernias could be
FIG. 2—Post-traumatic tibialis anterior 
muscle hernia in young woman.
either single or multiple and were often 
bilateral. Obermayer and Wilson15 noted 
that most hernias occurred approximately 
15 cm above the lateral malleolus, the 
area in which the small saphenous vein 
connects with the deep venous system. 
McMaster7 postulated that herniation 
occurred at the site where the superficial 
peroneal nerve exits the anterior compart­
ment fascia. Herniation at this site could 
lead to nerve entrapment and be a cause 
of symptoms. Traumatic defects (Fig. 2) 
can be either direct or indirect. Direct her­
nias result from injury to the muscle fas­
cia, as with a sharp penetrating wound. 
Indirect hernias are the result of a blow 
to the contracted muscle causing rupture 
of the fascia and subsequent muscle her­
niation.7
Clinical Presentation
Most patients present with a well- 
circumscribed mass at the junction of the 
middle and distal thirds of the tibia that 
may be asymptomatic but causes the 
patient concern because of the cosmetic 
deformity or the possibility of a tumour. 
Symptoms include aching after prolonged 
exertion that subsides with rest. On phys­
ical examination the fascial margins are 
easily palpable.1'7’9’15 The hernias are 
usually soft and easily reducible and can 
be accentuated by various maneuvers 
including the “ fencer’s lunge” position 
(the patient weight bearing and the hip, 
knee and ankle all flexed) described by 
Pichon.3 The differential diagnosis 
should include thrombophlebitis,16 vari­
cosities,1,7 hem atom a,1 lipoma,7,13’15 
fibroma, angioma1315 and soft-tissue 
sarcoma.
Treatment
Conservative therapy such as the use of 
support hose1’10,13 may be beneficial if 
symptoms are mild. Various surgical 
procedures have been advocated, ranging 
from simple fascial suturing5,6,17 to 
repair of the fascial defects with fascia 
lata grafts.9,11,12 More recently, Boriani13 
advocated a periosteal patch graft for fas­
cial defects that are adjacent to the 
anterior tibial border and LeRiche pro­
posed a longitudinal fasciotomy for 
symptomatic hernias.13
Discussion and Conclusions
Closure of a fascial defect in the 
anterior muscle compartment of the leg 
by simple suturing or patch grafting will 
inevitably lead to elevated pressures 
within that compartment by converting 
an open system to a closed system with 
a fixed volume capacity. Postoperative 
edema and hematoma formation will 
accentuate this increase in pressure and 
may lead to a compartment syndrome.
Simple repair of a fascial defect by 
direct apposition of fascial edges is espe­
cially dangerous because not only does it 
close the compartment but it also reduces 
the volume of that osteofascial compart­
ment. There are reports in the 
literature9,18 of compartment syndrome 
following simple muscle hernia repair. We 
consider it an unacceptable complication.
Other procedures that have met with 
some success include fascia lata 
grafts9,11,12 and periosteal patch grafts 
from the tibia.13 We have no experience 
with these techniques and, theoretically, 
the risk of compartment syndrome is 
higher. We propose the following guide­
lines for the management of tibialis 
anterior muscle hernia.
• Asymptomatic muscle hernias need 
no treatment. Cosmesis is usually not an 
indication for surgery as operative com­
plications are serious.
• For mild cases with symptoms, use 
of support hose may be of benefit.
• Surgery may be considered for 
patients with moderate to severe sym­
ptoms and unsuccessful conservative 
management. Simple fascial repair should 
never be attempted.
If fascial patch grafting is the proce­
dure chosen, great care should be taken 
not to close the compartment tightly, and 
careful postoperative monitoring is neces­
sary. We suggest longitudinal fasciotomy 
to decompress the entire anterior com­
partment and avoid the potential compli­
cation of compartment syndrome.
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Long-Term Review
of the McGoey-Evans High-Friction Uncemented
Total Hip Arthroplasty
To assess the long-term clinical results 
of uncemented total hip arthroplasty 
with the McGoey-Evans bipolar high- 
friction hip prosthesis, the authors 
reviewed the findings in 86 such hip 
replacements. The minimum patient 
follow-up was 5V2 years (mean 9 years). 
Overall, satisfactory results were 
obtained in 46.5%  of cases. There were 
no deep infections. In contrast to the 
experience with the cemented hip 
replacements, the authors found that the 
results were better in men than women 
and that most of the revisions were done 
within 5 years of the original operation. 
Tissue hypersensitivity resulted in 
implant loosening in only two cases and 
no harmful systemic effects arose from 
the use of this uncemented cobalt- 
chromium prosthesis.
Although this particular hip prosthesis 
is not recommended because of its 
inferior design, the findings of the study 
could be useful in the current practice of 
uncemented hip arthroplasty.
Dans le but d'evaluer les resultats a long 
terme de I'arthroplastie complete de la 
hanche n'utilisant aucun ciment et fai- 
sant appel a la prothese bipolaire a fric­
tion elevge McGoey-Evans, les auteurs 
ont passe en revue les observations de 
86 arthroplasties de ce type. Les 
patients ont fait I'objet d'examens de
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surveillance pendant un minimum de 51/2 
ans (moyenne de 9 annees). Dans 
I'ensemble, des resultats satisfaisants 
ont et£ obtenus dans 46.5%  des cas.
On n'a constat^ aucune infection pro- 
fonde. Contrairement a ce que Ton sait 
des proth6ses cimentees de la hanche, 
les auteurs ont observe que les r6sultats 
ont 6te meilleurs chez les hommes que 
chez les femmes et que les revisions ont 
et£ effectuees dans les 5 annees qui sui- 
virent la premiere operation. L'hypersen- 
sibilite tissuiaire fut la cause d'un rela- 
chement de la prothese dans deux cas 
seulement. Aucune reaction systemique 
adverse n'a et6 reliee a I'utilisation de la 
prothese au cobalt-chrome.
Bien que cette prothese particuliere de 
la hanche ne puisse etre recommandee 
du fait de sa moins bonne conception, 
les observations recueillies dans cette 
etude peuvent servir dans la pratique 
actuelle des arthroplasties de la hanche 
sans ciment.
A significant early contribution to hip 
arthroplasty was that of Smith-Petersen 
who, in 1923, introduced the cup 
arthroplasty to cover the reshaped 
femoral head.1 Subsequently Moore2 and 
Thomson3 described proximal femoral 
hemiarthroplasty. A few years later, 
Urist4 and McBride5 introduced the 
acetabular cup replacement arthroplasty. 
The combination of an acetabular cup 
with a proximal femoral replacement 
started the modern era of total hip 
arthroplasty. The early prostheses, with 
all-metal components, were implanted 
into bone either with or without the use 
of acrylic cement. In 1964 McGoey and 
Evans in Toronto started using a cement­
less all-metal total hip replacement 
prosthesis. Based on the concept of low 
friction, hip arthroplasties6’7 sharply 
improved results and with time rendered 
early total hip systems obsolete. However, 
long-term studies have shown a number 
of late complications related to these
prostheses, the most common of which 
is component loosening, a particularly 
worrisome complication in younger active 
patients.8-12 These long-term problems 
have led to the promotion, especially in 
Europe, of newer types of uncemented 
hip arthroplasties.13-16 Long-term follow­
up results of these new uncemented 
arthroplasties with respect to durability 
and biocom patibility are no t yet 
available.17
The renewed interest in the uncemented 
total hip replacement prompted us to 
review the long-term results obtained with 
the M cG oey-Evans h igh -fric tion  
uncemented hip prosthesis, in the hope 
that some of the lessons learned from its 
use would apply to the current practice 
of cementless hip replacement surgery.
Patients and Methods
To make the results of this study 
meaningful we included only cases in 
which the patient was followed-up for at 
least 5!/2 years; that is, patients who had 
undergone a McGoey-Evans uncemented 
total hip replacement arthroplasty  
between 1964 and 1976. In 121 patients 
(48 men, 73 women), 135 prostheses were 
implanted (14 bilateral replacements). 
The mean age of patients at the time of 
surgery was 60 years (range from 17 to 
84 years). Indications for operation were 
osteoarthritis (81 hips), congenital hip dis­
location (17), post-traumatic hip arthro­
sis (13), rheumatoid arthritis (10), 
osteonecrosis (7), hip degeneration related 
to slipped femoral capital epiphysis (4), 
ankylosing spondylitis (1), hip arthrosis 
secondary to Morquio’s syndrome (1) and 
pathologic fracture of the femoral neck 
due to a bone cyst (1 hip). In 20 of the 
hips other reconstructive procedures had 
been performed previously; they included 
Moore’s hemiarthroplasty (2 hips), 
acetabuloplasty with a McBride’s cup (1), 
resectional hip arthroplasty (1) and hip 
fusion (1). The surgeons who developed
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the hip replacement under review per­
formed all the operations.
The Prosthesis
The prosthesis was a combination of 
McBride’s acetabular cup and Moore’s 
femoral endoprosthesis (Fig. 1). Both 
components were constructed from vital- 
lium (a cobalt-chromium alloy). The com­
ponents were correctly paired to allow 
total contact during weight-bearing (Fig. 
1).
Operative Technique
The hip joint was approached through 
a long lateral skin incision followed by an 
inverted Y trochanteric osteotomy (Olym­
pic approach to the hip joint) (Fig. 2). Ini­
tially, stabilization of the acetabular cup 
was obtained by pressing the three dor­
sal fins of the cup into the decorticated 
acetabulum. Later the early stability of 
the socket was enhanced by cancellous 
screws inserted through pierced projec­
tions placed superolaterally in the rim of
FIG. 1—McGoey-Evans uncemented total 
hip prosthesis. Original McBride cup has been 
modified by adding two pierced superolateral 
projections for screw fixation.
FIG. 2—Olympic approach to hip joint. 
Greater trochanter is divided (left) with one 
vertical and two oblique cuts at 120° to each 
other. Two fragments are retracted (right) 
laterally and superiorly to facilitate exposure.
the cup. On the femoral side, the Moore’s 
prosthesis was inserted in the regular 
fashion. Care was taken to insert the 
prosthesis with the widest proximal stem 
for optimal bone-implant contact. The 
two trochanteric fragments were then 
reapproximated and held together by 
either a single wire loop (in most cases) 
or two long screws.
All operations were carried out in a 
standard operating room without clean 
air or laminar flow system.
Perioperative Care
immediately after occurred in nine 
patients. One patient died of myocardial 
infarction. Four patients sustained pul­
monary embolism and another five 
suffered deep venous thrombosis.
Results
We were able to locate 68 of the origi­
nal 121 patients. Sixteen others had died 
and the remaining 37 were lost to follow­
up. In 57 of the 68 patients, the 
McGoey-Evans hip prostheses were still 
in place (7 patients had bilateral replace-
None o f the patients received 
anticoagulants or antibiotics prophylac- 
tically. They were kept in bed for an aver­
age of 30 days then gradually mobilized 
using crutches and canes.
Complications of the Operation (Table I)
Systemic problems intraoperatively or
Table 1-Local Complications
Complication No.
Intraoperative
Fractured acetabulum 1
Split fracture of proximal femur 1
Postoperative
Superficial infection 6
Hematoma (sterile) 1
Wound dehiscence 1
Dislocated prosthesis 1
Subluxation of prosthesis 2
Dislodgement of femoral 1
component secondary to 
femoral split fracture
FIG. 3—Results of McGoey-Evans total hip 
arthroplasty in men and women. White bars 
= satisfactory, hatched bars = unsatisfactory, 
black bars = revisions.
FIG. 4—Results of McGoey-Evans total hip arthroplasty in three age groups. It is evident 
that men (top) obtained better results overall than women (bottom). White bars = satisfac­
tory, hatched bars = unsatisfactory, black bars = revisions.
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ment); the remaining 11 had undergone 
revision. (In the charts of patients who 
died or who did not return for follow-up 
we found that 11 had undergone revisions 
of this prosthesis. Thus, the total 
documented revised cases were 22.)
The long-term results are based on 79 
(62%) patients with 86 prostheses. 
Included are all the recalled patients and 
all those with documented revisions. The 
average follow-up was 9 years (range 
from 5l/2 to 16 years). The results were 
assessed objectively, subjectively and.
whenever possible, radiologically. For the 
objective assessment, the Harris hip evalu­
ation system was used.18 The results were 
classified as satisfactory if the hip score 
was 80 to 100 points and unsatisfactory 
if less than 80 points; revisions were con­
sidered failures. The patient’s own satis­
faction with the performance of the artifi­
cial joint was used for the subjective 
evaluation. Assessed radiologically were 
the formation of heterotopic bone, 
loosening of the component, subsidence 
of the femoral prosthesis and union of the
greater trochanter. The method of Jowsey 
and colleagues19 was used to classify het­
erotopic bone formation. A component 
was considered loose whenever 2 mm or 
more of radiologic lucency was seen 
between it and the adjacent sclerotic 
bone. Subsidence was considered a 
change in distance between the inferior 
margin of the neck of the femoral com­
ponent and the proximal part of the lesser 
trochanter.
Objective Results
Overall, a satisfactory result with this 
prosthesis was obtained in 46.5% of 
cases. Further analysis of the results 
showed substantially different success 
rates between the two sexes. In men, the 
rate was 64.3% (18 of 28) compared with 
38% (22 of 58) in women (Fig. 3). The 
favourable results in men were apparent 
in every age group (Fig. 4). Furthermore, 
although there were five women over the 
age of 60 years with very low hip scores 
(less than 40), no man of any age had a 
hip score of less than 50. In six of seven 
patients with bilateral hip replacement, 
both hips had similar scores. No deep 
infections were recorded in this group of 
patients.
Subjective Results
Most patients stated that it took 1 to 
2 years before they regained maximum 
strength at the operated site. Many com­
plained of persistent stiffness, but 85% 
of the 57 patients questioned expressed 
satisfaction with the overall performance 
of the artificial hip.
Radiologic Results
The x-ray films of 44 hips were availa­
ble for review.
Heterotopic bone form ation .—This 
was seen predominantly in men with 
osteoarthritis and considered extensive in 
11 hips (Fig. 5). In all but one of these 
cases, it was associated with a radiologi­
cally loose implant.
Radiologic loosening. —Components 
of 11 hip arthroplasties were considered 
loose radiologically (Fig. 6); 3 involved 
the acetabular cup, 3 the femoral com­
ponent and 5 both of these. A poor func­
tional result correlated with radiologic 
loosening in only five cases; two involved 
both components, two the acetabular cup 
and one the femoral stem only.
Subsidence.—Consecutive x-ray films 
of 23 hips were available. In seven, some 
settling of the femoral component was 
measured (in most cases between 1 and 
2 cm). No clinical correlation between this 
subsidence and the clinical outcome was 
found.
FIG. 5—Bilateral McGoey-Evans total hip arthroplasty for osteoarthritis. In this case proce­
dure on left side was performed 6 months after that on right. Follow-up at 10 'A and 11 years 
respectively showed that both prostheses were performing satisfactorily (hip score 94 bilaterally).
FIG. 6—This McGoey-Evans prosthesis had been inserted 9 years previously. At follow­
up, results were rated as poor (hip score 54). There are signs of loosening of femoral compo­
nent and marked heterotopic ossification.
VOLUME 30, NO. 2, M ARCH 1987 /  THE CANADIAN JOURNAL OF SURGERY 83
Trochanteric union.—All but one 
osteotom ized greater trochanters 
reunited. Clinically, the patient with 
nonunion exhibited a notable pelvic lurch 
during walking and had an overall 
unsatisfactory objective result.
Revisions
The revision rate for the McGoey- 
Evans total hip arthroplasty in this study 
was 26% (22 of 86). Closer analysis 
showed that the incidence of revision in 
men was less than that of women (21% 
versus 27.5%), middle-aged women had 
the highest revision rate (Fig. 4) and most 
revisions (17 of the 22) were performed 
within 5 years of the original replacement. 
Seventeen patients who underwent revi­
sion surgery stated that they were never 
relieved of their symptoms after the origi­
nal hip replacement. The remaining five 
(two men, three women) enjoyed a pain- 
free period ranging from 3 to 9 years 
before symptoms began. None of the revi­
sions were done as a result of acute injury.
In 18 revisions, the reasons were 
recorded clearly — a loose acetabular cup 
(8), a loose femoral component (5) and 
loosening of both components (5). Infec­
tion was never recorded as a cause of revi­
sion. Severe metal reaction was seen in the 
tissues of two patients with revision. In 
both cases (revision performed after 3 Vi 
years and 7 years) the surgeon attributed
prosthetic loosening to this local tissue 
reaction.
Discussion
The McGoey-Evans uncemented total 
hip arthroplasty is outdated and does not 
have a place in the current practice of hip 
surgery. However, retrospective review of 
the results obtained with this prosthesis 
(the first long-term follow-up of an 
uncemented hip arthroplasty in North 
America) has yielded certain interesting 
findings that may be useful in prosthetic 
hip replacement of the cementless variety 
today.
The fact that we found no deep infec­
tions in the patients reviewed is of par­
ticular importance when one considers 
that antibiotics were not given prophylac- 
tically and no ultra-clean operating rooms 
were used. We believe that the absence of 
bone cement may have been a major fac­
tor, and experimental evidence supports 
this. As shown in the laboratory, the 
methylmethacrylate bone cement inter­
feres with the ability of the local tissues 
to destroy bacteria by depressing the 
chemotactic factors of the complement 
sequence20 and by reducing the ability of 
the leukocytes to phagocytose.21 Also, it 
has been noted tha t cemented 
arthroplasties in experimental animals 
tend to fail from sepsis much more fre­
quently than uncemented ones.22
That younger patients and male sex 
benefitted the most from this prosthesis 
is contrary to the experience with the 
cemented hip prostheses8’11’12’17 but is in 
accord with the results obtained so far 
with the newer generation of uncemented 
hip replacements.13’23’24 We believe this 
finding suggests that the strength of the 
biologic fixation is closely related to the 
quality of the host bone. The difference 
in the good results between men and 
women noted in our study has not previ­
ously been reported. The increased ten­
dency for osteoporosis in women might 
have been the underlying cause.25
The revision pattern of this prosthesis 
differs from that of the cemented ones. 
Here the majority of the patients who 
required revision never became symptom- 
free, but most patients with cemented 
prostheses usually enjoy a few years of 
painless hip motion.10,17’26 The explana­
tion for this should be sought in the 
difference in implant fixation. With the 
cemented hip replacement maximal fixa­
tion is obtained at the time of surgery,17 
whereas in the noncemented one the bio­
logic fixation, by fibrous membrane or, 
in the newer uncemented prosthesis, by 
bone ingrowth, takes place gradu­
ally.23’27 This is the reason why the 
symptoms after a noncemented hip 
arthroplasty disappear gradually. The 
persisting symptoms that often lead to 
revision surgery should be attributed to
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the failure, for whatever reason, of this 
natural bond to mature.
The loosening in 2 of the 22 revised 
arthroplasties was attributed to local tis­
sue hypersensitivity. A similar low inci­
dence of loosening related to local tissue 
reaction has been reported before.27'28 
Local tissue hypersensitivity to the metal­
lic implant, therefore, appears to be a 
minor factor in prosthetic loosening. 
Finally, despite the prolonged presence of 
these implants in living tissues no evidence 
of systemic toxic side effects to cobalt or 
chromium or development of a malignant 
lesion near the implant was noted.
Conclusions
Although the advances in the total joint 
replacement technology have made the 
McGoey-Evans prosthesis obsolete, long­
term review of the results o f its use 
showed that an uncemented prosthesis 
carries a low risk of infection, patients 
with good quality bone (younger, male) 
get better results, revision of the 
arthroplasty is more frequent early and 
less frequent later after the initial replace­
ment and local metal hypersensitivity is 
an uncommon cause o f prosthetic 
loosening.
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Is Preoperative Colonoscopy in Carcinoma 
a Realistic and Valuable Proposition?
Colonoscopy was performed preopera- 
tively in 100 consecutive patients as a 
prospective study to establish the feasi­
bility of the procedure and its value, 
which was considered "adequate"when 
the colon remaining after surgical resec­
tion had also been examined preopera- 
tively. Colonoscopy was adequate in 35 
of 46 patients (7 6 % ) with malignant 
tumour located in the cecum and 
ascending and transverse colon, but in 
only 15 of 54 patients (2 8 % ) who had a 
tumour in the left colon or rectum. Syn­
chronous malignant tumours were 
present in 2 patients, and 54 additional 
adenomas were discovered in 29 
patients. These adenomas could be 
removed endoscopically in 13 patients 
and were included in the standard resec­
tion in 12. Extension of the planned 
operation was necessary in only four 
patients with synchronous adenomas. 
Routine preoperative colonoscopy to 
assess the presence of synchronous 
colonic tumours is more likely to be ade­
quate in proximal or right-sided large- 
bowel tumours than in left-sided tumours 
because of the annular configuration of 
the latter. Because of the high rate 
(46% ) of synchronous adenomas in ade­
quate examinations, inadequate preoper­
ative colonoscopy should be com­
plemented by a repeat examination 3 to 
6 months postoperatively in every 
patient with a malignant tumour of the 
large bowel.
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Afin d'etablir les possibilites et la valeur 
reelle d'une coloscopie preoperatoire 
dans le cancer du gros intestin, les 
auteurs ont fait une 6tude prospective 
chez 100 patients consecutifs porteurs 
d’un cancer du colon et du rectum oil 
une coloscopie preoperatoire a ete ten- 
tee. Ms avaient considere que cette 
coloscopie etait adequate si la portion 
non r6sequ6e du colon a la suite de leur 
operation avait ete examinee endoscopi- 
quement. Ainsi la coloscopie a ete jugee 
comme etant adequate chez 35 des 46 
malades (7 6 % ) oil la tumeur maligne 
etait localisee dans la partie proximale du 
colon (caecum, colon ascendant et trans­
verse). Par ailleurs, elle ne fut adequate 
que chez 15 des 54 patients (28% ) oil la 
lesion maligne etait situee dans le colon 
gauche et le rectum. La presence de 
deux lesions malignes synchrones addi- 
tionnelles fut etablie et 54 adenomes 
synchrones ont egalement ete demontres 
chez 29 patients. Ces adenomes £taient 
enlevables endoscopiquement chez 13, 
furent inclus dans le specimen standard 
de resection chez 12 et necessitgrent 
une extension de cette resection stan­
dard chez seulement 4 patients avec des 
adenomes additionnels. Les auteurs esti- 
ment que la coloscopie preoperatoire de 
routine pour le cancer du colon afin de 
determiner la presence de tumeurs 
synchrones a plus de chance de reussir 
et d'etre adequate pour les cancers du 
colon proximal a cause de la nature ste- 
nosante des tumeurs situ£es dans le 
colon gauche. Aussl a cause du haut 
taux (46% ) d'adenomes synchrones lors- 
que I'examen du colon fut adequat les 
auteurs recommandent qu'une colosco­
pie postop£ratoire dans un delai de 3 a 6 
mois soit faite pour tous les cas de can­
cers operas chez qui une coloscopie 
preoperatoire n'a pu etre tentee ou 
reussie.
Resection of a segment of large bowel 
remains the most appropriate treatment 
for colorectal carcinoma.1 Standard pat­
terns of resection, depending on the site 
of the tumour, are well established.2
Total colectomy and even proctocolec­
tomy have been advocated for multiple 
malignant lesions and for concomitant 
benign and malignant neoplasms in 
separate segments o f the co lon .3 
Although these extensive resections may 
be indicated for synchronous carcinomas, 
they are now rarely performed for syn­
chronous benign adenomas, since total 
colonoscopy allows both excision o f the 
adenom as and follow -up o f  the 
patient.4*6 The surgeon performing a 
colonic resection for carcinoma is anx­
ious to ensure that all tumour has been 
removed. The reliability of barium exami­
nations to reveal additional lesions in the 
colon is often discussed.7,8 Careful pal­
pation o f the colon at laparotomy may 
reveal gross tumour,9 but the soft or 
small, benign, villous adenomas are likely 
to be missed. For these reasons, several 
authors10-14 have recently proposed total 
colonoscopy to achieve proper screening 
of the bowel for synchronous tumours. 
These reports generally mention a 5% 
prevalence o f synchronous carcinomas 
and 25% to 50% of benign adenomas. 
Unfortunately, the majority o f these 
studies do not report consecutive 
cases,10-12,14 some include postoperative 
examinations11,13 and others exclude 
incomplete colonoscopy.11-14 Because a 
realistic picture of the expectations of 
routine preoperative colonoscopy is not 
adequately presented, we carried out a 
prospective study to assess the value and 
feasibility o f this procedure.
Beginning in January 1984 colonoscopy 
was attempted preoperatively in 100 con­
secutive patients with colorectal car­
cinoma.
Patients
There were 56 men and 44 women 
ranging in age from 35 to 90 years (mean 
64 years). The proportion o f index 
tumours according to nonmodified 
Dukes’ staging was class A — 17, B — 
45 and C — 21; 17 had distant metastases. 
Barium enema established the presence of 
carcinoma in 75 patients. In seven,
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colonoscopy was performed to assess a 
questionable finding of barium enema. In 
11, the barium enema findings were nor­
mal and colonoscopy was performed in 
an effort to elucidate symptoms; finally, 
in 7, barium enema was not done, as 
colonoscopy was the primary procedure 
that led to the diagnosis of carcinoma. 
Ninety-five patients underwent some type 
of curative or palliative resection. One 
woman had a transanal excision of a 
small rectal lesion and four tumours were 
judged unresectable; we did an internal 
bypass of the tumour in three and the 
other had laparotomy only.
For analysis, patients were divided into 
two groups according to the site of the 
carcinoma: group 1,46 patients in whom 
the primary tumour was located in the 
right colon (cecum and ascending and 
transverse colon) and group 2, 54 patients 
who had primary tumour in the left colon 
(from the splenic flexure to the rectum). 
One patient had two primaries, one on 
each side of the colon, and was placed in 
group 1.
Preoperative colonoscopy was consi­
dered “ adequate” if the unresected por­
tion of the colon had been examined (i.e., 
in group 1 to the level of the ileocolonic 
anastomosis and in group 2 to the cecum).
Results
Preoperative colonoscopy was adequate 
in 50 patients (35 [76%] group 1 patients 
and 15 [28%] group 2). Reasons for 
inadequate examinations in both groups 
are listed in Table I. The technical failures 
were due either to fixation of the sigmoid 
colon by previous pelvic surgery or to 
excessive redundancy. In three instances, 
preoperative colonoscopy was inadequate 
because the resection was palliative, leav­
ing intact a portion of bowel proximal to 
the lesion that had not been visualized by 
endoscopy; all tumours were transverse 
colon primaries. In two patients with low 
rectal lesions, the pain was severe, and 
physical and endoscopic examinations 
had to be done under anesthesia, which 
limited the extent of the endoscopy. In 30 
group 2 patients the tumour narrowed the 
lumen to the extent that the endoscope
could not be passed. No complications 
occurred from the procedure.
Synchronous carcinomas were present 
in two patients, but since both were seen 
on barium enemas their finding cannot be 
credited to the colonoscopic inspection. 
Fifty-four benign adenomas were dis­
covered at colonoscopy in 29 patients: 
in 23 of the 50 who had adequate colono­
scopy and in 6 of the 50 who had inade­
quate colonoscopy. Thirty-two (59%) of 
these adenomas were less than 1 cm in 
dimension and of the other 22, 4 were 
greater than 2 cm. Their distribution 
throughout the colon is shown in Table 
II; the majority (80%) were located in the 
left colon.
Extension of the standard resection for 
one primary carcinoma was performed in 
the two patients with two primaries but 
cannot be credited to preoperative 
colonoscopy for the reason already men­
tioned. The adenomas were included in 
the standard resection for the malignant 
tumour in 12 patients. In 17, they were 
beyond the limits of the standard resec­
tion but were removed or judged to be 
removable at a later time by endoscopy 
in 13 patients. Therefore extension of the 
standard cancer resection was indicated 
in only four patients to include the benign 
adenoma(s), because of their size or ses­
sile configuration in three patients, and 
because of their number (seven) in the 
fourth.
Discussion
The concept of preoperative 
colonoscopy in colorectal carcinoma has 
evolved from the studies of synchro­
nous3'915 and metachronous16,17 tumours 
in the bowel. Several authors3,6 have 
stated that a metachronous lesion disco­
vered within 1 or 2 years of surgery is 
really a missed synchronous tumour. On 
the basis of 4884 cancer operations per­
formed between 1928 and 1970, investi­
gators at St. Mark’s Hospital have estab­
lished the incidence of synchronous 
carcinoma at 3%.18 This rate was further 
analysed by Heald and Bussey,9 who 
noted that in only 16% was the diagno­
sis of two cancers known to the surgeon 
preoperatively. Moreover, in 54%, the
second cancer was found only in the 
resected specimen. Colonoscopy has since 
re-established the incidence of syn­
chronous carcinoma at 5% .13 The fre­
quency of benign adenomas in patients 
suffering from colorectal carcinoma has 
been determined by pathological studies 
of operative specimens to be 28%.19 
Colonoscopy theoretically allows inspec­
tion of the entire large bowel and it is not 
surprising that the number of syn­
chronous adenom as should be 
greater,12,14 especially if we accept Cohen 
and Waye’s estimate20 that 10% of 
polyps are likely to be missed at the ini­
tial colonoscopic examination. The pur­
pose of our study was not to establish a 
similar or distinct rate for synchronous 
tumours but to put into a proper perspec­
tive both the limitations and benefits of 
systematic preoperative colonoscopy.
We thought it preferable to analyse a 
consecutive series of cases and, although 
limited to 100 patients, our study did not 
exclude a single case of colorectal cancer 
and in this way, differs from those previ­
ously published.
Reilly and associates,10 in a study of 
157 cases, 65 of which were examined 
postoperatively, reported a 7.6% inci­
dence of synchronous carcinoma. Their 
polyp yield (62%) seems elevated but was 
based on a 5-year follow-up. Maxfield,11 
who studied 114 cases but excluded 
incomplete examinations, reporting on 
90, gave an incidence of 4.4% and 40% 
for synchronous carcinomas and ade­
nomas respectively. The extension of 
resection is mentioned only for the 
patients with carcinoma. Pagana and 
colleagues12 studied 185 patients and 
reported on 157 after excluding the 
incomplete examinations. Their rates 
were 7.2% and 28.7% for synchronous 
carcinomas and adenomas. They also 
mentioned extension of the resection in 
11% of patients overall and in 26.3% of 
those with synchronous polyps, both 
figures being substantially higher than in 
our own experience. Langevin and 
Nivatvongs13 reported a 4.8% incidence 
of multiple carcinoma and 27.7% of syn­
chronous adenomas in 166 consecutive 
patients, a study that also excluded the 
incomplete examinations and was based 
on pre- and postoperative colonoscopic 
examinations. They also stated that 67% 
of the adenomas were found in anatomi­
cal segments of the colon distinct from
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the carcinoma, but they made no mention 
of the impact of these findings on the 
extent of resection. The most recent study 
by Thorson and colleagues14 with 176 
non-consecutive preoperative examina­
tions (excluding incomplete studies) 
reported rates for synchronous carcinoma 
and adenomas of 3.4% and 55.1%.
In our study we did not exclude any of 
100 patients and we also report on the so- 
called incomplete colonoscopy specifically 
to assess the feasibility of routine 
endoscopic examination of every patient 
with colorectal carcinoma.
Our definition of adequate rather than 
complete colonoscopy seems more 
appropriate for the purpose of preoper­
ative colonoscopy, since adequate 
colonoscopy asserts that no substantial 
benign or malignant tumour is left behind 
at operation. The word “ clearance” of 
the colon has been used by some6,21 to 
define this aim which can be divided in 
three components: (a) to determine the 
presence of more than one malignant 
lesion, (b) to discover benign adenomas 
that must be removed by extending the 
standard planned procedure and (c) to 
remove all endoscopically excisable ade­
nomas.
In that respect, we found a 29% inci­
dence of associated adenomas. This figure 
is in accordance with some of the previ­
ously mentioned figures, but rises to 46% 
if we include only the adequate examina­
tions. In 12 patients, the adenomas were 
to be part of planned surgical resection, 
but in only 4 of the remaining 17, was 
extension of the resection judged 
necessary.
Extension of a standard resection for 
a single malignant tumour as a subtotal 
or total abdominal colectomy has long 
been advocated for multiple carcinomas 
and for a single carcinoma associated with 
adenomas in a different segment.3'15 This 
recommendation still holds for multiple 
carcinomas especially when they are in 
separate segments9 but is debatable for 
synchronous adenomas.22 Colonoscopy 
allows removal of the majority of those 
adenomas and provides appropriate 
follow-up to remove newly formed ones. 
Extension of any standard resection to 
include adenomas in other segments 
should be reserved for those that would 
not be excisable endoscopically because 
of their size, configuration, possible 
malignancy or the risk of complications 
from the polypectomy.
The percentage of inadequate examina­
tions in our study seems elevated. 
Others11,12 have mentioned a high failure 
rate due to the obstructive nature of left­
sided colonic tumours. Most reports do 
not dwell extensively on incomplete 
colonoscopic examinations: they either 
exclude them13'14 or simply mention 
them when they are done postoperatively.
Conclusions
Physicians attempting routine preoper- 
tive colonoscopy in patients with colorec­
tal carcinoma should expect an overall 
adequacy rate of 50%: 76% in tumours 
of the proximal half of the bowel and 
20% in tumours of the distal half.
Synchronous adenomas will be present 
in up to 46% of patients in which the 
colonoscopy is adequate.
Extension of the standard cancer oper­
ation to include adenomas will be needed 
in 4%, which represents 14% of the 
patients with additional adenomas.
Because of the high rate of adenomas 
found when preoperative colonoscopy 
was adequate, we recommend interval 
postoperative colonoscopy in patients in 
whom preoperative colonoscopy could 
not adequately be performed.
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The exam inations o f the Royal College 
are held in September o f each year. Can­
didates w ish ing to s it fo r the exam ina­
tions should note the fo llo w in g :
1. Every candidate fo r admission to  the 
exam inations m ust subm it an app li­
ca tion fo r assessment o f tra in ing .
2. Candidates in tra in ing  in Canada 
should apply fo r prelim inary assess­
m ent o f tra in ing at least one year 
before the date on w hich they expect 
to  s it fo r the exam inations, th a t is to  
say not later than September 1 o f the 
preceding year. Candidates w ho have 
had training outside o f Canada should 
subm it the ir in itia l application fo r 
assessment at least 18 m onths 
before they expect to  s it fo r the exa­
m inations, tha t is by March 1 o f the  
preceding year. Only candidates 
w hose assessment o f credentia ls is 
com ple te  w ill be accepted to  s it fo r 
the examinations.
3. Candidates w ho desire to  s it fo r  an 
exam ination, having com plied w ith  
the above requirement o f prelim inary 
assessment o f tra in ing , m ust n o tify  
the Royal College in w ritin g  o f the ir 
in te n t before February 1 o f the  year 
o f the  exam ination. Upon rece ip t o f 
th is  notice o f in ten t, the evaluation 
o f the  ca nd ida te 's  pe rfo rm ance  
during tra in ing w ill be added to  the 
previously completed assessment of 
credentials. Each candidate w ill then  
receive no tifica tion  as to  e lig ib ility  
together w ith  an application fo rm  fo r 
adm ission to  the exam ination to  be 
com pleted and returned.
4. The fo llow ing  docum ent m ay be 
obtained from  the Royal College 
o ffice :
(a) Application form s fo r assessment 
o f train ing;
(b) General in fo rm ation  bookle t on 
tra in ing requirem ents and exam i­
nations;
(c) Specific requirements fo r tra in ing  
and regulations relating to  the 
exam inations o f each specia lty . 
Requests should indicate the spe­
c ia lty  or specialties o f in te rest to  
the applicant;
(d) Listing o f specia lty  tra in ing  pro ­
grams in Canada accredited by 
the Royal College.
5. Address all enquires to:
Dr. R.F. Maudsley, Director, 
Office of Training and Evaluation, 
The Royal College of Physicians 
and Surgeons of Canada 
74 Stanley,
Ottawa, Canada 
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(613) 746-8177.
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MORE CONFIDENCE IN A N T I T H R O M B O T IC  TH ER A PY
New Guidelines for 
Antithrombotic Therapy 
In Surgical Cases
The American College of Chest Physi­
cians and the National Heart, Lung and 
Blood Institute recently issued new 
guidelines for antithrombotic therapy.1 
There were four Grade A recom­
mendations for the use of warfarin 
(Coumadin®) in surgical cases. In each 
of these four (and other Grade A and B 
recommendations for Coumadin®) a PT 
ratio of 1.2-1.5 (rabbit brain) was 
emphasized for clinical efficacy and 
reduced side-effects risk.
INDICATIONS: Elective hip surgery/ 
surgery for fractured 
hips.
"  . . . patients undergoing elective hip surgery 
should be pretreated prophylactically with 
adjusted-dose heparin or moderate-dose war­
farin sodium . .
. patients undergoing surgery for fractured 
hips should be treated prophylactically with 
moderate-dose warfarin.
INDICATION: Prophylaxis of venous 
thromboembolism.
"It is strongly recom m ended that the 
therapeutic range for prophylaxis . . . in high- 
risk medical or surgical patients should be 
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Portal Vein Injury
With the increasing number of traumatic 
injuries being seen in emergency depart­
ments, physicians must be aware of the 
less common and less obvious types of 
serious injury. Portal vein injury is seri­
ous (death rate 50%) and may be diag­
nosed only at laparotomy. Fortunately 
this injury is rare. Its management can 
be difficult, but an awareness of the 
possible methods of treatment could be 
life-saving. The authors report their 
experience with this injury and survey 
the literature on the subject.
Comme les salles d'urgence voient de 
plus en plus de blessures individuelles, il 
est important de pouvoir reconnattre cer- 
taines lesions moins frequentes. Une 
atteinte a la veine porte est heureuse- 
ment assez rare. Elle peut n'etre recon- 
nue qu'a la laparotomie. Son exploration 
et sa reconstruction peuvent etre 
difficiles, et une bonne connaissance des 
resultats possibles du traitement peut 
etre vitale, cette lesion entramant une 
mortalite de 50%. Les auteurs font part 
de leur experience personnels et presen- 
tent une revue des autres travaux deja 
publies.
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Published reports of portal vein injury are 
uncommon, possibly because of the rar­
ity of the injury or because such patients 
often die o f exsanguination before surgi­
cal exploration can be carried out. We 
report three cases, review the literature 
and discuss the possible methods of 
managing this injury.
Case Reports
Case 1
A 36-year-old man was admitted to the emer­
gency department with a knife wound to the 
right upper abdomen. On examination he was 
unresponsive and there was no blood pressure. 
There was little response to attempted resus­
citation  so he underw ent im mediate 
laparotomy. The knife wound was seen to 
penetrate the liver and there was a large hema­
toma around the free edge of the gastrohepatic 
omentum. This area was rapidly cleared and 
a severed posterior superior pancreaticoduo­
denal artery ligated. Continued bleeding, on 
further exploration, was found to be coming 
from the portal vein. Finger compression was 
applied to the area while adequate dissection 
of the vein was carried out to control the bleed­
ing. Anterior and posterior lacerations of the 
portal vein, behind the head of the pancreas, 
were repaired by lateral venorrhaphies. Fur­
ther exploration of the area, including the right 
renal vessels, revealed no abnormalities. The 
abdomen was closed and the patient made an 
uncomplicated recovery. A total of 8.6 L of 
fluid was given intravenously; this included 
2 L of saline given immediately on admission 
and 3 L of blood.
Case 2
Twenty-four hours after the patient in case 
1 was admitted, a 13-year-old boy was trans­
ferred from a hospital 250 km away with a 
knife wound in the right upper abdomen. He 
had already received 2 L of crystalloid solu­
tion intravenously. On arrival, his blood pres­
sure was 70/50 mm Hg and his pulse rate 150 
beats/min. Laparotomy again revealed a large 
hematoma in the area of the porta hepatis, and 
exploration uncovered the following injuries: 
a through-and-through stab wound to the left
branch of the portal vein at the porta hepa­
tis, a tear in the anterior wall of the inferior 
vena cava and a completely severed left hepatic 
duct. The Pringle maneuver was used to con­
trol bleeding from the portal vein to permit 
lateral venorrhaphy of the inferior vena cava 
and exposure of the proximal portal vein. 
Fogarty balloon catheters were only moderately 
successful in controlling back bleeding in the 
right and left portal veins. Intermittent finger 
pressure was therefore necessary until the left 
branch of the vein was repaired, again by 
lateral venorrhaphies. The left hepatic duct was 
repaired over a stent and the abdomen was 
closed. Blood loss was estimated to be 5 L. The 
patient was given 7 L of crystalloid fluid and 
eight units of blood as replacement. He had 
a smooth recovery. A T-tube cholangiogram 
before discharge showed that the duct repair 
was satisfactory and when seen at 6-month 
follow-up he was well.
Case 3
During the course of a subtotal pancreatec­
tomy for intractable pain in a 61-year-old man 
with chronic pancreatitis, the portal vein was 
inadvertently injured at its origin. Both ends 
were immediately controlled by vascular 
clamps and the subtotal pancreatectomy was 
completed. An attempt at end-to-end anasto­
mosis was not successful as the gap between 
the superior mesenteric vein and the portal vein 
itself was too great. The segment of splenic 
vein, removed with the specimen, was dissected 
off the tail of the pancreas and used as an inter­
position graft. Flow through the graft was 
satisfactory. A superior mesenteric angiogram 
3 months later showed, in the venous phase, 
that the interposition vein graft was patent and 
of normal calibre. Blood loss during this proce­
dure was 2 L.
Discussion
The portal vein averages 2 cm in 
diameter, has a blood pressure o f 10 mm 
Hg and a flow rate o f approximately 1 
L/min. Injury to this vein therefore will 
almost certainly result in hypovolemic 
shock. Review o f the literature and our 
own experience confirms that this is the 
usual clinical picture. Fifty percent of 
these patients will have a temporary
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initial response to resuscitation with intra­
venous fluids, while the remainder will 
fail to respond before laparotomy and 
control of the bleeding.
Again, review of the literature and our 
two trauma cases, show that at least one 
other organ will be injured (Table I), and 
70% of these organs will be other major 
vascular structures, giving an overall 
death rate of 46% in the reported cases. 
Because of the seriousness of this injury 
there are very few preoperative diagnos­
tic measures on record; the diagnosis is 
usually made only at the time of 
laparotomy, where rapid control of bleed­
ing is the obvious but often difficult solu­
tion. It may be necessary to cross-clamp 
the aorta below the diaphragm to achieve 
local control and permit the patient’s con­
dition to be stabilized. Exploration of the 
portal vein itself requires adequate 
mobilization of the duodenum enhanced 
by division of the cystic duct with even­
tual cholecystectomy, thus allowing more 
mobilization of the structures in the porta 
hepatis. If the injury lies behind the neck 
of the pancreas, division of that organ 
will be required.
There are various methods of dealing 
with portal vein injury (Table II). Lateral 
venorrhaphy, if possible, gives an excel­
lent result. The portal vein will frequently 
have a through-and-through injury mak­
ing lateral venorrhaphy more difficult, 
but narrowing of the vein is acceptable 
under these circumstances.
When lateral venorrhaphy is not feasi­
ble, Stone,1 in his latest series, considers 
ligation to be the method of choice. In his
Table I—Other Organs and Arteries Injured in 
Conjunction With Portal Venous Injuries (in 
Descending Order of Frequency)
Stomach
Liver
Inferior vena cava
Duodenum
Pancreas
Small bowel
Colon
Aorta
Spleen
Bile ducts
Kidney
Hepatic artery 
Superior mesenteric artery
last 10 cases, treated by ligation, the death 
rate was lowered to 20%.
End-to-end anastomosis is rarely pos­
sible but obviously would restore con­
tinuity.
Free interposition grafting, using either 
a vein or a synthetic graft, would appear 
to be ideal, where appropriate, but to our 
knowledge this procedure has only been 
carried out on three occasions. In the ser­
ies of Petersen and colleagues,2 and in 
our third case, the splenic vein was used. 
Other veins available for grafting in the 
abdomen are the inferior mesenteric or 
the left renal vein, while the internal jugu­
lar or the long saphenous vein are avail­
able from the periphery. On the one occa­
sion when a synthetic graft was used it 
thrombosed necessitating exploration the 
following day, but the patient died.3
Control of bleeding is certainly the 
most difficult problem and although 
cross-clamping of the aorta will slow the 
flow of blood, retrograde bleeding will 
continue to be a problem. Use of Fogarty 
balloon catheters may help locally in the 
portal vein, but the Pringle maneuver 
likely will be the most useful method of 
local control until dissection and vascu­
lar clamps or catheters can be used at a 
distance. It may be necessary to defer 
management of the injury to the portal 
vein while other major vascular structures 
(the inferior vena cava, the aorta, or the 
renal vessels) are being repaired. 
Although Stone’s results with ligation 
were excellent, there is no long-term 
follow-up of the effects of portal vein 
ligation, his follow-up of 3 years without 
problems being the longest reported. 
When the portal vein is ligated, overtrans­
fusion is necessary because of the pool­
ing of blood in the portal system leading 
to systemic hypovolemia. Johnstone4 
recorded a 50% reduction in the circulat­
ing blood volume of experimental animals 
after ligation of the portal vein. Starzl and 
colleagues5'6 indicated possible endocrine 
deprivation of the liver and showed that 
insulin is required for the total integrity 
of the liver cells. Neidner and Mattes 
(quoted by Hubbard7) and Patton and 
Johnson8 reported the development of 
portal hypertension with its consequences 
in patients who had previously undergone 
ligation of the portal vein due to injury. 
Chisholm and Lenio3 reported thrombo­
sis of the portal venous system after liga­
tion and suggested a second-look proce­
dure, after 24 hours, to exclude this and 
to assess the bowel for areas of vein 
thrombosis and infarction.
If the patient’s condition permits, an 
interposition graft should be considered 
when safe closure of a portal vein injury 
is impractical. Busuttil and associates9 
and Petersen and colleagues2 used this 
method with apparently excellent results.
Synthetic grafts are unsatisfactory in 
this situation.
Conclusions
The preoperative, perioperative and 
intraoperative management of portal vein 
injury is a formidable undertaking, car­
rying a death rate of 50%. For the sur­
geon who is not well versed in vascular 
surgery, ligation appears to be the method 
of choice, but lateral venorrhaphy, when 
possible, will give a much more satisfac­
tory result. If Starzl and colleagues5,6 are 
correct in suggesting that there is a fac­
tor that is necessary for the integrity of 
liver cells, and since the long-term effects 
of ligation are unknown, vascular recon­
struction using a vein graft should be con­
sidered whenever possible.
As reported in the literature, portacaval 
shunting under these circumstances car­
ries an extremely high incidence of 
encephalopathy and should not be con­
sidered as an immediate method of 
management. Patient survival is para­
mount, secondary problems such as por­
tal hypertension can be dealt with later.
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Direct Effects of Autotransfused Blood on Myocardial Muscle
Mechanics in Man
Homologous blood transfusions carry 
risks — febrile reactions, isoimmunization 
incompatibility reactions and transmis­
sion of infectious diseases such as AIDS 
and hepatitis. Although autotransfusion 
techniques will reduce the need for 
banked homologous blood, autologous 
shed blood does contain various cellular 
fragments that may act directly as 
myocardial depressants. Accordingly, the 
myocardial muscle mechanical properties 
of isolated human right atrial trabeculae 
contracting in vitro were measured in a 
bath containing either blood collected in 
the Sorensen ATS Autotransfusion 
Receptal unit or arterial autologous 
blood. Muscles were tested randomly in 
each solution by measuring their isomet­
ric resting and developed forces and the 
mean rate of developed force at different 
stimulation rates (force-frequency rela­
tion). In addition, biochemical, hemato­
logic and immunologic assays were per­
formed on each blood specimen. 
Significant increases (p < 0.05) in 
potassium and plasma-free hemoglobin 
indicated that cell disruption had 
occurred in blood collected in the 
autotransfusion apparatus; however, 
there was no statistically significant 
difference in mechanical performance 
between muscles contracting in either 
solution. From these results, the authors 
conclude that autotransfused blood does 
not directly affect human heart-muscle 
mechanics.
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La transfusion de sang homologue 
entraine certains risques — reactions 
febriles, iso-immunisation, reactions 
d'incompatibilite et transmission de mala­
dies infectieuses telles que le SIDA et 
I'hepatite. Meme si les techniques 
d'autotransfusion peuvent reduire les 
besoins en reserves de sang homologue. 
le sang autologue renferme divers frag­
ments cellulaires susceptibles d'agir 
directement comme depresseurs du myo- 
carde. En consequence, on a etudie les 
proprietes mecaniques du myocarde en 
mesurant in vitro les contractions des 
colonnes charnues de coeur humain iso­
lees dans un bain renfermant soit du 
sang recueilli a I'aide d'un recipient 
d'autotransfusion Sorensen ATS, soit du 
sang arteriel autologue. Les muscles ont 
ete testes au hasard dans chacune des 
solutions par la mesure des forces iso- 
metriques de repos et d'effort, et le taux 
moyen de la force developpee a divers 
frequences de stimulation (rapport 
force-frequence). De plus, des epreuves 
biochimiques, hematologiques et immu- 
nologiques ont ete effectuees sur chaque 
echantillon de sang. Des augmentations 
significatives (p < 0.05) du potassium et 
de I'hemoglobine libre de plasma indi- 
quaient qu'il y avait eu bris cellulaire 
dans I'equipement d'autotransfusion. 
Neanmoins, on n'a enregistre aucune dif­
ference significative de fonctionnement 
mecanique entre les muscles qui se con- 
tractaient dans I'une ou I'autre des solu­
tions. A  partir de ces resultats, les 
auteurs concluent que le sang autotrans­
fuse n'affecte pas directement la mecani­
que du muscle cardiaque humain.
In our institution, up to one-third of all 
banked blood is used for cardiovascular, 
thoracic and trauma surgery. There is 
increasing concern over the risks of using 
banked blood and the rising costs of 
processing. To reduce the amount of 
blood used, autotransfusion has become 
popular, especially in cardiac surgery 
where notable conservation has been
achieved.1 However, autotransfusion 
carries potential risks.2 Autotransfused 
blood contains products of cellular autol­
ysis that may affect hemodynamics, either 
directly or indirectly. The administration 
of autotransfused blood is sometimes 
accompanied by a marked decrease in 
blood pressure. This may result from the 
release of vasoactive products acting 
alone, peripherally, or combined with 
electrolyte changes, or acting directly as 
myocardial depressants. The direct effect 
of autotransfused blood has not been 
assessed. The purpose of this study was 
to evaluate the direct myocardial 
inotropic responses to autotransfused 
blood using one of the clinically availa­
ble units.
Material and Methods
The atrial muscles and blood Used for 
this study were taken from eight patients 
(five men, three women) who underwent 
coronary artery bypass grafting. Patients 
ranged in age from 44 to 70 years (mean 
± SEM, 51.3 ± 3.3 years).
The Sorensen Mediastinal ATS Recep­
tal System (Sorensen Research Corp., Salt 
Lake City, Utah) was evaluated at the 
University of Ottawa Heart Institute on 
patients who underwent open-heart sur­
gery. Right atrial appendages were taken 
from consenting patients at the time of 
cardiopulmonary bypass. As cannulation 
was proceeding, the Receptal unit was 
connected to the cardiotomy suction 
apparatus by way of plastic tubing (the 
system was used in accordance with the 
manufacturer’s specifications). Patients 
were heparinized (300 mg/kg) before 
cardiopulmonary bypass was instituted 
and blood was suctioned from the 
pericardial cavity and mediastinum 
directly into the Receptal unit. This 
arrangement was designed to assess the 
effects of the Receptal unit on blood, 
independent of the damaging effects of 
the cardiopulmonary bypass circuit. The 
appendage and two blood samples (100 
ml of suctioned blood and 50 ml of the 
patient’s heparinized arterial blood) were
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sent to the laboratory. The blood samples 
were analysed for their electrolyte com­
position (Technicon SMAC; Technicon 
Instruments Corp., Tarrytown, NY), 
hemoglobin content (Coulter counter, 
Model S-Plus IV; Coulter Electronics 
Inc., Hialeah, Fla.) and serum comple­
ment levels — C3 and C4 with the Beck­
man ICS Analyze II (Beckman Instru­
ments Inc., Toronto, Ont.) and CH50 by 
hemolytic assay.
Myocardial performance was assessed 
using individual trabeculae isolated from 
the patient’s right atrial appendage. The 
muscles were placed between two 
stainless-steel clips of a muscle stand. The 
upper clip was attached to a force trans­
ducer (Statham-Gould UC-2; Statham 
Instruments, Oxnard, Calif.) whose out­
put was amplified and recorded on a 
writer-recorder (Grass, model 7 poly­
graph; Grass Instruments, Quincy, 
Mass.). Muscles were immersed in a mus­
cle bath containing a buffered Tyrode’s 
solution aerated with 95% oxygen and 
5% carbon dioxide and maintained at 
34°C by a water-jacketed thermoregulat­
ing system. Field stimulation (Grass 
stimulator, model S88) was used to induce 
isometric contractions using square-wave 
pulses 5 to 10 milliseconds in duration at 
voltages 20% greater than that required 
to elicit a maximal response. Muscles were 
first lightly preloaded and stimulated at 
0.1 Hz for 30 minutes then at 1 Hz for 
15 minutes. Muscles were stretched until 
maximum force developed (Lmax, peak 
of Frank-Starling relation) and then 
maintained at this length for the duration 
of the experiment. Conditions and proce­
dures have already been reported.3
Muscle mechanical performance was 
measured from isometric contractions in 
terms of isometric resting force (RF) and 
developed force (DF) and mean rate of 
developed force (MRDF). Once muscles 
had equilibrated for 10 minutes, the bath 
was drained and replaced with either the 
arterial blood or the Receptal blood in 
random fashion. After a 10-minute 
equilibration period, a frequency-force 
relation was determined by stimulating 
the muscle at different frequencies ran­
domly; 0.5, 1.0, 1.5, 2.0 and 2.5 Hz. The 
muscle was allowed to contract for 2 
minutes before measurement of RF, DF 
and MRDF at each frequency. When 
the frequency-force measurements were 
completed, the bath was again drained 
and replaced with the remaining blood 
solution (either arterial or Receptal unit).
Statistical analysis of the muscle 
mechanical and blood test results was per­
formed using a paired /-test. Probability 
values less than 0.05 were considered sig­
nificant. At the time of cannulation, some 
saline was introduced into the pericardial 
cavity. Results of the complement test 
were corrected for dilution by multiply­
ing the Receptal unit results by a correc­
tion factor (arterial hemoglobin/ Receptal 
hemoglobin).
Results
The eight trabeculae used in this study 
had an average muscle length of 6.44 ± 
1.05 mm at Lmax, a weight of 6.54 ±
1.01 mg, and a calculated cross-sectional 
area of 0.93 ± 0.09 mm2. Control mus­
cle mechanical measurements in Tyrode’s 
solution at a stimulation rate of 1.0 Hz 
were 0.19 ± 0.05 g RF, 1.30 ± 0.08 g 
DF and 13.05 ± 0.71 g/s MRDF.
A comparison of the RF, DF and 
MRDF between Receptal and arterial 
blood at each frequency revealed no 
statistically significant differences (Fig. 
1) .
There were significant differences in 
concentrations of electrolytes between 
samples from the Receptal unit and 
arterial blood. The most striking differ­
ence was seen in potassium concentration 
(5.3 versus 3.9 mmol/L [mean values] in 
Receptal and arterial blood, respectively) 
(Fig. 2).
The total hemoglobin level was signifi­
cantly lower in the Receptal blood than 
arterial blood (92 g/L versus 110 g/L). 
Plasma free hemoglobin concentration 
was higher in the Receptal blood (3.2 g/L 
versus 0.12 g/L) (p < 0.05). C3, C4 and 
CH50 were corrected for dilution. The 
differences between Receptal and arterial
FIG. 1—Myocardial mechanical results 
(mean ± SEM) of human atrial trabeculae 
contracting on arterial (white bars) blood 
and to blood collected by Receptal unit 
(dotted bars).
blood were not statistically significant 
(Fig. 3).
Discussion
Autotransfusion reduces homologous 
blood transfusion requirements1,2,4 and 
was popularized in the 1960s in Viet­
nam.5 With respect to cardiac surgery, 
41.7% of the patients in our institution 
bled more than 500 ml in the first 4 hours 
after surgery (unpublished data), a large 
percentage who may require blood trans­
fusions. Schaff and colleagues1 demon­
strated a 50% reduction in the use of 
banked blood when patients who bled 
more than 400 ml in the first 4 hours 
postoperatively were autotransfused 
(52.3% of patients). Cosgrove and 
coworkers6 at the Cleveland Clinic 
reported that more than 60% of patients 
who underwent cardiac surgery did not 
require banked blood transfusions as a 
result of autotransfusion. These results 
are impressive.
The risks of homologous blood trans­
fusion are well known. They include 
febrile reactions, isoimmunization, 
incompatibility reactions and transmis­
sion of infectious diseases such as hepa-
FIG. 2—Electrolyte data (mean ± SEM) for 
serum sodium, chloride, potassium and cal­
cium. White bars = arterial blood, dotted bars 
= Receptal blood.
Total Hb Plasma Hb C3 C4 CH50
(g/L) (g/L) (g/L) (g/L) (x1Cr3U/L)
* p  < 0 .05
FIG. 3—Hemoglobin and complement levels 
(mean ± SEM) from arterial (white bars) and 
Receptal (dotted bars) blood. (Note: Receptal 
complement values have been corrected for 
dilution.)
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titis and AIDS. There may also be 
problems with coagulation disorders and 
citrate toxicity. Autotransfusion has its 
own risks. They include sepsis, microem­
bolism, hemolysis, thrombocytopenia, 
coagulopathies and renal failure.5
Although it is now clear that there are 
increasing risks and costs associated with 
banked blood transfusions, there are 
numerous questions to be resolved con­
cerning the considered alternative. 
Autotransfused blood has increased 
plasma-free hemoglobin levels1'7 as a 
result of hemolysis. With cellular disrup­
tion there is a release of intracellular con­
stituents including electrolytes, enzymes 
and hemoglobin. Electrolyte changes 
affect myocardial performance8 and 
there is the possibility that other released 
factors may have myocardial depressant 
actions. This study tried to assess the pos­
sible direct effects that autotransfused 
blood might have on myocardial perfor­
mance.
The Receptal unit was used in such a 
way that its effect on blood could be 
assessed directly without the derange­
ments created by passing blood through 
the cardiopulmonary bypass system. The 
protocol for this study used samples of 
fresh arterial blood and the right atrial 
appendage from the same patient. To test 
the effects of mediastinal shed blood col­
lected postoperatively, the patient’s own 
appendage would not be of use since 
information (unpublished data) indicates 
that the mechanical performance of this 
unique preparation would deteriorate 
with time and thus limit its capacity to 
evaluate the inotropic properties. We 
recognize that blood collected from the 
mediastinum postoperatively contains 
more cellular debris than the blood tested 
in the present study, but our primary con­
cern was to evaluate the Receptal unit 
itself. Although the results indicate that 
the unit will not produce or induce a nega­
tive inotropic response, further experi­
ments with a different protocol may be 
warranted to evaluate the combined 
effects of the Receptal unit and mediasti­
nal shed blood. At the time of cannula- 
tion, saline introduced into the pericardial 
cavity diluted the blood collected in the 
Receptal unit, leading to a small but 
important rise in sodium and chloride and 
a decrease in calcium. Also there was a 
marked increase in potassium, which was 
underestimated because of the dilutional 
effect of the saline and presumably was 
a result of hemolysis. While the total 
hemoglobin value was reduced in the 
Receptal blood (due to dilution), plasma 
free hemoglobin was markedly increased. 
Changes in complement levels did not 
reach statistical significance which is sur­
prising since contact with foreign surfaces 
is supposed to be a major activating fac­
tor as seen with cardiopulmonary 
bypass.9'10 This finding might suggest
that the physical trauma of cardiopulmo­
nary bypass (bubble oxygenation and 
roller pumping) is the culprit in comple­
ment activation.
A useful way to study the impact of the 
above changes in blood composition on 
cardiac function is using isolated 
myocardial muscle contracting in vitro. 
It has been demonstrated that the relation 
between frequency of activation of 
human atrial muscle and the force of con­
traction describes a fundamental property 
of this tissue11-12 and has been termed the 
Bodwitch phenomenon. Using this tech­
nique, we could find no difference in the 
contractile performance of human atrial 
trabeculae either in Receptal or arterial 
blood, despite differences in their com­
position. This leads us to suggest that any 
changes in hemodynamics due to 
autotransfusion are more likely to be 
indirectly or peripherally mediated. It 
should be noted that these trabeculae were 
adequately oxygenated so that the results 
from these studies may only be valid for 
normoxic hearts in the postoperative sit­
uation.
We thank Mrs. Diane Ayres for her techni­
cal assistance in performing these studies and 
Miss Maura Watson for her assistance with the 
graphs in this manuscript.
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SESAP V Question
3. An 11-year-old boy arrives in the emergency department after trau­
matic amputation of the right middle fingertip. An open wound through the 
pulp measures 1 cm in diameter. No bone is exposed. Appropriate treatment 
for this injury is
(A) split-thickness skin graft to the wound
(B) removal of the distal third of the distal phalanx with primary 
closure
(C) full-thickness skin graft from the postauricular area
(D) occlusive dressings
(E) cross-finger flap from the dorsal skin of the ring finger
For the incomplete statement above, select the one completion that is best of 
the five given.
For the critique of Item 3 see page 131.
(Reproduced by permission from SESAP V Syllabus; Surgical Education and 
Self-Assessment Program No. 5. For enrolment in the Surgical Education and 
Self-Assessment Program No. 5, please apply to the American College of Sur­
geons, 55 East Erie St., Chicago, IL 60611.)
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Surgical Treatment of Bronchogenic Carcinoma: 
the Importance of Staging in Evaluating Late Survival
From 1971 to 1980, 1292 patients with 
lung cancer were admitted to the Hdpital 
du Sacre-Coeur de Montreal. This diag­
nosis represented 0 .5 %  of admissions 
in 1971 and 1 .7%  in 1980 (240%  
increase). Only 4 %  of patients were 
nonsmokers. Patients ranged in age from 
30 to 93 years with a male to female 
ratio of 5.5 to 1.
Of 414 cervical mediastinoscopies car­
ried out for right and left pulmonary 
tumours, 120 (29% ) showed mediastinal 
lymph-node metastasis (positive biopsy). 
For 35 left-sided lesions, both cervical 
and left parasternal mediastinoscopies 
produced 13 (37% ) positive biopsies.
For 45 left upper lobe and left hilum 
tumours, left parasternal mediastinos­
copy alone yielded 18 (4 0 % ) positive 
biopsies. Only 297 (23% ) of the 1292 
patients were considered to have opera­
ble lesions and they underwent thoraco­
tomy —  164 (5 5 % ) lobectomies, 104 
(3 5 % ) pneumonectomies, 2 (1 % ) seg- 
mentectomies and 27 (9 % ) exploratory 
thoracotomies.
The most common postoperative com­
plication was respiratory failure —  in 27 
cases (9 % ); there were 12 (4 % ) bron­
chopleural fistulas. The operative death 
rate was 5 %  —  1.8%  for lobectomy, 
7 .4 %  for exploratory thoracotomy and 
9 .6 %  for pneumonectomy. Causes of 
death were respiratory failure (60%  of 
the deaths), hemorrhage (1 3 % ), cardiac 
events (13% ) and bronchopleural fistula 
(1 3 % ). The overall 5-year survival was 
9 .2 % . For the 297 patients operated on, 
the survival at 5 and 10 years was 55%
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and 36% for stage I disease, 30%  and 
2 0 %  for stage II disease and 10% and 
8 %  for stage III disease, respectively.
The mean postoperative follow-up was 
41.5 months (range from 3.5 to 14 
years). The incidence of cancer of the 
lung is still increasing. Pre-treatment sta­
ging according to the TNM  system is 
essential. Long-term survival is related to 
the stage of the disease at the time of 
surgical treatment. Pneumonectomy is 
associated with a relatively high death 
rate.
De 1971 a 1980, 1292 patients avec 
cancers du poumon furent admis a 
I'Hopital du Sacre-Coeur de Montreal. 
Cette pathologie representait 0 .5%  des 
admissions en 1971 et 1.7%  en 1980, 
pour une augmentation de 240% . La 
moyenne d'age des patients etait de 61 
ans, variant de 30 a 93 ans et seulement 
4 %  des patients etaient non fumeurs. Le 
rapport homme-femme 6tait 5.5:1. Dans 
revaluation preoperatoire, des 414 
mediastinoscopies cervicales pratiquees 
pour des tumeurs pulmonaires droite et 
gauche, 120 (29% ) ont demontre des 
metastases ganglionnaires mediastinales 
(biopsies positives). Pour 35 tumeurs du 
poumon gauche, des mediastinoscopies 
cervicales et parasternales ont resulte en 
13 (37%) biopsies positives, tandis que 
pour 45 lesions du lobe sup6rieur gauche 
et du hile gauche, seule une mediastinos- 
copie parasternale gauche fut pratiquee, 
donnant lieu a 18 (4 0 % ) biopsies positi­
ves. De tous les patients, seulement 297 
(23% ) furent consideres comme opera­
te s : 164 (5 5 % ) ont subi une lobecto- 
mie, 104 (3 5 % ) une pneumonectomie, 2 
(1 % ) une segmentectomie et 27 (9% ) 
une thoracotomie exploratrice.
La complication postoperatoire la plus 
frequente fut I'insuffisance respiratoire 
dans 27 cas (9 % ); 12 (4 % ) fistules 
broncho-pleurales furent relevees. La 
mortality postoperatoire fut de 5% :
1 .8%  pour les lobectomies, 7 .4%  pour 
les thoracotomies exploratrices et 9.6%  
pour les pneumonectomies. Les causes 
de dec&s furent I'insufficance respiratoire 
(60% ), l'h6morragie (1 3 % ), une fistule
broncho-pleurale (13% ) et d'origine 
cardiaque (1 3 % ). La survie globale a 5 
ans, des 1292 patients, fut de 9 .2% .
Pour les 297 cas chirurgicaux, la survie a 
5 ans et a 10 ans fut de 55%  et 36%  
pour les stades I, de 30%  et 20%  pour 
les stades II et de 10% et 8 %  pour les 
stades III, respectivement. La relance 
moyenne fut de 41.5 mois allant de 3.5 
a 14 ans. L'incidence de cancer du pou­
mon continue d'augmenter dans notre 
centre hospitalier. Nous concluons que la 
stadification selon la methode TNM est 
essentielle, que la survie 6 long terme 
est reliee au stade de la maladie au 
moment du traitement et que la pneu­
monectomie est associee a un taux 
relativement eleve de mortality.
The occurrence of lung cancer is still 
increasing annually at an incredible rate, 
especially for women. It is a worldwide 
problem, particularly in industrial coun­
tries. For annual death rate, Canada 
ranks 17th in the world for men and 11th 
for women.1
The published results of treatment have 
varied greatly over the years, but with 
more uniform staging of the disease, it is 
becoming easier to evaluate and to com­
pare results.
The purpose o f this study was to evalu­
ate our results of surgery for lung carci­
noma, using the staging method of the 
American Joint Committee for Cancer 
Staging and End Results Reporting.2
Method
We reviewed the medical records of 
1292 patients with bronchial carcinoma 
admitted to the Hopital du Sacre-Coeur 
de Montreal, from Jan. 1, 1971 to Dec. 
31, 1980. Our study was limited to 
patients with histologically or cytologi- 
cally confirmed carcinoma of the lung 
according to the World Health Organi­
sation classification.3'4 Data on the sex 
of patients, age at time of diagnosis and 
history of cigarette smoking were tabu­
lated.
Patients were staged according to the 
methods of the American Joint Commit-
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tee for Cancer Staging and End Results 
Reporting.2 Patients who were possible 
candidates for surgery underwent further 
staging procedures. Early in the series, 
concurrent scalene-node biopsy and cer­
vical mediastinoscopy were done rou­
tinely, but the former procedure was 
discontinued5 because of the low yield of 
positive biopsies. Beginning late in 1974, 
left parasternal mediastinoscopy was 
added as a staging procedure for left­
sided tumours. Later, left parasternal 
mediastinoscopy alone was carried out for 
left upper lobe tumours as pre-treatment 
staging of mediastinal lymph nodes. 
Some results and the surgical technique 
of this procedure were reported previ­
ously.6
Mediastinal node metastasis (positive 
biopsy) at mediastinoscopy and a 
preoperative diagnosis of small-cell 
tumour were considered contraindications 
to surgery. All patients who underwent 
thoracotomy had routine intraoperative 
staging with sampling of nodes from the 
bronchopulmonary area, hilum and medi­
astinum. Positive mediastinal node biopsy 
at the time of thoracotomy was not neces­
sarily a contraindication to resection. All 
postoperative hospital deaths were 
included in the surgical death rate.
Data were entered on a CYBER-70 
(Control Data, Arden Hills, Minn.) for 
validation and statistical analysis. The 
SPSS (Statistical Software for Social 
Sciences) was used to perform actuarial 
analysis which was based on the method
described by Berkson and Gage.7 The 
differences between the actuarial distri­
butions were compared by the x2 test, 
using Lee and Desu’s algorithm.8
The accuracy of mediastinal node stag­
ing by cervical mediastinoscopy, left 
parasternal mediastinoscopy and by both 
techniques, was evaluated using the 
method of Galen:9 sensitivity = TP/(TP 
+ FN); specificity = T N / 
(TN + FP); efficiency = (TP + 
TN)/(TP + TN + FP + FN); pre­
dictive value of a positive test = TP/(TP 
+ FP); predictive value of a negative test 
= TN/(TN + FN), where TP is true 
positive, FN is false negative, TN is true 
negative and FP is false positive.
Findings
Patient Data
Of the 1292 patients, 199 were women, 
giving a male to female ratio of 5.5:1. Of 
19 415 patients admitted to our hospital 
in 1971, 87 (0.5%) bore this diagnosis, 
compared with 280 (1.7%) of 16 098 in 
1980, for an increased incidence of 240%. 
In 1971, 7% (4 of 59) of newly diagnosed 
cases of lung cancer were in women com­
pared with 20% (33 of 168) in 1980. The 
average age of the group was 61 years 
(ranging from 30 to 93 years). Data on 
smoking habits were available for 1122 
(87%) patients. Only 4% (45) had never 
smoked and 76% had smoked 20 or more 
cigarettes a day.
Pathological Features
The histologic diagnoses for 1175 
patients were as follows: 510 (43%) 
squamous-cell carcinomas, 241 (21%) 
sm all-cell carcinom as, 214 (18% ) 
adenocarcinomas, 127 (11%) large-cell 
carcinomas, 18 (1.5%) adenosquamous 
carcinomas and 65 (5.5%) miscellaneous 
undifferentiated cell type. For 117 (9.1%) 
of the 1292 patients, the diagnosis was 
made on positive cytologic findings alone 
without definition of the exact cell type.
Staging
Of the study group, surgery was con­
traindicated in 995 (77%) patients, 
because of extension of the disease, inade­
quate pulmonary, cardiac or renal func­
tion, or because they refused surgical 
treatment. Cervical mediastinoscopy was 
done for right- and left-sided tumours in 
414 patients. For 35 with left-sided 
tumour, both cervical and left paraster­
nal mediastinoscopy were carried out. 
Forty-five patients underwent left 
parasternal mediastinoscopy alone, for 
left upper lobe and left hilar lesions. 
Mediastinal lymph-node metastasis was 
identified through these staging proce­
dures in 151 patients. Results of pre­
treatment staging are shown in Tables I 
and II. Table II includes the number of 
patients found to have unexpected medi­
astinal node metastasis at operation 
(false-negative staging procedure) and the
Table 1- Staging Procedures, Tumour Location and Results of Nodal Biopsy
Tumour site
Right Right Left Left
upper Middle lower Right upper lower Left Not
Procedure/positive biopsy lobe lobe lobe hilum lobe lobe hilum localized
Cervical mediastinoscopy, no. 153 18 85 4 70 64 12 8
Positive biopsy, no. (%) 
Cervical and left parasternal
54 (35) 6 (33) 20 (24) 2 150) 14(20) 18(28) 3(25) 3(38)
mediastinoscopy, no. - - — - 23 11 1 —
Positive biopsy, no. (%) 
Left parasternal
— _ 11 (48) 2(18) 0 _
mediastinoscopy, no. - — - - 42 — 3 -
Positive biopsy, no. (%) - - - - 16(38) - 2(66) -
Table II— Overall Results and Value of Pre treatment Staging
Staging procedure
Cervical mediastinoscopy Cervical and parasternal Parasternal
Results (n = 414) mediastinoscopy (n -  35) mediastinoscopy (n -  45)
Positive biopsy, no. % 120 (29) 13(37) 18(40)
Thoracotomy, no. 
Mediastinal metastasis
225 19 27
at thoracotomy, no. (%) 45 (20) 2(11) 3(11)
Sensitivity, % 73 87 86
Specificity, % 
Predictive value of a
100 100 100
positive test, % 
Predictive value of a
100 100 100
negative test, % 80 89 89
Efficiency, % 87 94 93
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accuracy of these procedures as deter­
mined by statistical analysis.
Results o f  Surgery
Of the 1292 patients, only 297 (23%) 
were found suitable for surgical treat­
ment. Further staging was performed at 
the time of thoracotomy. There were 184 
(62%) squamous-cell carcinomas, 60 
(20%) adenocarcinomas, 30 (10%) 
large-cell carcinomas, 12 (4%) small-cell 
carcinomas, 9 (3%) adenosquamous car­
cinomas and 2 (0.7%) undifferentiated 
carcinomas.
The type of operation performed and 
the hospital death rate are set out in Table 
III. The cause of death was secondary to 
respiratory failure in 9 (60%) instances, 
to cardiac events in 2 (13.3%), to bron­
chopulmonary fistula in 2 (13.3%) and to 
hemorrhage in 2 (13.3%).
Complications related to operations 
were not uncommon. Respiratory failure 
(prolonged intubation or reintubation) 
was encountered in 27 (9.1%) cases, 
atelectasis in 25 (8.4%) and pneumonia 
in 8 (2.7%). There were 12 bron­
chopleural fistulas (4%). Morbidity from 
cardiac causes was related to arrhythmia 
in 16 (5.4%) instances and to cardiac 
failure in 15 (5.1%). Hemorrhage, neces­
sitating multiple transfusions postopera- 
tively or repeat thoracotomy, occurred in 
five (1.7%) and of the four repeat thora­
cotomies for hemorrhage, three followed 
a pneumonectomy. There was one post­
operative cerebrovascular accident and 
one upper gastrointestinal hemorrhage. 
Miscellaneous complications such as 
superficial wound infection, urinary tract 
infection and gastric dilatation occurred 
in 21 (7%) patients.
Survival
Overall survival for the 1292 patients 
was 9.2% ± 0.5% (±  standard error) at 
5 years and 5.8% ± 0.8% at 10 years. 
For the 995 patients who had no surgical 
treatment, 91% ± 0.5% died in the 12 
months after diagnosis. At 3 years, only 
2% ± 0.5% were alive and at 5 years, 1% 
±  0.5%. Overall survival for the 297 
patients who were operated on was 36% 
+ 3% at 5 years and 24% ± 3% at 10 
years. Mean follow-up was 41.5 months 
(ranging from 3.5 to 14 years). Overall 
survival after operation was significantly
(p < 0.0001) greater for patients with 
stage I disease than for those with stages 
II and III disease (Fig. 1). Figure 2 indi­
cates that overall survival after operation 
for patients with no lymph-node involve­
ment (NO) or minimal involvement (Nl) 
is significantly (p <  0.0001) greater than 
that for patients with mediastinal node 
involvement (N2).
Five- and 10-year survival after surgery, 
according ro cell type, was 39% ± 3.8% 
and 25% ± 3.9% for 184 squamous-cell 
carcinomas, 35% ± 6.5% and 22% ± 
6.8% for 60 adenocarcinomas, 28% ± 
8% and 17% ± 8% for 30 undifferen­
tiated large-cell and 18% ± 12% and 0% 
for 12 undifferentiated small-cell carci­
nomas. Comparison of the probability of 
survival by cell type was not statistically 
significant. Best results were obtained in 
patients having T1N0 disease: 5- and 
10-year survival for 33 squamous-cell car­
cinomas was 73% ± 8% and 50%, ± 
10% and for 15 adenocarcinomas 59% + 
13% and 50% ± 14% respectively.
Discussion
The trend in our hospital to increasing 
incidence of lung cancer, particularly in 
women, is consistent with Canadian and 
North American tendencies.1,10-12 All 
physicians involved agree on the impor­
tance of an accurate assessment of 
patients with lung cancer in order to select 
the proper treatment. Consideration must 
be given to cardiopulmonary status, histo­
logic findings and stage of the disease 
according to the TNM system.2 Particu­
lar attention must be given to the nodal 
status which is directly related to long­
term results (Fig. 2).
We believe that preoperative mediasti­
nal node evaluation by mediastinoscopy 
is necessary for all bronchial tumours, the 
only exceptions being peripheral lesions 
smaller than 2 cm.5 Cervical medi­
astinoscopy in this series yielded 29% 
positive node biopsies which is compara­
ble to the results of others.13,14 Many 
thoracic surgeons believe that left upper 
lobe tumours cannot be adequately staged 
by cervical mediastinoscopy alone.5,14-17 
Lymphatic vessels of the superior regions 
of the left upper lobe drain into the liga­
ment node of Botallo and then to the peri­
aortic nodes. The ligament node may also 
communicate with the left paratracheal
area. The lower area of the left upper lobe 
has lymphatic connections with the liga­
ment node and the tracheobronchial 
nodes.18,19
Table II indicates the accuracy of the 
staging procedures. We believe that no 
attempt should be made to compare the 
accuracy of cervical mediastinoscopy and 
left parasternal mediastinoscopy, as thesd 
procedures are complementary, each 
assessing different nodal areas. In our ser­
ies, the accuracy of cervical medi­
astinoscopy for right and left lung 
tumours was not as high as that demon­
strated by others,13,20 but all mediastinal 
node metastases found at thoracotomy 
were listed as false negative, and no 
attempt was made to exclude node 
metastases that might be judged inacces­
sible by mediastinoscopy. On the other 
hand, our results indicate that left 
parasternal mediastinoscopy alone is 
quite accurate to assess left upper lobe 
and left hilar tumours (sensitivity = 
86%). It does not appear that both proce­
dures, cervical and left parasternal medi­
astinoscopy, add substantially to the 
accuracy of preoperative assessment of 
mediastinal lymph nodes for left upper 
lobe tumours. More recently, the trend 
toward extensive lymph-node mapping21 
has led us to perform more routinely both 
cervical and parasternal mediastinoscopy 
for left-sided lesions.
FIG. 1—Actuarial survival curves of 297 
surgical patients according to stage of disease. 
Percentages are cumulative probabilities ± 
standard error.
FIG. 2—Relationship of nodal status to 
survival in 297 surgical patients with bron­
chogenic carcinoma.
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For some authors mediastinal node 
metastasis is not a contraindication to sur­
gery, especially if curative resection can 
be accomplished.21-23 These surgeons 
usually do not carry out mediastinoscopy 
preoperatively. On the other hand, when 
mediastinal node involvement is demon­
strated at mediastinoscopy, others have 
shown that the results of surgical resec­
tion are very poor, particularly if the 
procedure is palliative.24,25 For these 
reasons, we like to avoid surgery 
and recommend palliative treatment if 
mediastinal node metastasis is demon­
strated at mediastinoscopy. Figure 2 illus­
trates the poor surgical results we have 
obtained with patients having N2 disease.
Among patients who underwent thora­
cotomy, a resectability rate of 91%, a 
hospital death rate of 5% and a 4.4% 
incidence of bronchopleural fistula are all 
good results, comparable to data found 
in the literature.26-31
The death rate following pneumonec­
tomy remains high but comparable to that 
of other reports and is directly related in 
most instances to resected functional pul­
monary parenchyma leading to respira­
tory failure. Of the 10 deaths after pneu­
monectomy, 8 were secondary to respi­
ratory failure either as the main cause of 
death or as an important contributing 
factor.
The overall 5-year survival of 9.2% for 
patients with bronchial carcinoma has not 
changed much in the past decades. 
Results after resection have improved 
because of better patient selection for sur­
gery. If surgical resection is performed 
early, better survival is to be expected. 
Overall survival of 36% and 24% at 5 and 
10 years for the 292 patients who under­
went surgery is comparable to the rates 
in many series.26-31 Figures 1 and 2 
clearly show that if the tumour itself is 
invasive or there is nodal involvement, 
survival decreases rapidly. We had poor 
results in patients with stage III disease, 
especially when mediastinal nodes were 
involved. Our longest survival rates were, 
of course, obtained in early-stage 
squamous-cell carcinoma: a small tumour 
(3 cm or less in dimension) without node 
involvement (T1N0).
Conclusions
The incidence of bronchogenic carci­
noma is still increasing in Canada and is 
reflected in our hospital admissions. The 
increase is even more striking in women. 
The use of the TNM staging system as 
recommended by the American Joint 
Committee for Cancer Staging and End 
Results Reporting is most important, not 
only for evaluation but also to compare 
results.
Mediastinoscopy as pre-treatment stag­
ing is an excellent means of assessing 
superior mediastinal nodes. Left paraster-
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nal mediastinoscopy with or without cer­
vical mediastinoscopy is essential for ade­
quate evaluation of left upper lobe 
tumours.
The final solution to lung cancer is 
prevention, but results of treatment are 
excellent if the cancer is detected and sur­
gical treatment instituted early. At an 
earlier stage of the disease, a lobectomy 
can usually be carried out, but in more 
advanced disease, a pneumonectomy with 
its associated higher morbidity and mor­
tality is often necessary.
We thank Line Trudeau for data collection, 
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CORRESPONDENCE  
continued from page 75
Two new Port-A-Cath devices were 
used. One was tested with repeated punc­
tures at 90° through the septum using a 
22-gauge Yale hypodermic needle and the 
other using a 22-gauge Huber-point nee­
dle. After each 10 punctures with the 
same type of needle, the seal was checked 
by injecting air from a 10-ml syringe 
through the catheter, with the reservoir 
placed under water. After 100 punctures 
the seal was checked again by injecting 
air through the needle in the septum, with 
the reservoir under water and the catheter 
clamped.
An air leak was found at 1150 punc­
tures with the regular 22-gauge Yale 
hypodermic needle and at 1165 punctures 
with the Huber-point needle. The centre 
of the septum in both devices was 
macerated.
We, therefore, could make the follow­
ing conclusions.
• The self-sealing septum showed signs 
of leakage at 850 punctures less than that 
stated by the manufacturer, regardless of 
the type of needle used.
• The 22-gauge Yale hypodermic nee­
dle seems to be as safe as the Huber-point 
needle.
• A safe number of punctures would 
be 1000 regardless of the needle used.
• Because the Huber-point needle costs 
$1.74 versus $0.26 for the Yale hypoder­
mic needle (a difference of $1.48), the lat­
ter is more cost effective.
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Serious Infectious Complications of Open-Heart Surgery
Serious infectious complications of open- 
heart surgery in 521 adults who under­
went 534 open-heart procedures are 
reviewed. Bacteremia complicated seven 
(1 .3 % ) of the procedures, carditis six 
(1 .1 % ) and deep sternal wound infec­
tions nine (1 .7% ). The overall rate of 
these infections was 4 .1 %  with an 
associated death rate of 11 .7%  (2 of 
17). With respect to the risk of this com­
plication, no differences were noted in 
the age of the patients, duration of sur­
gery or perioperative prophylaxis with 
cephalothin or cloxacillin. The chance of 
carditis developing was significantly 
related (p < 0.001) to a valve replace­
ment procedure and the risk of a deep 
sternal wound infection (p <  0.01) to a 
procedure classed as "other". 
Staphylococci remained the most com­
monly isolated pathogens with an almost 
equal frequency of Staphylococcus 
epidermidis and Staphylococcus aureus. 
Gram-negative aerobes and Strep­
tococcus faecalis were found to be other 
important pathogens in this clinical 
setting.
On a etudie les complications infectieu- 
ses serieuses qui sont apparues chez 
521 adultes ayant subi 534 operations a 
coeur ouvert. Une bacteriemie est venue 
compliquer sept (1 .3% ) de ces interven­
tions, une cardite six (1 .1 % ), et une 
infection de plaie sternale profonde, neuf
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(1 .7 % ). Pour I'ensemble, le taux d e fe c ­
tion a ete de 4 .1 % , avec une mortalite 
associee de 11.7%  (2 cas sur 17). En ce 
qui a trait au risque de complication 
infectieuse, aucune difference n'a ete 
observee pour I'age des malades, la 
duree de la chirurgie ou I'usage prophy- 
lactique peroperatoire de cephalothine ou 
de cloxacilline. Le risque de voir se deve- 
lopper une cardite a ete significativement 
relie a une valvoplastie (p <  0.001), et le 
risque d'infection de plaie sternale pro­
fonde, a une operation classifiee comme 
"autre" (p < 0 .0 1 ). Les staphylocoques 
demeurent les pathog&nes les plus fre- 
quemment isoles. Staphylococcus epider­
midis et Staphylococcus aureus etant a 
peu pr6s retrouves avec une egale fre­
quence. Dans cet environnement Clini­
que, les aerobies gram-negatifs et Strep­
tococcus faecalis ont ete les autres 
pathogenes importants.
Serious infectious complications of open- 
heart surgery include bacterem ia, 
endocarditis, purulent pericarditis and 
deep sternal wound infections. The fre­
quency of endocarditis has ranged from 
1% to 10%,1-5 with associated death 
rates as high as 86% ,2,3,6-8 The rate of 
sternal wound infections and mediastini- 
tis is reported to range from 0.6% to 
8.1%,9-15 with associated death rates of 
2.3% to 71%.n '13'14 Factors associated 
with an increased incidence of sternal 
wound infections and mediastinitis 
include the type of closure,10,11 
tracheostomy,9-11 prolonged mechanical 
ventilation,10,11 reoperation for bleed­
ing,9-12 closed-heart massage,9,10 low 
cardiac output postoperatively,9,12 
prolonged perfusion time,12 surgery last­
ing longer than 6 hours16 and age over 65 
years.16 Despite the lack of adequate 
placebo-controlled trials,17 antibiotic 
prophylaxis is recommended for patients 
who undergo cardiac valve replace­
ment.17,18 A few studies19,20 have shown 
the value of antibiotic prophylaxis in 
decreasing the incidence of sternal wound 
infections after cardiac surgery, and at 
present it is recommended for all open- 
heart surgical procedures.18
Staphylococcus sp. are the most com­
mon pathogens in postoperative 
endocarditis6,7 and sternal wound 
infections9,12,14,21 with Staphylococcus 
epidermidis being recognized most fre­
quently in these clinical settings.1,9,12,22 
Changing antibiotic sensitivity of the 
staphylococci, including resistance to con­
ventional agents, have been 
reported.22-27 Gram-negative aerobes are 
also important pathogens.6,9,10,21,28 These 
issues have raised questions regarding the 
adequacy and appropriateness of the 
present regimens used for antibiotic 
prophylaxis.
The purpose of this retrospective 
review was to determine the frequency of 
serious infectious complications of open- 
heart surgery, death rates associated with 
these complications and factors that may 
relate to the development of such com­
plications. The organisms involved in 
these infections and their antibiotic sen­
sitivity patterns were also examined.
Patients and Methods
We reviewed the medical records of 521 
adults (mean age 56 years, range from 23 
to 78 years) who underwent 534 open- 
heart surgical procedures at the Univer­
sity of Alberta Hospital between Jan. 1, 
1981 and Nov. 30, 1982. The procedures 
were considered in four groups — coro­
nary artery bypass, valve replacement, 
combined coronary bypass and valve 
replacement, and “ other” . The last 
category included pericardiotomies, ven­
tricular aneurysm repairs, removal of 
atrial myxomas and repair of congenital 
cardiac defects. Data relating to infectious 
complications of these procedures were
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noted. An infection was defined as seri­
ous if it involved bacteremia, carditis or 
deep sternal wound infection. The term 
carditis was used to include both 
endocarditis and purulent pericarditis. 
Endocarditis was diagnosed if positive 
blood cultures were accompanied by clin­
ical features compatible with endocardi­
tis or if bacterial cultures of valvular 
material obtained at surgery were posi­
tive. Clinical criteria supporting a diag­
nosis of endocarditis included a new or 
changing murmur, fever, clubbing, 
splenomegaly, conjunctival petechiae, 
Osier’s nodes, Janeway lesions and 
embolic phenomena. Purulent pericardi­
tis was confirmed by positive bacterial
cultures of pericardial fluid. Deep sternal 
wound infections included sternal 
osteomyelitis, mediastinitis and sternal 
dehiscence associated with positive bac­
terial cultures of bone, mediastinal fluid, 
surgical tissue or sternal wound drainage. 
Sternal wound cellulitis that responded 
favourably to a short course of parenter- 
ally administered antibiotics was not con­
sidered a serious infectious complication.
Death rates within 2 months of surgery 
were examined and correlated with the 
presence or absence of infectious compli­
cation as defined above.
Factors examined that may have been 
related to these serious infections included 
age of the patient, type of surgical proce­
dure, duration of surgery and the 
prophylactic agent used. During the early 
part of 1981, we used cloxacillin routinely 
for prophylaxis in patients who under­
went open-heart surgery. It was ad­
ministered intravenously in 1-g doses 1 
hour preoperatively and every 6 hours for 
72 hours postoperatively. Cephalothin 
subsequently replaced cloxacillin in the 
same dosage.
The organisms involved in the serious 
infectious complications were examined, 
with sensitivity reports based on agar 
diffusion studies.
As this was a retrospective study, the 
data may be incomplete. Patients who 
may subsequently have been admitted to
_______________________________ Table 1—Clinical Data in Seven Cases of Bacteremia After Open-Heart Surgery
Patient Age, Duration of Organism
no. Sex yr Procedure operation, h Surgeon isolated Resistant to Prophylaxis Outcome
1 F 71 CAB X 2 
+ MVR
5 B Staphylococcus
aureus
Penicillin Cephalothin Cerebral infarct, 
discharged
2 M 65 CAB X 1 
+ AVR
12 A Streptococcus
m itis
Erythromycin Cephalothin Discharged
3 M 66 CAB X 4 
+ MVR
8 B Serratia
marcescens
Cephalothin,
ampicillin,
tetracycline,
chloramphenicol
Cephalothin Deep sternal wound 
infection, 
discharged
4 M 67 CAB X 2 4.5 C Staphylococcus
aureus
Penicillin Cephalothin Deep sternal wound 
infection, 
discharged
5 M 60 CAB X 2 5 C Propionobacter + Cephalothin Deep sternal wound 
infection, 
disharged
6 F 67 CAB X 2 5.5 0 Staphylococcus 
epidermidis 
(2 strains)
1 -  penicillin, 
erythromycin
2 -  +
Cloxacillin Superficial sternal 
wound infection, 
discharged
7 M 50 MVR 5 A Staphylococcus
aureus
+ Cloxacillin Purulent
pericarditis,
discharged
CAB = coronary artery bypass, MVR = mitral valve replacement, AVR = aortic valve replacement, + = sensitive to all antibiotics tested.
Table II—Clinical Data in Six Cases of Carditis After Open-Heart Surgery
Patient
no. Sex
Age,
yr Procedure
Duration of 
operation, h Surgeon
Organism
isolated
Culture
site Resistant to Prophylaxis Outcome
7 M 50 MVR 5 A Staphylococcus 
aureus (1 mo 
postop)
Blood,
pericardial
fluid
Penicillin Cloxacillin Alive
8 M 37 AVR 4 C Staphylococcus 
epidermidis 
(7 wk postop)
Blood Penicillin,
erythromycin
Cephalothin Alive
9 M 61 MVR 5 A Staphylococcus 
epidermidis 
(3 strains)
(3 wk postop)
Streptococcus 
faecalis 
(2.5 mo postop)
Blood
Valve
1 — penicillin
2 — penicillin, 
gentamicin, 
erythromycin
3 -  clindamycin, 
clotrimazole
Gentamicin,
penicillin,
erythromycin
Cephalothin Died after 
valve
replacement
10 M 34 AVR 6 B Streptococcus 
faecalis 
(3 wk postop)
Blood Cephalothin,
gentamicin,
penicillin,
erythromycin
Cephalothin Marfan's 
syndrome, 
died after 
dissection
11 M 54 AVR 4 C Diphtheroids 
(4 mo postop)
Blood Penicillin,
cloxacillin
Cloxacillin Alive
12 M 63 AVR 3.5 B Staphylococcus 
epidermidis 
(2 mo postop)
Blood,
valve
ring
Not available Cloxacillin Alive
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other institutions with complications 
would not have been included. The x2 
test and paired Student’s /-test were used 
for statistical analysis.
Findings
Four-hundred and one cardiac proce­
dures were performed on men and 133 on 
women. The majority of the procedures 
(435 [81%]) were elective and all were 
performed by one of four cardiovascular 
surgeons.
Of the 534 procedures performed, 383 
(72%) were coronary artery bypasses, 97 
(18%) were cardiac valve replacements 
and 37 (7%) were classed as “ other” .
Overall, the mean duration of surgery
was 4.6 hours. When examined by proce­
dure, it was 4.5 hours for coronary revas­
cularization, 4.7 hours for valve replace­
ments alone, 6.3 hours for combined 
coronary revascularization and valve 
replacement and 4.5 hours for the proce­
dures classified as “ other” .
Cloxacillin was administered in 168 
(31.5%) of the 534 procedures and 
cephalothin in 348 (65.2%). In 18 (3.4%) 
of the procedures, there was either no 
prophylaxis or some other agent was 
used.
Tables I to III outline the clinical details 
of the serious infectious complications 
documented in this review. Excluding 
cases of endocarditis, 7 (1.3%) of the 534 
procedures performed were complicated
by bacteremia (Table I) occurring within 
4 weeks of surgery. Carditis (Table II) was 
a complication of six (1.1%) procedures 
(five cases of endocarditis and one of 
purulent pericarditis). Four of the five 
cases of endocarditis occurred within 2 
months of surgery. Nine (1.7%) open- 
heart procedures were complicated by 
deep sternal wound infections (Table III). 
Five patients had more than one serious 
complication. Three patients with deep 
sternal wound infections and the sole 
patient with purulent pericarditis also had 
bacteremia. In the fifth patient prosthetic 
valve endocarditis developed after valve 
insertion and, 1 year later, a deep sternal 
wound infection developed after surgery 
to repair his paravalvular leak. In total,
Table Ill-Clinical Data in Nine Cases of Deep Sternal Wound Infection After Open-Heart Surgery
Patient
no. Sex
Age,
yr Procedure
Duration of 
operation, h Surgeon
Organism
isolated Resistant to Prophylaxis Outcome
3 M 66 CAB X 4 
+ MVR
8 B Serratia
marcescens
Staphylococcus 
aureus 
(2 strains)
Cephalothin,
tetracycline,
ampicillin,
chloramphenicol
1 — penicillin
2 — +
Cephalothin Debridement 
rectus flap, 
alive
4 M 67 CAB X 2 4.5 C Staphylococcus
aureus
Penicillin Cephalothin Debridement 
rectus flap, 
alive
5 M 60 CAB X 2 5 C Diphtheroids
Staphylococcus
epidermidis
Serratia
marcescens
Penicillin,
cloxacillin,
gentamicin
Penicillin
Cephalothin,
tetracycline,
ampicillin,
chloramphenicol
Cephalothin Debridement X 3
12 M 63 Suturing
paravalvular
leak
3.5 B Staphylococcus
epidermidis
Penicillin,
cloxacillin,
erythromycin
Cloxacillin Debridement,
alive
13 M 61 CAB X 2 4.5 A Streptococcus
viridans
+ Cephalothin Debridement 
rectus flap, 
alive
14 M 56 Removal left 
atrial myxoma
3 C Klebsiella
pneumoniae
Ampicillin,
kanamycin,
Cloxacillin Debridement X 2, 
alive
15 M
16 M
17 M
35
64
Staphylococcus
aureus
Staphylococcus 
epidermidis 
(2 strains)
Tetralogy 
of Fallot 
repair
CAB X 4
65 CAB X 3
4.5
3.5
Staphylococcus
aureus
Staphylococcus
epidermidis
Proteus
mirabilis
Streptococcus
faecalis
Staphylococcus
epidermidis
penicillin,
erythromycin
1 -  penicillin, 
erythromycin, 
gentamicin
2 — penicillin, 
erythromycin, 
gentamicin, 
cloxacillin, 
cephalothin, 
kanamycin
Penicillin
Penicillin
Tetracycline,
colistin
Cephalothin,
gentamicin,
penicillin
Cephalothin
Cephalothin
Cephalothin
Drainage,
debridement,
alive
Debridement X 2, 
muscle flap, alive
Debridement,
alive
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22 serious infectious complications were 
documented following 534 open-heart 
surgical procedures, a rate of 4.1 %. These 
complications occurred in 17 (3.3%) of 
the 521 patients and were evenly dis­
tributed among patients operated on by 
the four cardiovascular surgeons.
The mean age of patients with serious 
infections was 57.8 years compared with 
55.9 years for those who did not 
experience such complications. This 
difference was not statistically significant, 
nor was the mean duration of surgery in 
patients with (5.4 hours) and without (4.6 
hours) serious infectious complications.
In 15 (4%) of the 348 procedures that 
were perform ed with cephalothin 
prophylaxis there were infectious compli­
cations compared with 7 (4%) in the 168 
procedures performed with cloxacillin 
prophylaxis. There was no significant 
difference between cephalothin and clox­
acillin prophylaxis and the risk of serious 
postoperative infection as determined by 
X2 analysis. This held true for all compli­
cations combined (p > 0.6) and when 
each com plication was examined 
separately (bacteremia p > 0.8, carditis 
p > 0.35 and sternal wound infection p 
>  0.5).
In examining the relationship of proce­
dure and risk of serious infection, we 
noted that all six patients with carditis had 
undergone valve replacements alone. This 
complication was significantly (p < 
0.001, x2 test) related to procedure. 
There was also a significant (p < 0.01, 
X2 test) relation between the development 
of sternal wound infection and the patient 
having undergone a procedure classified 
as “ other” . There was no statistically sig­
nificant relation between bacteremia and 
any of the procedures performed. Table 
IV presents the numbers and types of 
infectious complications as a function of 
each group of procedures. Although bac­
teremia was not statistically related to 
procedure as determined by x2 analysis, 
three of seven episodes occurred in 
patients who had undergone combined 
coronary artery bypass and valve replace­
ment, of which 23% were complicated by 
a serious infectious complication.
Thirty-two of 521 patients died within 
2 months of surgery — an early death rate 
of 6.1%. Of these 32, only 2 (6%)
patients had a documented serious 
postoperative infection. The death rate of 
those with serious infectious complica­
tions, however, was 11.8% (2 of 17), 
almost double the overall death rate.
The organisms most frequently isolated 
from patients with serious infectious com­
plications were staphylococci, isolated in 
14 of the 22 complications. There was an 
almost equal frequency of isolation of 
Staphylococcus aureus (8 of 22 compli­
cations) and S. epidermidis (9 of 22 com­
plications). Two of the 13 strains of S. 
epidermidis involved in these infections 
were reported resistant to cloxacillin. The 
sensitivity of another 1 of the 13 strains 
was unavailable. None of the S. aureus 
isolates were cloxacillin resistant. Gram­
negative aerobic bacteria were isolated in 
5 of the 22 complications. Of interest is 
that Streptococccus faecalis was isolated 
from two cases of early prosthetic valve 
endocarditis and, in association with 
another organism, from one case of ster­
nal wound infection.
Figure 1 outlines the distribution of 
serious infectious complications with 
respect to the time of operation and spe­
cifically to the 18 surgical procedures that 
were associated with a serious infectious 
complication. These infections occurred 
randomly with no evidence of clustering. 
It should be noted that in those months 
when more than two infections occurred, 
the surgeon and infecting organisms 
differed for each infection.
Discussion
Our study demonstrates that despite 
antibiotic prophylaxis, serious bacterial 
infections can occur following open-heart 
surgery. The reported rate of bacteremia 
in this review was 1.3%, carditis 1.1% 
and deep sternal wound infections 1.7%, 
with a combined frequency of 4.1%. 
Although these figures are relatively low, 
and in keeping with the less than 5% rate 
expected for clean surgical procedures,17 
the associated mortality and morbidity 
were substantial. Two of the seventeen 
patients (11.7%) with such complications 
died. Of the five patients with endocardi­
tis, four underwent repeat surgery for 
replacement of their infected valve. Five 
of the nine patients with deep sternal
wound infections required myocutaneous 
flaps in addition to debridement. Despite 
the rather low rate of serious infectious 
complications following open-heart sur­
gery and the controversy regarding the 
need for antibiotic prophylaxis in clean 
surgery,17 the mortality and morbidity 
associated with these complications 
supports the practice of antibiotic 
prophylaxis for patients who undergo 
open-heart surgery.17’18’29
A change in the antibiotic used in our 
centre occurred during the study and 
allowed us to compare the efficacy of 
cloxacillin and cephalothin in preventing 
endocarditis and sternal wound infection. 
The study showed no significant differ­
ence in rates of serious infectious com­
plications in patients receiving either of 
these agents prophylactically. This was in 
keeping with the findings of Myerowitz 
and colleagues30 and Fong and asso­
ciates19 who used methicillin or cephalo­
thin with no significant difference. It is 
interesting to note that in a number of 
cases, the isolated pathogen was sensitive 
to the prophylactic agent used. During the 
study period, 1-g doses of cloxacillin and 
cephalothin were used and one might 
speculate that this dose was too low to 
produce adequate blood levels in patients 
placed on the bypass pump.
The cephalosporins have become the 
preferred prophylactic agents for open- 
heart surgery even though comparative 
trials have failed to support their superi­
ority.19,30 Theoretical advantages such as 
their broadened gram-negative activity 
and in-vitro sensitivity of methicillin and 
oxacillin-resistant staphylococci may have 
been considerations accounting for this
FIG. 1—Distribution of serious infectious 
complications with respect to time of oper­
ation.
Table IV-Serious Infectious Complications and Procedures
Procedure
CAB
Valve
replacement
CAB + 
valve
replacement Other Totals
No. of patients (% of total) 383 (72) 97(18) 17(3) 37 (7) 534
No. of infectious complications* (%) 8 (2) 7 (7) 4(23) 3(8) 22
Bacteremia 3 1 3 0
Carditis 0 6 0 0
Sternal wound infection 5 0 1 3
'These 22 complications occurred in 17 patients, whose clinical features are detailed in Tables I, II and III.
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practice. However, increasing reports 
o f m ethicillin-resistant staphylo­
cocci,24-26’31 and reports o f cross­
resistance to the cephalosporins22,24 leave 
open to question the widely accepted use 
o f the cephalosporins as prophylactic 
agents for open-heart surgery. Although 
our figures did not suggest methicillin 
resistance was a major problem at our 
centre, oxacillin and methacillin resistance 
was documented in 2 of the 13 strains of 
S. epidermidis involved in the serious 
infectious complications reviewed. Data 
from other centres22,24,25,31 should alert 
us to potential future problems with 
methicillin-resistant staphylococci.
Although staphylococci were the most 
frequently documented pathogens, our 
study confirmed the importance of gram­
negative aerobes as pathogens in this set­
ting. Interestingly, three of the five gram­
negative pathogens isolated were resistant 
to cephalothin, the agent administered 
prophylactically during the procedure.
The isolation of S. faecalis in 3 of 22 
patients with infectious complications 
suggests this organism may also be impor­
tant in open-heart surgery. This would be 
of particular relevance since enterococci 
are generally resistant to the 
cephalosporins.
In examining factors that may have 
been associated with the development of 
a serious infectious complication, we 
found a significant relation between cer­
tain procedures performed and specific 
infectious complications that developed. 
All cases of carditis occurred in patients 
who had undergone valve replacements. 
There was also a statistically significant 
relation (p < 0.01) between the risk of 
suffering a sternal wound infection and 
having undergone a procedure defined as 
“other” . Although one might expect such 
procedures to be more complicated than 
bypass procedures or valve replacement, 
this is not reflected in an increased dura­
tion o f surgery, and other factors need to 
be considered. Of interest is that all 
patients who had sternal wound infections 
were men, raising the question of the 
importance of preoperative shaving of the 
chest and its relation to wound infection. 
Cruse and Foord32 in their extensive 
review, found that shaving the operative 
site increased the infection rate of clean 
wounds. It is important to indicate that 
at the time of this review, preoperative 
shaving of the chest was standard proce­
dure at this institution. No statistically 
significant correlation was demonstrated 
between age of the patient or duration of 
surgery and the risk of a serious postoper­
ative infection.
One of the priorities in cardiovascular 
surgery is to define factors predisposing 
to serious infections and minimize them. 
The relation between operative procedure 
and specific complications needs to be
more closely examined since other factors 
such as shaving may be important. 
Staphylococci and gram-negative aerobes 
were the most frequently isolated patho­
gens and the prophylactic agent or agents 
used should provide coverage for most o f 
these organisms. By using broad- 
spectrum antibiotics we may encourage 
the development of multiresistant organ­
isms and possibly superinfections due to 
enterococci or fungi. Narrower spectrum 
drugs, on the other hand, directed at 
staphylococci alone might promote gram­
negative infections. Although this study 
showed no significant differences between 
cephalothin and cloxacillin, it would 
appear that better controlled trials of 
prophylactic agents for open-heart sur­
gery are appropriate.
We acknowledge the cooperation of the staff 
of the Division of Cardiovascular Surgery, 
University of Alberta Hospital, and the statisti­
cal expertise of Philip Ng, MD, Ph D, in the 
preparation of this paper.
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Pancreatic Islet-Cell Neoplasia, With Secretion of a 
Parathormone-like Substance and Hypercalcemia
In a 47-year-old woman with a pan­
creatic mass associated with hypercalce­
mia and mental confusion, medical meas­
ures failed to restore her serum calcium 
level to normal. To do so, radical resec­
tion of a locally invasive vascular 
neoplasm arising from the body and tail 
of the pancreas was necessary. The 
neoplasm was a pancreatic islet-cell 
tumour. Serum parathormone assays 
demonstrated abnormally high secretion 
of a parathormone-like substance.
Ectopic secretion of such substances 
from islet-cell tumours should be consi­
dered in association with refractory 
metabolic disturbances. In view of the 
often indolent clinical course of islet-cell 
tumours and the potential for life- 
threatening hormonal effects, biopsy 
confirmation of adenocarcinoma should 
be obtained before resorting to palliative 
surgical management of pancreatic 
neoplasms.
Les mesures medicales habituelles ont 
echoue a retablir une calcemie normale 
chez une femme de 47 ans presentant 
une masse pancreatique associee a une 
hypercalcdmie et a de la confusion men- 
tale. Pour y  parvenir, il fallut pratiquer 
une resection radicale d'une neoplasie 
vasculaire localement envahissante, 
affectant le corps et la queue du pan­
creas. II s'agissait d'une tumeur pancrea­
tique des cellules des Hots de Langer- 
hans. Les dosages de la parathormone 
serique ont revele une sdcrdtion anorma- 
lement elevee d'une substance semblable 
a la parathormone. Une secretion ectopi- 
que de telles substances a partir d'une 
tumeur des cellules insulaires doit etre 
envisagee en presence de troubles meta- 
boliques refractaires. Devant revolution 
souvent indolente des tumeurs des celiu-
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les insulaires et le risque d'effets hormo- 
naux pouvant entratner la mort, une con­
firmation par biopsie d'adenocarcinome 
doit etre obtenue avant d'en venir au 
traitement chirurgical palliatif des neopla- 
sies pancreatiques.
The majority of pancreatic tumours are 
adenocarcinomas, neoplasms with a poor 
prognosis and a low rate of resectabil­
ity.1 Physicians are understandably pes­
simistic when faced with pancreatic 
neoplasms and have adopted a conserva­
tive approach to their surgical manage­
ment. Occasionally, neoplasms arise from 
the endocrine pancreas; they are easily 
misdiagnosed as inoperable carcinoma, 
but have a much slower rate of growth 
and warrant a more aggressive attitude in 
regard to resection.2 Moreover, these 
tumours can secrete a variety of hor­
mones,3-6 any of which may produce 
bizarre systemic syndromes and have been 
associated with elevation of the serum cal­
cium level not related to bone metastases 
or hyperparathyroidism.7-11
Case Report
A 47-year-old woman was admitted to the 
Flalifax Infirmary with a 1-month history of 
left upper quadrant abdominal pain associated 
with fatigue and a weight loss of 14 kg. Apart 
from hypertension, treated with diuretics, she 
had been well. The liver edge was palpable just 
below the costal margin and there was an ill- 
defined mass in the left subcostal area. Physi­
cal examination was otherwise unremarkable.
Complete blood count and urinalysis gave 
normal results. The erythrocyte sedimentation 
rate was 22 mm/h. The following were also 
within normal limits: serum phosphate, 
bilirubin, transaminase, creatinine, blood urea 
nitrogen, albumin and globulin levels and pro­
tein electrophoresis. Serum electrolyte levels 
were normal apart from mild hypokalemia. 
Urinary cyclic adenosine monophosphate levels 
were not determined. The serum calcium level 
was elevated to 4.14 mmol/L (normal 2.13 to 
2.63 mmol/L). The serum uric acid level was 
elevated to 530 ^mol/L and alkaline phospha­
tase to 161 U /L.
A chest x-ray film and electrocardiogram 
obtained on admission appeared normal. A 
technetium liver-spleen scan disclosed no
abnormalities. Abdominal ultrasonography 
demonstrated an irregular mass, 9 cm in 
diameter, in the left upper quadrant of the 
abdomen, possibly arising from the left lobe 
of the liver or tail of the pancreas.
Computerized tomography of the abdomen 
confirmed a large retrogastic, soft-tissue mass 
involving the body and tail of the pancreas, 
possibly obstructing the splenic vein (Fig. 1).
Shortly after admission, the patient became 
confused and lethargic with loss of orientation. 
Neurologic examination revealed no focal 
abnormalities; an electroencephalogram sug­
gested a diffuse metabolic disorder. Her 
elevated serum calcium level, repeatedly con­
firmed, was aggressively treated with saline diu­
resis and furosemide and gradually brought 
under control, with return of normal mental 
status.
In the absence of clinical and radiologic evi­
dence of skeletal disease, the cause of the 
patient’s hypercalcemia was unclear. The pos­
sibility of primary hyperparathyroidism was 
considered as was the potential for secretion 
of a hypercalcemic stimulant by her abdomi­
nal tumour. Serum parathormone assay was 
carried out and reported as 291.0 pg/ml from 
the C-terminal mid-region (normal, less than 
500 pg/ml) which, in association with a total 
calcium concentration of 4.1 mmol/L was 
thought to be compatible with ectopic secre­
tion of a parathormone-like substance.
Laparotomy, after her serum calcium level 
had stabilized, disclosed a highly vascular mass 
arising from the body of the pancreas, infiltrat­
ing the greater curvature of the stomach and 
the splenic hilum (Fig. 2). The mass appeared 
fixed retroperitoneally but was not associated 
with hepatic or lymph-node metastases. An 
incisional biopsy of the lesion was attempted 
but abandoned because of profuse bleeding. 
In view of the apparent invasion of adjacent
FIG. 1—Abdominal computerized tomo­
gram demonstrates mass arising from pancreas 
(arrows) infiltrating splenic hilum with anterior 
displacement of stomach.
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organs, resection was judged to be unfeasible 
and the abdomen was closed.
Postoperatively, despite continued saline 
infusion with diuretics, high-dose prednisone 
and treatment with calcitonin and mithramy- 
cin, her serum calcium level remained elevated 
although her mental status was normal. Before 
resorting to chemotherapy, we decided to 
repeat the laparotomy in an attempt at radi-
FIG. 2—Tumour in body of pancreas with 
extensive neovasculature.
FIG. 3—Mesenteric angiography demon­
strates vascular neoplasm (arrow) within body 
of pancreas.
FIG. 4—Histologic section of tumour with 
well-defined cells and minimal evidence of 
cytologic atypia or pleomorphism (hematoxy­
lin and eosin, original magnification x 63).
cal resection of the tumour. Preoperative 
mesenteric angiography confirmed a highly 
vascular irregular mass in the region of the 
lesser sac and splenic hilum, encasing the 
splenic vessels and suggesting an islet-cell 
tumour of the pancreas or retroperitoneal sar­
coma (Fig. 3).
In an attempt to reduce tumour vascularity 
before operation, the patient received a 3300 
R course of external cobalt radiation. Because 
of continued nausea and inability to maintain 
adequate caloric intake, total parenteral nutri­
tion was begun. Two episodes of subclavian 
catheter-induced sepsis occurred, necessitating 
its removal and replacement. A cellulitis sur­
rounding the catheter insertion site responded 
to cloxacillin.
At the second operation a thoracoabdomi­
nal approach was used to mobilize the pancreas 
and spleen from surrounding retroperitoneal 
structures. It was apparent that despite local 
invasion of the fundus of the stomach and 
spleen, the tumour was resectable. There was 
no evidence of invasion of the left kidney or 
of intra-abdominal metastases. An en bloc 
resection of the body of the pancreas, spleen 
and greater curvature of the stomach was car­
ried out and a feeding jejunostomy tube placed 
so that total parenteral nutrition could be with­
drawn.
Histopathologically, the pancreatic tumour 
was composed of small regular uniform cells 
displaying little or no mitotic activity (Fig. 4). 
These cells occurred in small ribbons and nests 
diagnostic of an islet-cell tumour of the pan­
creas. The margins of excision were free of 
tumour and regional lymph nodes were unin­
volved. Immunoperoxidase staining for 
parathormone was not carried out.
Postoperatively, there was a prompt and per­
manent fall in her serum calcium level, and 
during the early postoperative period she 
required intravenous calcium supplementation 
to maintain normocalcemia.
Her postoperative course was uncomplicated 
until day 4 when there was evidence of systemic 
sepsis. After appropriate culture specimens 
were taken, she was started on broad-spectrum 
antibiotics intravenously. Despite thorough 
clinical and radiologic investigations no focus 
of sepsis could be determined.
One week later, despite a normal serum cal­
cium level, she became confused and dysar- 
thric, as she was preoperatively. Blood and 
urine cultures now became consistently posi­
tive for Staphylococcus aureus. The investiga­
tions for phlebitis were negative and despite 
intravenous administration of cloxacillin, her 
neurologic symptoms failed to improve. A pan- 
systolic murmur developed and echocardiog­
raphy confirmed subacute bacterial endocardi­
tis with mitral regurgitation. Despite high-dose 
cloxacillin and fusidic acid therapy, her cardiac 
status deteriorated and placement of a porcine 
mitral valve was necessary. Postoperatively, her 
sepsis was controlled and her neurologic sta­
tus improved with a return of orientation and 
speech. Two years postoperatively her neuro­
logic status and serum calcium and serum 
parathormone levels were normal, with no clin­
ical evidence of tumour recurrence.
Discussion
The association of hypercalcemia with 
malignant disease is not uncommon and 
usually suggests metastatic disease involv­
ing bone or unrecognized hyper­
parathyroidism. Recent reports have 
drawn attention to the ability of various 
tumours to produce an elevated serum 
calcium level independent of bone 
metastases or parathyroid dysfunction, 
compatible with “ ectopic hyper­
parathyroidism” .7_11
Considerable controversy exists as to 
whether the hypercalcemia is indeed 
linked to ectopic production of parathor­
mone or to tumour synthesis of nonhor- 
monal substances capable of inducing 
hypercalcemia by separate mechanisms. 
These include osteoclast-activating factor 
and prostaglandins of tumour origin with 
effects on bone mimicking the action of 
parathormone. Recent work12 has sug­
gested that certain tumours induce hyper­
calcemia by stimulating adenylate cyclase 
in bone through secretion of substances 
immunologically distinct from parathor­
mone. As suggested by Skrabanek and 
colleagues13 criteria that suggest ectopic 
parathormone secretion include: hyper­
calcemia with normal parathyroid glands, 
the absence of bone metastases, correc­
tion of hypercalcemia following removal 
of the tumour and elevation of parathor­
mone in the tumour and the blood. A 
thorough analysis of the literature failed 
to reveal any case reports that unequivo­
cally met these criteria and it was sug­
gested that hypercalcemia in association 
with neoplasia may have a variety of etiol­
ogies independent of parathormone.
A number of recent case reports7'11 
have described the association of hyper­
calcemia with islet-cell neoplasia of the 
pancreas. As in our case, the rigid criteria 
for ectopic hyperparathyroidism are 
difficult to fulfil with certainty, and these 
cases possibly represent secretion by the 
tumour of a stimulus of hypercalcemia 
distinct from parathormone.
The ability of pancreatic endocrine cells 
to secrete a variety of hormonally active 
peptides, including parathormone, may 
be linked to the APUD concept, the islet 
cell being one of a number with a com­
mon neural crest origin.14-15 This imma­
ture stem cell likely becomes undifferen­
tiated with the neoplastic process and 
acquires the ability to secrete peptides 
with varying endocrine effects.16
Although hypercalcemia in association 
with a pancreatic mass is easily attributed 
to skeletal metastases, isolated spread to 
bone is uncommon in pancreatic 
adenocarcinoma17 and should suggest 
other causes. The diagnosis of hyper­
parathyroidism is suggested by a series of 
associated biochemical abnormalities 
including decreased serum phosphate and 
elevated serum chloride levels, both of 
which are also compatible with pseudo­
hyperparathyroidism. The differentiation 
of these two disorders may be made by 
the detection of an elevated serum 
parathormone level in primary hyper-
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parathyroidism. However, the value o f 
parathormone radioimmunoassay 
remains controversial because o f difficul­
ties in interpreting values as a result o f 
immunologic heterogeneity and inter­
laboratory variation.18 The finding o f a 
normal serum parathormone level in our 
patient suggests the presence o f other fac­
tors related to the neoplasm that may 
have induced hypercalcemia.
Although thiazide diuretics may induce 
hypercalcemia, it persisted in our patient 
for several weeks after they were discon­
tinued. The multiple endocrine adenoma­
tosis, type 1, syndrome is always a diag­
nostic consideration in association with 
endocrine tumours o f the pancreas. It 
could reasonably be excluded in our 
patient by the presence o f a normal skull 
x-ray film and computerized tomogram 
indicating the absence o f pituitary 
neoplasia.
The symptoms o f hypercalcemia are 
often nonspecific, with involvement o f 
multiple organ systems that may easily be 
attributed to the neoplasm itself rather 
than the underlying metabolic distur­
bance. Prompt recognition o f hypercalce­
mia associated with neoplasm is impor­
tant because o f its often fulminant course 
and failure to respond to conservative 
medical measures. Our case illustrates this 
point with permanent control o f the 
serum calcium level being achieved only 
after the tumour had been surgically 
resected.
Unlike adenocarcinoma, islet-cell 
tumours o f  the pancreas are often indo­
lent, slow-growing neoplasms with the 
potential for long-term patient survival 
after recognition and appropriate 
management. For this reason it is imper­
ative that any mass arising from the pan­
creas be confirmed as adenocarcinoma 
before abandoning an aggressive surgical 
approach. As in our case, this lesion may 
be highly vascular with a risk o f profuse 
bleeding at attempted biopsy.
Because o f the poor prognosis o f pan­
creatic adenocarcinoma, with invasion 
into contiguous organs, radical surgery is 
contraindicated. In contrast, the less- 
aggressive nature o f islet-cell neoplasms 
warrants an en bloc resection o f all 
involved tumour if  technically feasi­
ble.2’9'19 Indeed, in view o f the possibil­
ity of life-threatening associated hor­
monal effects, resection o f isolated 
hepatic metastases has been advocated, as 
this may provide effective palliation for 
the slow-growing tumour. Unresectable 
or metastatic tumours have been reported 
to respond favourably to streptozotocin 
chemotherapy with prompt regression o f 
associated systemic effects.7,8
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Snowblower Injuries to the Hand
A single heavy snowstorm in Saskatoon 
in late 1984 resulted in nine patients 
sustaining snowblower injuries to 19 
digits. Factors leading to injury included 
rapid onset of colder temperatures, sud­
den reuse of snowblowers after storage 
for the summer, a heavy mid-week storm 
that created a sense of urgency to clear 
snow in dusky light conditions after a 
day at work, frustration as exit chutes 
became repeatedly clogged with heavy 
wet snow and limited operator educa­
tion. The injuries themselves resembled 
low-velocity "missile" injuries. A practi­
cal preventive measure would be to 
encourage manufacturers to equip 
machines with remotely located spring­
opening clutches.
Au cours d'une seule tempete de neige 
forte survenue a Saskatoon a la fin de 
1984, neuf patients ont subi des blessu- 
res causee par des souffleuses a neige, 
impliquant 19 doigts. Plusieurs facteurs 
ont contribue aux blessures dont une 
chute rapide de la temperature, la reutili­
sation soudaine de la souffleuse a neige 
aprbs remisage pour l'etd, une forte tem­
pete en milieu de semaine qui a cree un 
besoin urgent de nettoyer la neige dans 
la semi-obscurity apres une journge de 
travail, la frustration decoulant du bio- 
cage repute de la cheminee d'evacuation 
par une neige lourde et mouillee et le 
peu d'experience des utilisateurs. Les 
blessures en soi ressemblaient a des 
Idsions par des "projectiles" a faible 
velocite. Une mesure pryventive pratique 
consisterait a inciter les fabriquants a 
equiper leurs machines d'embrayages a 
ressort places y distance.
On Oct. 16, 1984, an unusually early 
snowstorm hit Saskatoon. Forty cen­
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timetres of wet heavy snow fell on the city 
— an unusual occurrence in an area that 
usually receives a light fluffy powder. 
Driving was nearly impossible and a sense 
of urgency forced people to clear away 
the rapid accumulations of snow. The wet 
snow did not flow smoothly through 
snowblowers and accidents happened. 
Within 48 hours we saw and treated nine 
patients with injuries to 19 digits caused 
by snowblowers.
Mechanism of Injury
Snowblower design varies, but the typi­
cal homeowner’s model is a two-stage 
gasoline-powered machine (Figs. 1 and 2). 
The first stage is a slowly rotating auger 
mounted at the front. This passes snow 
back to the second stage which is an 
impeller blade that rotates rapidly to 
throw snow out of an exit chute. Both 
auger and impeller are driven from the 
gasoline-powered engine. A system of 
belts and pulleys reduces the high engine 
revolutions to the correct rate for the 
turning blades. A clutch allows for dis­
engagement of the auger and impeller 
from the engine.
Most hand injuries occur when the 
patient’s fingers are struck by the impeller 
blade whilst clearing snow out of a 
clogged exit chute. The impeller blades 
are close to the exit chute opening which 
is frequently not guarded.
Patients and Method
The inpatient and outpatient charts of 
the nine patients (eight men, one woman)
FIG. 1—Typical homeowners’ two-stage gasoline-powered snowblower.
were analysed with respect to age, sex, 
hand dominance, location of accident, 
injuries sustained, management and out­
come. Nine months after treatment, all 
patients were called back for follow-up 
examination and more-detailed question­
ing about the circumstances of their 
injury.
Findings
Nine patients sustained 21 injuries to 
19 digits (Fig. 3). Six had multiple finger 
involvement with segmental injuries to 
two digits. The patients ranged in age 
from 25 to 68 years. All patients were 
right handed and in only one was the non­
dominant hand involved. Only one acci­
dent occurred in the work place, the 
remainder happened at the patient’s 
home.
Two patients sustained their hand 
injuries unclogging jammed first-stage 
augers. The other seven patients were 
injured by second-stage impeller blades, 
six of them attempting to clear clogged 
exit chutes and one when using the exit 
chute as a handle to lift the machine out 
of a snow drift. None of the machines 
were fitted with proper safety clutches. 
Asked how their injuries had occurred, 
seven of the nine said they put their hands 
into the moving blades hastily without 
thinking or because they thought there 
was more distance between the exit-chute 
opening and the rotating impeller blade 
or because they thought that the first- 
stage auger was the only blade on the 
machine. Two patients, however, had 
turned their snowblower off but reached
FIG. 2—Diagrammatic representation of working parts of two-stage gasoline-powered snowblower.
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inside before the blades had stopped 
spinning.
All injuries were distal to the metacar­
pophalangeal joints and in each case the 
blade hit the dorsum of the digit. Apart 
from the complete amputations, there 
were no flexor tendon injuries and only 
one digital nerve laceration. This was on 
the radial side of a ring finger and, 
because it was only partial and very dis­
tal, repair was not carried out. Injuries 
ranged from skin lacerations through 
open fractures to complete amputations. 
All patients were treated with antibiotics, 
tetanus prophylaxis when necessary, 
wound excision, primary repair and 
closure of tissues. Efforts were made to 
conserve as much of the patients’ fingers 
as possible.
Ten amputations occurred, 7 through 
distal phalanges and 3 through middle 
phalanges. Replantation was not possible 
for any of the amputations, either because 
injuries occurred distal to the digital 
artery trifurcation or because of distal 
segment damage. Three amputations were 
distal with no exposed bone. These were 
covered with a split-thickness skin graft. 
The seven others were closed with phalan­
geal shortening and using local skin flaps.
There were eight open fractures, two 
in middle phalanges and six in distal 
phalanges. In each case, the fracture was 
explored and its wound excised and copi­
ously irrigated. After reduction, Kirsch- 
ner wires were used for internal fixation, 
avoiding transfixion of the distal inter- 
phalangeal joint whenever possible. Apart 
from carefully repairing the specialized 
nailbed tissue, all other lacerated skin was 
only very loosely approximated.
There was one open dislocation of a 
distal interphalangeal joint. This was 
cleaned like an open fracture and then
FIG. 3—Distribution of injuries sustained 
by nine patients.
primarily fused with a single transarticu- 
lar Kirschner wire. The remaining two 
injuries were skin lacerations, which were 
excised, irrigated and sutured.
All patients had sutures removed within 
7 to 10 days and were followed up for 9 
months.
There were no postoperative infections 
or ischemic flaps or fingertips. No ampu­
tations required revision and, in particu­
lar, there were no problems with digital 
nerve neuromas, paresthetic flaps or tight 
or unsightly amputation stumps. None of 
the patients who had undergone ampu­
tation  experienced quadriga or 
“ lumbrical-plus” syndrome. In patients 
with proximal digital injuries, tendon 
adhesion was not a problem and thus 
tenolysis was never necessary. Intolerance 
to cold was experienced by six patients but 
was always mild. Other forms of cutane­
ous hypersensitivity were not seen. The 
patient with the digital nerve injury 
achieved 8-mm two-point discrimination 
by the end of follow-up and this pro­
duced no functional disability.
Rehabilitation was started immediately 
postoperatively as none of the injuries 
needed cast immobilization. Patients were 
seen weekly until rehabilitation was com­
plete and the clinic therapist strongly 
encouraged active motion. Only two 
joints did not achieve a full active range 
of motion within 6 weeks. One was the 
fused distal interphalangeal joint, in 
which there was complete bony union and 
good function by 3 months. The other 
was in a patient with an open fracture of 
the distal phalanx who received 1 week 
of formal hand therapy during the second 
month and eventually achieved 0° to 40° 
of active motion. All patients had 
returned to work by 6 weeks.
Discussion
Few publications have reported on 
snowblower injuries to the hand. There 
have been three epidemiologic studies,1-3 
which demonstrated that most injuries 
occurred when patients used their hands 
to clear blocked exit chutes. Accidents 
were most likely in heavy wet snow con­
ditions and at a time when people were 
relatively unprepared, not having used the 
machines over the summer months. Other 
etiologic factors were operator inex­
perience and inadequately functioning 
machines. In our study, factors leading 
to injury were similar: rapid onset of 
colder temperatures, sudden need for 
snowblowers after storage for the sum­
mer, a mid-week storm with an urgency 
to clear snow in poor light after a day at 
work, frustration as exit chutes became 
repeatedly clogged with heavy wet snow 
and limited operator education.
Only one previous paper4 has been 
concerned with the injuries themselves. In 
a biomechanical study, Barry and Linton
compared the speed of the blade tips and 
kinetic energy between rotary lawn- 
mowers and snowblowers. Results 
showed that lawnmower injuries were 
comparable to those from high-velocity 
missiles whereas snowblower injuries were 
more like those from low-velocity mis­
siles. For this reason, patients in this series 
were treated with thorough but minimal 
wound excision and wounds were closed 
primarily. The cosmetic and functional 
results were good, patients returned to 
work early, and the troublesome compli­
cations that frequently occur after trauma 
to the fingers were not seen. These results 
were typical of those associated with low- 
velocity missiles.
With respect to the exact mechanism of 
injury, snowblower injuries, unlike many 
other forms of accident are frequently 
related to the machines themselves. Most 
of the people stated that they were sur­
prised how close the impeller was to the 
exit chute opening and some did not even 
know that there was a second-stage 
impeller. Improved operator education 
would theoretically be the ideal way to 
prevent these injuries from occurring. 
Unfortunately, because of the sporadic 
use of snowblowers by the casual opera­
tor, simple safety rules have either never 
been learned or been long forgotten. Most 
patients also admitted that, at the time of 
injury, they were hurrying to keep up with 
an overwhelming quantity of snow, were 
frustrated because of the repeatedly 
clogged exit chutes and acted hastily 
without really thinking about what they 
were doing.
Several newer snowblower models have 
spring-loaded safety clutch bars mounted 
on the handles and require two hands to 
be gripping the handle bar in order to 
have power engaged on the rotating 
blades. With machines constructed in this 
way, it should not be possible to reach 
both clutch bars and rotating blades at the 
same time. Theoretically, therefore, if all 
machines were built in this manner, the 
number of accidents could be considera­
bly reduced, particularly if impeller blades 
were made to stop turning abruptly when 
the clutch bar was released.
It would seem that the most practical 
preventable measure would be to improve 
the safety of snowblowers, and manufac­
turers should be encouraged to fit all 
snowblowers with similar remotely 
located spring-opening clutches.
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BILL 022
Rx FOR QUALITY HEALTH CARE
The new drug patent bill has sparked political debates, advocacy cam­
paigns, and a degree of public 
concern. PMAC wishes all 
practising health professionals 
to  understand how these 
changes will affect the quali­
ty of health care and the cost
of drugs for Canadians. Here are the facts from which you 
can judge the benefits of Bill C-22 for yourself and your 
patients.
KEY FEATURES OF BILL C-22
Recognizes intellectual property o f health scientists 
Bill C-22 restores partial recognition of the intellectual prop­
erty of the inventors of new and improved drug products by 
preventing a generic company from copying the product for 
seven or ten years depending on whether or not the generic 
company makes the fine chemical in Canada. These fixed 
periods of protection are shorter than those provided by all 
of our western industrialized trading partners. Nevertheless, 
Bill C-22 does establish a fixed period of protection where 
none exists today.
Creates a Favorable Investment Climate 
Fourteen individual PMAC members have already public­
ly announced that they will spend more than $500 million 
over the next five years on new research and development. 
In total, PMAC has made a commitment to the government 
to double the rate of research and development spending over 
the next ten years. Total funding will be $3.0 billion, of which 
$1.4 billion is due to changes in Bill C-22 and the favorable 
investment climate it creates. This funding will directly create 
3,000 high-tech jobs. The Bill also establishes a full govern­
ment review of the industry’s commitments after four and 
ten years. Failure to honor these commitments will result in 
a loss of protection.
Improves Quality o f Health Care 
Quality biomedical research is at the heart of the best health 
care systems. The more we have of biomedical research of 
the highest calibre, the more our society gains from earlier 
access to new medicines and medical procedures with an 
overall improvement in quality of life. The $3.0 billion that 
the industry will spend on Canadian research over the next 
ten years is more than j ust money and high-tech jobs for our 
university graduates. It is an investment in new, high quali­
ty treatment for AIDS, cancer, Alzeheimer’s and other 
diseases. It is an investment in the health care of the 21st 
century.
Protects Patients from  High Prices
Bill C-22 creates a Drug Price Review Board which will limit
the amount manufacturers can charge for a new product
C a n a d a  s  n e w
DRUG PATENT BILL C-22 
-W HAT DOES IT M EAN  
FOR YOU
AND YOUR PATIENTS?
and the am ount o f yearly 
price increases. The Board will 
determine if the prices of new 
products are excessive by com­
paring them against the prices 
of existing products in the 
same therapeutic class. The 
Board will limit the rate of an­
nual price increases for all pro­
tected products to no more than that of the Consumer Price 
Index. Manufacturers that fail to abide by a directive of the 
Price Board will immediately lose protection for their 
products.
Maintains Availability o f Generic Products 
Under Bill C-22, all generic products on the market will re­
main on the market. Forty (40) more high volume generic 
products will reach the market over the next five years as pro­
tection periods expire. This is three times the number of gen­
eric products that reached the market in the past five years.
BILL C-22 A QUALITY Rx FOR CANADA
. ill C-22 is a positive reward to the inventor who has 
.investigated 10,000 chemicals, spent ten years time, 
'  and invested $100 million to develop his one new pro­
duct for better health. Bill C-22 stimulates biomedical 
research in Canada to develop cures for the 21st century. Bill 
C-22 protects patients by creating a new powerful Board to 
regulate prices. Bill C-22 is a fair balance to all.
You be the judge. If you think the benefits of Bill C-22 are 
good for Canada, please write to the Prime Minister, or 
sign and send him  this 
prescription for Canadian 
health care.
PMAC thanks you for your 
support.
B!
PHARMACEUTICAL MANUFACTURERS ASSOCIATION OF CANADA 
Innovation ond Social Responsibility
For:
Address:
Date:
Rx
The Honourable Brian Mulroney, Prime Minister of Canada 
Langevin Building, Wellington Street 
Ottawa, Ontario K1A 0A2
BILL C-22
A sound policy for consumer protection, expanded biomedical 
research, and quality health care for all Canadians.
As a Canadian professional health practitioner, I support this 
policy.
LE PROJET DE LOIC-22
Rx: SO IN S DE QUALITE
Le nouveau projet de loi sur Ies brevets pharma- ceutiques a dedenche un debat politique, des campagnes 
d ’opinion et une certaine contro- 
verse publique LACIM souhaite 
que tous les praticiens du secteur 
de la sante soient au courant de 
la faqon dont les reformes pro­
posers influeront sur la qualite 
des soins et sur le cout des medicaments. Voici done des faits qui 
vous permettront de juger des avantages que presente le projet 
de loi C-22 pour vous-meme et pour vos patients.
LES GRANDES LIGNES DE LA REFORME
Reconnaissance de la propriete intellectuelle des scientifiques 
Le projet de loi C-22 retablit en partie les droits de propriete in­
tellectuelle de ceux qui decouvrent de nouveaux medicaments 
ou qui perfectionnent des produits pharmaceutiques existants. 
Pour ce faire, la nouvelle loi in terdira aux fabricants de 
medicaments generiques de copier les produits brevetes pendant 
une periode de sept ou dix ans selon qu ’ils se livrent ou non a la 
production de chimie fine au Canada. La duree de cette protec­
tion est certes plus courte que celle que garantissent tous nos 
partenaires industrialises occidentaux, mais l’adoption d ’une 
periode fixe est deja un grand progres pour le Canada.
Instauration d 'un climat favorable aux investissements 
Quatorze laboratoires pharmaceutiques membres de l’ACIM ont 
deja annonce q u ’ils ailoueront plus de 500 millions de dollars 
leurs budgets de recherche-developpement au cours des cinq pro- 
chaines annees. Au total, l’ACIM s’est engagee envers le gouveme- 
m ent a  doub le r le niveau des depenses de recherche- 
developpement dans un delai de dix ans. Le budget total de la 
recherche s’elevera a 3 milliards de dollars, dont 1,4 milliard pro- 
venant directement des reformes introduites par le projet de loi 
C-22 et du climat favorable qu ’il contribuera a creer en matiere 
d ’investissement. Ce niveau de financement permettra de creer 
directement 3 000 emplois dans un secteur de pointe. La nouvelle 
loi prevoit egalement que les pouvoirs publics passeront integrale- 
ment en revue le niveau de realisation des engagements pris par 
l’industrie quatre ans et dix ans apres 1’adoption de la reforme. 
Les entreprises qui ne tiendront pas promesse seront privees de 
leur exclusivite.
Une garantie contre !a cherte des 
medicaments
Le projet de loi C-22 prevoit la 
creation d ’un Conseil d ’examin 
des prix des medicaments qui 
limitera le prix de lancement des 
medicaments nouveaux et le 
montant des hausses periodi- 
ques. Pour les nouveaux medi­
caments, le Conseil procedera 
par comparaison avec les prix des produits existants dans cha- 
que categorie therapeutique. Le prix d ’aucun produit exclusif ne 
pourra augmenter plus vite que la progression annuelle de l’in- 
dice des prix a la consommation. Tout laboratoire qui ne respecte 
pas les directives du Conseil d ’examin sera immediatement prive 
de son exclusivite pour ses produits.
Maintien des produits generiques sur le marche
Aux termes de la nouvelle loi, tous les produits generiques ac- 
tuels pourront rester sur le marche Une quarantaine de nouveaux 
produits generiques a grand debit seront mis sur le marche d ’ici 
cinq ans a  mesure q u ’expireront les brevets qui les protegent en­
core Ce chiffre est cinq fois plus eleve que le nombre de produits 
generiques lances depuis cinq ans.
LE PROJET DE LOI C-22: Rx QUALITE POUR LE CANADA
Le projet de loi C-22 recompense de facon tangible l’inven- teur qui, en dix annees de travail, a etudie 10000 molecules et investi 100 millions de dollars pour mettre au point un 
medicament nouveau afin de proteger la sante. Le projet de loi 
C-22 stimule la recherche biomedicale au Canada pour conquerir 
les maladies du X X Ie siecle. Le projet de loi C-22 protege les 
patients en creant une puissant Conseil d ’examin des prix. Le pro­
jet de loi C-22 rend justice a tous.
Jugez-en vous-meme. Si vous pensez que le projet de loi C-22 est 
bon pour notre pays, ecrivez 
au  P rem ier m in istre  du 
Canada, ou signez cette or- 
donnance dum ent remplie 
pour assurer la sante future 
des Canadiens.
L’ACIM  vous rem ercie de 
votre appui.
L e n o u v e a u  p r o  je t
DE LOI CANADIENNE 
SUR LES BREVETS (C-22): 
REPERCUSSIONS POUR VOUS 
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Amelioration de la qualite des soins
La qualite de la recherche biomedicale est garante de la qualite 
des soins. Plus le niveau de la recherche biomedicale canadienne 
s’eleve, plus notre pays profite de la disponibilite immediate de 
medicaments et traitements nouveaux, et plus notre qualite de 
vie s’ameliore. Les 3 milliards de dollars que l’industrie consacrera 
en dix ans a la recherche canadienne ne serviront pas seulement 
a ameliorer les revenus de nos chercheurs et a creer des emplois 
pour nos diplomes. C ’est un investissement dans la qualite future 
des soins qui permettront de lutter contre le SIDA, le cancer, la 
maladie d ’Alzheimer et les autres maladies encore invaincues ou 
imparfaitement maitrisees. C ’est un investissement dans la sante 
des Canadiens au XXL' siecle.
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Arthrodesis of the Wrist
In a retrospective study, the wrists of 18 
patients who underwent arthrodesis by 
the AO technique were assessed clini­
cally, for hand strength and function. 
Follow-up averaged 4 years (range from 
1 to 7 years). Although wrist arthrodesis 
improved grip strength, it was still only 
50% to 60% of normal. Hand function 
improved to within normal limits in 78% 
of patients and bony union occurred in 
94.4% . Thirteen patients were back at 
work within 18 months. The AO tech­
nique of wrist arthrodesis allows correc­
tion of deformity, relief of pain, 
increased grip strength and improved 
hand function.
Ce fut une etude retrospective de 18 
patients ayant recu une arthrodfese du 
poignet utilisant la techique AO. La 
moyenne de post-observation fut de 4 
ans avec une portde de 1 S 7 ans. Tous 
les patients furent cliniquement evalues 
ainsi que d'eprouver des assais formaux 
pour I'intensite et fonction de la main. 
Les r6sultats ont demontre que le taux 
d'union fut 94.4% . Malgrds que I'arthro- 
dese du poignet amdliore la force de ser- 
rage; ce n'est que 50% & 60% dans les 
limites de la normal chez 78% des 
patients. Treize patients retourn&rent au 
travail en dedans de 18 mois. Alors la 
technique AO d’arthrod&se du poignet 
alloue une bonne amelioration de ddfor- 
mite, soulage la douleur, augmente I'in- 
tensite de serrage et am£liore la fonction 
de la main.
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Arthrodesis is an excellent procedure for 
improving function in a disabled wrist. 
Although the literature shows that sur­
geons agree on the desirability for a posi­
tion of slight dorsiflexion, the technique 
used to achieve fusion varies.1-6 In this 
study the method of compression arthro­
desis of the wrist was in accordance with 
the principles for stable internal 
osteosynthesis described by Muller and 
colleagues.7
The current indications for wrist fusion 
include irreversible destruction secondary 
to rheumatoid arthritis or osteoarthritis, 
causing prolonged pain and deformity, 
and flaccid or spastic paresis causing 
difficulty in using the hand.
Materials and Methods
The charts of 30 patients who under­
went wrist arthrodesis at the Victoria 
General Hospital in Halifax in the 7 years 
between 1974 and 1981 were reviewed. Of 
these, 18 patients were assessed clinically 
and form the basis of this study. In 15 
cases the fusion was required for trau­
matic osteoarthritis, in 2 it was secondary 
to inflammatory disease and in 1 to a 
spastic monoplegia secondary to trauma. 
The follow-up averaged 4 years (range 
from 1 to 7 years).
Operative Method
Under general anesthesia, a tourniquet 
is applied high on the upper arm and 
inflated to 250 mm Hg. The wrist area is 
prepared and draped. The joint is exposed 
with a standard dorsal approach.. Artic­
ular cartilage is removed with hand-held 
curettes, rongeurs and a Hall drill. A 
trough is then created from the radius to 
the second and third metacarpals and a 
bone graft from the iliac crest is fashioned 
as a slab to fit the trough. Small cancel­
lous bone grafts should be packed into the 
intercarpal and radiocarpal joints. The 
dynamic compression plate (six- to seven- 
holes narrow 4.5 mm) is then contoured 
to 10° to 20° of dorsiflexion while its 
position on the second metacarpal should 
allow 5° of ulnar deviation. The plate is
anchored over the bone graft by at least 
two screws in the second metacarpal, one 
in the carpus and at least three in the 
radius. Care should be taken to prevent 
the extensor pollicis longus from cross­
ing a screw head, as there have been 
reports of rupture secondary to attrition. 
The tourniquet is released, hemostasis 
obtained and the wound irrigated and 
closed over a Hemovac drain. Operating 
time is approximately 60 minutes.
Postoperative Care
All patients wore a protective gauntlet 
for 2 to 4 weeks. Physiotherapy was 
begun within 7 days. The hardware was 
left in for an average of 2 years.
Results
The patients in this study were tested 
for hand strength by the method outlined 
by the Sister Kenny Institute,8 and for 
hand function according to the method 
of Jebsen and colleagues.9 These inves­
tigators administered tests to more than 
300 people with normal hands and drew 
up tables, adjusting the results for age, 
sex and dominant versus non-dominant 
hand.
In order to assess hand strenght, 
the 18 patients were first given four 
tests: grip strength, palmar pinch, three- 
point pinch and lateral pinch. The results 
were compared with those for normal 
hands (Table I). The wrist that required 
arthrodesis for painful tenosynovitis, was 
in the 90*70 to 100% group. The two 
wrists in the 10% to 25% group were 
fused in 5% to 10% ulnar deviation. One 
of the three in the under 10% group had 
associated median and ulnar nerve pal-
Table 1--Hand Strength
Percent of normal Wrist arthrodesis
90 - 100 1
75 -  90 0
50 -  75 10
25 -  50 2
10 - 25 2
< 10 3
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sies, one had a pseudarthrosis and the 
third was the only patient in the study 
with spastic monoplegia.
Hand function was then assessed by 
giving each patient the following tests and 
relating them to time: (a) writing, (b) abil­
ity to pick up a small common object, (c) 
simulated feeding using a spoon, (d) abil­
ity to stack checkers, (e) ability to han­
dle large light objects and (f) ability to 
handle large heavy objects.
The results of these timed trials were 
then related to the normal, as drawn up 
by Jebson and colleagues9 (Table II). 
The patient with pseudarthrosis was 
within 1 standard deviation of normal but 
three others scored greater than two stan­
dard deviations. One had median and 
ulnar nerve palsies, one had spastic 
paraplegia and the third had chronic ulnar 
osteomyelitis. Therefore, after fusion, 
78% had acceptable hand function.
Patients were also asked to evaluate 
their wrists subjectively with respect to 
function and pain. The results were as fol­
lows: excellent -  no pain and unlimited 
activity, good -  no pain but some limited 
activity, fair -  minimal discomfort and 
limited activity, poor -  increased pain 
with activity (Table III). Two patients in 
the good group were unhappy with the 
wrist position, complaining of too much 
flexion. One in the fair group and one in 
the poor group complained of pain over 
the plate. All but one patient in the poor 
group, who had the pseudarthrosis, felt 
that the discomfort was much reduced 
and functional level improved over the 
preoperative state.
Complications
Only one pseudarthrosis developed, 
giving a union rate of 94.4%. This nonun­
ion was the direct result of a split frac­
ture of the second metacarpal which, 
despite external im m obilization, 
progressed to pseudarthrosis.
There were two infections. One was 
superficial and cleared with antibiotic 
treatment and wound care within 2 weeks. 
The other was treated with antibiotics for 
1 year and at follow-up after 5 years 
showed good union, with the plate still 
firmly in position.
Table 11-Hand Function
Range Wrist arthrodesis
Normal 14
1 std deviation 1
>  2 std deviations 3
Table II I- Subjective Evaluation of Function
Evaluation Wrist arthrodesis
Excellent 12
Good 3
Fair 1
Poor 2
Discussion
Previous techniques, using external fix­
ation to immobilize the wrists, were com­
plicated by pseudarthroses. With bone 
grafts the frequency of this complication 
is reported to range between 2% and 
12%. However, cast fixation for as long 
as 4 to 6 months, with further protection 
in a splint, may be required to obtain ade­
quate union. With the AO technique, 
union was obtained in our study in all 
wrists but one, and in that case nonun­
ion was secondary to a split fracture of 
the second metacarpal. If a split fracture 
does occur it should be repaired opera­
tively to achieve rigid internal fixation.
Arthrodesis of the wrist should result 
in an increase in the power of grip but, 
as this study shows, not much more than 
50% to 60% of normal can be expected. 
By using internal fixation the patient has 
an early start in the use of the hand, 
thereby minimizing the risk of adhesions 
between the skin and the gliding exten­
sor mechanism.
The plate should be placed on the 
second metacarpal bone, radial to the ten­
dons of the extensor digitorum communis 
muscle. It does not seem to impair func­
tion of the extensor pollicis longus 
although rupture of that tendon has been 
reported,7 probably caused by the ten­
don crossing over one of the screw heads.
The use of a dynamic compression 
plate is recommended, as opposed to the 
narrow plate and compression instrument 
described by Muller and colleagues.7 The 
dynamic compression plate gives ade­
quate compression and does not require 
the extra exposure demanded by the com­
pression instrument.
The plate should probably be removed 
between 6 and 12 months postoperatively. 
This is supported by Uhthoff and 
Dubuc10 who noted that periosteal 
resorption occurred after 6 months of 
application of a plate. However, it is very 
difficult to tell if the fusion is solid and 
this accounted for our delay. Bone 
remodelling and regression of the 
osteopenia occur after the plate is 
removed.10'11
Hand function was improved to within 
acceptable limits in 78% of the wrists 
operated on. The poor results were due 
to pseudarthrosis, nerve palsy, spastic 
monoplegia and chronic osteomyelitis. 
Seventy-two percent of our patients were 
back at work within 18 months of oper­
ation.
Arthrodesis of the wrist using the AO 
technique offers a stable internal fixation 
that gives optimum conditions for rapid 
bony union. It allows correction of defor­
mity, relief of pain, and better hand grip 
and function. The most important con­
tribution of this technique is the high rate 
of fusion despite major deformity 
preoperatively.
We acknowledge the work o f Cathy 
McAuley and Jill Tasker from the Dalhousie 
University Physiotherapy Department.
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NOTICES
First In ternationa l 
Shock Congress
The First International Shock Congress 
and the Tenth Annual Conference on 
Shock will be held in Montreal, June 
7-11, 1987. The scientific program will 
consist of workshops, symposia, submit­
ted papers and poster presentations. As 
well, the four finalists of the Young In­
vestigator Awards Competition will 
present their work. For information con­
tact Dr. Sherwood M. Reichard, Medi­
cal College of Georgia, Augusta, GA 
30912.
Continuing Education  
—  G astroentero logy
The University of Rochester School of 
Medicine is sponsoring a course entitled 
“ Rochester Review in Gastroenterology” 
in Toronto, Oct. 8-10, 1987. Dr. Jagdish 
C. Mangla is the course director and Dr. 
Sheila Sherlock from The Royal Free 
Hospital in London the guest speaker. In­
formation can be obtained from: Office 
of Continuing Professional Education, 
UR Medical Center, 601 Elmwood Ave., 
Box 677, Rochester, NY 14642 (tele­
phone: [716] 275-4392).
continued on page 141
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Successful Treatment of a Traumatic Hepatic 
Artery-Portal Vein Arteriovenous Fistula 
by Interpositional Mesocaval Shunting
Hepatic artery-portal vein fistula is an 
occasional sequel to invasive procedures 
on the liver, such as biopsy and trans- 
hepatic cholangiography. When the 
fistula is large it may result in portal 
hypertension, gastrointestinal bleeding 
and histologic and functional changes in 
the liver. Treatment is usually directed at 
the fistula, either embolizing, dividing or 
resecting it. Portal decompression has 
been discouraged in the past. The 
authors describe a case in which recur­
rent gastrointestinal bleeding, uncon­
trolled by attempts at embolization, was 
subsequently managed successfully by 
portosystemic shunting. They suggest 
that when the primary symptom related 
to the fistula is variceal bleeding, portal 
decompression is a reasonable therapeu­
tic option.
Une fistule entre Tartfere hepatique et la 
veine porte apparait en de rares occa­
sions comme sequelle d'une intervention 
avec penetration hepatique telle qu'une 
biopsie ou une cholangiographie trans- 
hepatique. Dans les cas de fistules 
importantes il peut s'ensuivre une hyper­
tension porte, des saignements gastro- 
intestinaux ainsi que des modifications 
histologiques et fonctionnelles du foie.
On s'applique habituellement a corriger la 
fistule, soit par embolisation, separation 
ou resection. Dans le passe, la decom­
pression du systeme porte a etd decon- 
seillee. Les auteurs decrivent un cas ou 
des saignements gastro-intestinaux reci- 
divants, non corriges par une tentative 
d'embolisation, ont pu etre reprimes par 
la suite par une derivation du systeme 
porte. Ms suggerent que quand le 
symptome primaire de la fistule est 
I'hemorragie variqueuse, la decompres­
sion du systeme porte est une option 
therapeutique acceptable.
From the *Department o f  Surgery and 
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Toronto, Toronto, Ont. and the %Division 
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Edmonton, Alta.
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Hepatic artery-portal vein arteriovenous 
fistulas are very rare but potentially fatal. 
A small number are congenital but most 
are a result o f penetrating trauma,1 
including surgical manipulation or inva­
sive diagnostic procedures such as needle 
biopsy or percutaneous transhepatic 
cholangiography.1 In fact, with the 
increased use of diagnostic angiography, 
asymptomatic arteriovenous fistulas 
secondary to percutaneous needle punc­
ture are often identified.2
Symptoms are proportional to the size 
o f the fistula, with large fistulas leading 
to portal hypertension and its complica­
tions. After angiographic confirmation of 
the diagnosis, treatment is usually surgi­
cal and directed at the fistula. Concern 
that treating the portal hypertension with 
a portosystemic shunt will precipitate 
cardiac failure appears to be more theo­
retical than real. This paper reports a 
patient with hepatic artery-portal vein 
fistula whose serious portal hypertension 
was treated successfully by mesocaval 
shunting.
Case Report
A 67-year-old woman, who had no history 
of alcoholism, was referred to the Toronto 
General Hospital in July 1984 for treatment of 
upper gastrointestinal bleeding. Her medical 
history included long-standing peptic ulcer dis­
ease, treated with cimetidine, and a gastric fun- 
doplication performed in 1977 at which time 
splenectomy was necessary due to intraopera­
tive injury. In 1978 a percutaneous needle 
biopsy of the right lobe of the liver was per­
formed during investigation of jaundice and 
dem onstrated steatosis histologically. 
Endoscopy carried out for an upper gastroin­
testinal hemorrhage in January 1982 revealed 
esophagitis and gastritis. A second percutane­
ous biopsy of the right lobe of the liver, done 
in 1982, showed nonalcoholic steatonecrosis 
and fibrosis. In May 1982, a second, major 
upper gastrointestinal hemorrhage occurred. 
Bleeding esophageal varices were seen on 
endoscopy; these were managed conservatively. 
Angiography demonstrated a large fistula 
between a branch of the right hepatic artery 
and the portal vein (Fig. 1). Gelfoam emboli­
zation of the right hepatic artery was per­
formed with successful closure of the fistula 
(Fig. 2). Hematemesis recurred in October 1983,
and endoscopy demonstrated a chronic duo­
denal ulcer and esophageal varices which were 
thought to be the source of the bleeding. A 
superior mesenteric arteriogram revealed that 
the hepatic arteriovenous fistula was patent, 
so embolization was repeated using wire coils 
(Fig. 3). At follow-up endoscopy 1 week later, 
the varices were flat with no evident bleeding.
A left nephrectomy was performed in 
November 1983 for removal of a suspicious left 
renal mass, which was found to be a benign 
nephroma. The patient remained well for 8 
months when she had massive hematemesis, 
preceded by a 2-week history of melena, nausea 
and malaise. No ulcer was present but
FIG. 1—Initial angiogram demonstrating 
fistula (arrow) between branch of right hepatic 
artery and portal vein.
FIG. 2—Angiogram after Gelfoam emboli­
zation of hepatic artery-portal vein fistula.
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esophageal varices were again seen. These were 
sclerosed with 3% sodium tetradecyl sulfate 
(Thrombovar) and an intravenous infusion of 
Pitressin was started. Angiography demon­
strated that the hepatic artery-portal vein 
fistula in the right lobe of the liver was again 
patent. She was transferred to the Toronto 
General Hospital for further management.
On admission she was hemodynamically sta­
ble, not icteric and had no peripheral stigmas 
of chronic liver disease. Her liver was mildly 
enlarged and nontender with no audible bruit 
in the epigastrium or right upper quadrant. 
Results of laboratory investigations, including 
liver function tests, were all within normal 
limits. Endoscopy revealed esophageal varices 
which were sclerosed with 10 ml of ethanoleum 
oleate.
In July 1984, after another variceal hemor­
rhage, a portal systemic mesocaval shunt was 
performed without difficulty using an inter- 
positional Weavenit graft (Meadox Medical 
Inc., Oakland, NJ). The liver appeared cir­
rhotic. A wedge biopsy from the right hepatic 
lobe demonstrated advanced macronodular cir­
rhosis, compatible with a previous viral infec­
tion. She made a smooth recovery and was dis­
charged 9 days later. An angiogram obtained 
before discharge revealed a patent mesocaval 
shunt and filling of the arteriovenous fistula 
through arterial collaterals with retrograde flow 
in the portal vein.
Follow-up endoscopy 3 months later showed 
flat esophageal varices, and 30 months 
postoperatively she remained well, with no 
recurrence of bleeding.
Discussion
Due to the close proximity of the 
biliary, arterial and venous conduits in the 
portal tract, there is a substantial risk of 
injury to adjacent structures in trauma 
and during invasive procedures aimed at 
deliberate transhepatic cannulation of the 
bile ducts. Okuda and colleagues2 
demonstrated that the risk of arteri­
ovenous fistula rises with increasing nee­
dle calibre and length of penetration of 
the instrument. None of the patients they 
studied experienced appreciable 
symptoms and several who had follow­
up arteriograms at 15 months and 5 years 
after percutaneous transhepatic proce­
dures failed to demonstrate a fistula. The 
authors suggested that small intrahepatic 
fistulas may be occluded by regenerating 
hepatocytes and fibrosis.2 Nevertheless, 
occasionally a hepatic artery-portal vein 
communication may persist, secondary to 
necrosis of sequestered hepatic paren­
chyma, breakdown of a necrotic vessel- 
wall hematoma or pseudoaneurysm for­
mation. Fistulas occurring after major 
liver trauma rarely close because of their 
large size and the greater destruction of 
surrounding hepatic parenchyma.3
Symptoms and signs vary, depending 
on the size of the fistula and the timing 
of presentation. When a hepatic artery- 
portal vein fistula occurs directly after 
abdominal trauma, acute portal conges­
tion and hyperemia of the intestinal 
mucosa may present an enteritis-like pic­
ture,4 with diarrhea, abdominal pain and, 
occasionally, gastrointestinal bleeding.
Careful clinical examination may rev­
eal a machinery type loud bruit over the 
liver or epigastrium. Such patients may 
deteriorate rapidly because of acute gas­
trointestinal or intrahepatic bleeding.5 If 
the fistula is small, collateral circulation 
may provide adequate compensation for 
the change in liver blood flow so that the 
patient remains asymptomatic. Eventu­
ally, usually after 4 or 5 years,3 the 
patient may present with the sequelae of 
portal hypertension — variceal bleeding 
and, less commonly, ascites. The 
hemodynamic alterations resulting from
a portal systemic fistula are such that the 
blood flow into the liver exceeds the 
capacity of the outflow tract, and portal 
hypertension ensues.6 However, unlike 
large systemic arteriovenous malforma­
tions, where tachycardia, elevated cardiac 
output, cardiomegaly, widened pulse 
pressure and heart failure are seen, 
cardiac effects are unusual with hepatic 
arterioportal fistulas.7 It appears that the 
high venous flow rate is dampened by the 
resistance of the hepatic sinusoids, 
thereby sparing the heart.8
The definitive diagnosis is made by 
angiography, although the history of 
trauma or an invasive procedure, fol­
lowed by symptoms of portal hyperten­
sion and an epigastric bruit detected on 
physical examination, are highly sugges­
tive. The typical angiographic picture, as 
seen in our patient, is one of early visuali­
zation of the portal vein on aortic or 
celiac artery injection, or filling of the 
portal vein on a selective hepatic arterio­
gram.4 Distal to the fistula arterial 
calibre is diminished and the portal vein 
may be tortuous and dilated.
Typically, liver function is normal, 
consistent with the normal histologic 
appearance of the liver parenchyma. 
Thickening of the muscularis of the por­
tal vein with dilatation of the liver sinu­
soids histologically is frequently described 
and has been termed hepatoportal scle­
rosis.6
Hepatic artery-portal vein fistulas, par­
ticularly those located in the periphery, 
are often small, have few collaterals and 
usually close spontaneously. In contrast, 
centrally located fistulas are often large 
and more hemodynamically important. 
Their large size and the collateral blood 
flow makes treatment difficult. The dual 
hepatic blood supply makes angiographic 
embolization an attractive treatment 
option,9"11 but fistula size and the large 
number of collaterals may reduce the 
likelihood or duration of success. Surgi­
cal obliteration is generally regarded as 
the treatment of choice.1,2'4,5'7 Proximal 
ligation of the hepatic artery frequently 
fails because there is a compensatory 
increase in the collateral flow, and the 
fistula persists. Division of the arterial 
venous channel is desirable but often tech­
nically impossible in deep-seated fistulas. 
In this situation hepatic lobe resection has 
been suggested.12 Attempts at reducing 
the portal hypertension by means of a 
portosystemic shunt have been con­
demned by several authors,1,4 who argue 
that this merely diverts the flow back to 
the systemic circulation, thereby risking 
the subsequent development of such 
hemodynamic side effects of a systemic 
fistula as cardiac failure.
In spite of this theoretical considera­
tion, we did not find any reports of sys­
temic complications resulting from a
FIG. 3—Angiogram demonstrating re-embolization of recurrent hepatic artery-portal 
vein fistula.
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functioning portosystemic shunt for 
hepatic artery-portal vein communica­
tion. Ryan and Lorber13 reported the 
case o f a 61-year-old man with a trau­
matic fistula treated successfully with a 
portacaval shunt. Ascites developed when 
the shunt thrombosed, but the condition 
was easily controlled medically. A  woman 
with a traumatic fistula was treated by 
Donovan and colleagues6 with an end-to- 
side portacaval shunt. The portal hyper­
tension was relieved and she did not suffer 
any deleterious cardiac effects.
Surgical treatment o f our patient was 
directed at relief o f the portal hyperten­
sion that led to life-threatening variceal 
bleeding. A  mesocaval shunt, function­
ally a side-to-side portosystemic shunt, 
was well tolerated and did not precipitate 
high output cardiac failure or other seque­
lae as has been suggested.1-4’14’15 Thirty 
months after the shunt procedure, she 
remains symptom-free. We suggest, con­
trary to long-standing beliefs, that por­
tosystemic shunting is a safe, well- 
tolerated means o f treating portal hyper­
tension associated with large hepatic 
artery-portal vein fistula, and it should 
be considered a therapeutic alternative if 
more conservative methods o f controll­
ing the fistula fail.
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Ticarcillin/Clavulanic Acid (Timentin) Compared to 
Metronidazole/Netilmicin in Preventing Postoperative 
Infection After Elective Colorectal Surgery
A randomized controlled trial was per­
formed to compare the effectiveness of 
ticarcillin/clavulanic acid to metronida- 
zole/netilmicin in preventing postopera­
tive infections after elective colorectal 
surgery. Ninety-two patients were ran­
domly allocated to receive three doses of 
ticarcillin, 3 g, with clavulanic acid, 100 
mg every 8 hours, or three doses of 
metronidazole, 500 mg, and netilmicin, 
80 mg intravenously every 8 hours. All 
patients received a mechanical bowel 
preparation with 3 L of Go-lytely 
solution.
There were no operative deaths. Eight 
patients had wound infections — three in 
the ticarcillin/clavulanic acid group and 
five in the metronidazole/netilmicin 
group. One patient in the ticarcillin/clavu­
lanic acid group had an intra-abdominal 
abscess. There were two anastomotic 
leaks, one in each group.
Ticarcillin/clavulanic acid and 
metronidazole/netilmicin appear to be 
equally effective in preventing postopera­
tive infections after elective colorectal 
surgery.
II s’agit d'un essai randomise et controle 
ou I'on a compare I'efficacitg d'un traite- 
ment ticarcilline/acide clavulanique et 
celle d'une association metronida- 
zole/netilmicine dans la prevention des 
infections postoperatoires consecutives a 
la chirurgie colorectale non urgente. 
Quatre-vingt-douze patients ont 6t6 
affectes au hasard a I'un de deux grou- 
pes destings a recevoir trois doses de 
3 g de ticarcilline et 100 mg d'acide cla­
vulanique aux 8 heures, ou trois doses 
de 500 mg de metronidazole et 80 mg 
de netilmicine par voie intraveineuse aux 
8 heures. Tous ont recu une preparation
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intestinale a I'aide de 3 L d'une solution 
de Go-lytely.
II n'y a eu aucun deces operatoire.
Huit patients ont eu des infections de 
plaies, trois dans le groupe ticarcilline/ 
acide clavulanique et cinq dans le groupe 
metronidazole/netilmicine. Un patient du 
groupe ticarcilline/acide clavulanique a 
souffert d'un abcgs intra-abdominal. On 
a enregistre deux bris d'anastomoses, un 
dans chaque groupe.
Les associations ticarcilline/acide cla­
vulanique et mgtronidazole/netilmicine 
semblent etre d'egale efficacite dans la 
prophylaxie des infections postopera­
toires secondaires a la chirurgie colo­
rectale non urgente.
It has long been recognized that surgical 
transection of the colon or rectum is 
associated with a relatively high rate (30% 
to 77%1_3) of postoperative wound infec­
tion in patients who undergo elective 
colorectal surgery without antibiotic 
prophylaxis. Although mechanical bowel 
preparation may reduce the volume of 
stool and thus, the volume of bacteria, 
it is now accepted that the short-term 
administration of antibiotics is necessary 
perioperatively in order to reduce the risk 
of postoperative wound infections.4 
Studies5 have indicated that anaerobes 
and gram-negative organisms are the 
most important causative organisms in 
this setting; therefore agents that are 
effective against these organisms should 
be used prophylactically. Timentin 
(Beecham Laboratories, Inc., Pointe 
Claire, PQ), a combination of a semisyn­
thetic penicillin (ticarcillin) and clavulanic 
acid, has been shown to be such an agent. 
The object of this study was to compare 
Timentin to a combination of metronida­
zole and netilmicin with respect to their 
effectiveness in preventing postoperative 
infections in patients who undergo elec­
tive colorectal surgery.
Patients and Method
All patients scheduled to undergo sur­
gery of the small bowel, colon or rectum 
at the Toronto General Hospital between 
Apr. 1,1984 and Mar. 31, 1985 were eligi­
ble for entry into the study provided that 
they had not been on antibiotics within 
7 days of operation. Excluded were 
patients with liver or renal disease, a 
bleeding disorder, a history of sensitivity 
to any of the study medications, and preg­
nant women. Informed consent was ob­
tained from all patients. The study was 
approved by the Research Ethics Com­
mittee of the Toronto General Hospital.
Ninety-nine patients were randomly 
grouped in blocks of 10. This was done 
by the pharmacy department at the hospi­
tal, according to a predetermined scheme. 
The clinicians and investigators were una­
ware of the treatment given to individual 
patients.
All patients received metoclopramide, 
10 mg intramuscularly, followed by 
mechanical bowel preparation consisting 
of clear liquids and 3 L of Go-lytely given 
over 3 hours.
Fifty patients were randomized to the 
ticarcillin/clavulanic acid group (group 
1); they received ticarcillin disodium 
equivalent to ticarcillin 3 g and potassium 
clavulanate equivalent to clavulanic acid 
100 mg in 100 ml of 0.9% sodium chlo­
ride solution infused over 15 minutes. In 
addition, 100 ml of normal saline was 
given as a placebo and infused over 15 
minutes. Forty-nine patients randomized 
to the metronidazole/netilmicin group 
(group 2) received metronidazole, 500 mg 
in 100 ml of sterile water, buffered with 
sodium phosphate, citric acid and sodium 
chloride, and netilmicin, 80 mg in 100 ml 
of 0.9% solution of sodium chloride, 
each infused over 15 minutes. All patients 
received three doses of the respective 
medications. The first dose was infused 
within 15 minutes of induction of 
anesthesia, and the second and third doses 
were given 8 hours and 16 hours later.
At surgery, the bowel preparation, the 
presence of sepsis or contamination, the 
amount of blood lost and the length of 
the operation were assessed and recorded. 
Postoperatively, wounds were examined 
and body temperatures recorded daily for 
1 week. Patients discharged from hospi­
tal within 1 week of operation were reas­
sessed at the clinic 2 weeks after the proce­
dure. A wound infection was recorded
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when the surgical wound or peritoneal 
cavity produced purulent discharge. Clin­
ically infected wounds were cultured both 
aerobically and anaerobically using stan­
dard procedures.6,7 Urine, blood, spu­
tum and wound tissue were cultured when 
patients had body temperatures of greater 
than 38.3°C on two occasions 4 hours 
apart (excluding the first 24 hours after 
surgery). Susceptibility of aerobes to 
netilmicin was tested at 4 and 8 mg/L 
by agar dilution according to standards 
of the National Committee for Clinical 
Laboratory Standards.8 Susceptibility of 
aerobes to Timentin was performed using 
the disk diffusion method.9 Susceptibil­
ity of anaerobes was performed using the 
disk elution method of Wilkins and 
Thiel.10 Five (5 gg) discs of metronida­
zole were added to 5 ml of anaerobic 
brain heart infusion broth to give a final 
concentration of 5 mg/L. Five Timentin 
discs were placed in anaerobic broth for 
final concentrations of 75 mg/L of ticar- 
cillin and 10 mg/L of clavulanic acid.
Findings
Of the 99 patients, 7 (4 in group 1 and 
3 in group 2) were excluded from the anal­
ysis because they failed to meet the pro­
tocol criteria. In three, the bowel was not 
opened at surgery, two received other 
antibiotics postoperatively and the wound 
was left open in one patient. The last 
patient was excluded because of excessive 
intraoperative bleeding which the sur­
geons believed may have been related to
the administration of ticarcillin/clavu- 
lanic acid. Later, it was recognized that 
the patient had had an elevated partial 
thromboplastin time preoperatively.
The remaining 92 patients (49 men, 43 
women) had a mean age of 43 years 
(range from 15 to 86 years). The groups 
were well matched according to patient 
characteristics, diagnosis and procedure 
(Table I).
The mechanical bowel preparation was 
modified in 45 patients — 21 in group 1 
and 24 in group 2. The antibiotic 
prophylaxis was modified in four 
patients. Two patients in group 1 received 
an average of 17 extra doses of 
metronidazole and netilmicin. In addi­
tion, one of these received 18 doses of 
cefazolin, 1 g intravenously, while the 
other received 23 doses of ampicillin, 500 
mg intravenously. Two patients in group 
2 received an average of 16 extra doses 
of the study medications. One of these 
also received 32 doses of cefazolin, 1 g 
intravenously, and the other 11 doses of 
ampicillin, 500 mg intravenously.
Bowel preparation, assessed in 89 
patients, was considered excellent in 62 
(69.7%), fair in 18 (20.2%) and poor in 
9 (10.1%). Fecal contamination occurred 
in three patients but none had septic com­
plications as a result.
The mean blood loss was 440 ml in 
group 1 and 490 ml in group 2. The mean 
operative times in the two groups were 2.9 
hours and 2.8 hours respectively.
There were no operative deaths. Com­
plications are listed in Table II. There
were no significant differences in the 
number of postoperative infections 
between the two groups. Escherichia coli 
was isolated from the wounds of two 
patients in group 1 and group D Strep­
tococcus from one of them. Escherichia 
coli was cultured from the peritoneal 
cavity of a third patient, and coagulase- 
negative staphylococci and Corynebac- 
terium sp. (most likely resident skin flora) 
from the wound. In group 2, a mixed 
growth of gram-negative organisms was 
identified. Escherichia coli was isolated 
from all patients and in addition, Proteus 
vulgaris (one patient), Proteus mirabilis 
(one), enterococci (one), group B Strep­
tococcus (two), Enterobacter cloacae 
(one) and Corynebacterium sp. (one) were 
also cultured.
One patient in each group with urinary 
tract infection had temperature spikes, 
but no source was identified nor was there 
microbiologic confirmation of sepsis. 
Both patients were treated with antibi­
otics. There were no complications 
attributable to the antibiotics. In partic­
ular, no bleeding complications or signifi­
cant changes in the partial thromboplastin 
time were detected in group 1 patients.
Discussion
The prophylactic use of broad- 
spectrum antibiotics is indicated for 
patients who undergo surgical resection 
of the colon or rectum. Ticarcillin is a 
parenteral semisynthetic penicillin effec­
tive against a wide range of bacterial 
infections including those caused by Pseu­
domonas aeruginosa. It is not, however, 
effective against certain bacteria that 
produce the /3-lactamase enzyme. In order 
to protect it from the destructive effect 
of these bacteria, ticarcillin has been com­
bined with potassium clavulanate which 
is a noncompetitive inhibitor of /3- 
lactamase. Ticarcillin/clavulanic acid has 
proven to  be effective against 
Staphylococcus aureus, Haemophilus 
influenzae, Neisseria gonorrhoeae, E. coli, 
Klebsiella sp., Enterobacter aerogenes, 
Providencia, Proteus mirabilis, P. vul­
garis and Bacteroides fragilis. Group D 
streptococci are moderately resistant to 
this combination.11
In this study, wound infection rates 
were low: 6.5% in group 1 and 10.9% in 
group 2. Previous tria ls2,12"17 have 
docum ented the effectiveness o f 
metronidazole as a prophylactic agent in 
colorectal surgery, although the wound 
infection rates have varied from 0% to 
25%. Jagelman and colleagues14 
reported no wound or intra-abdominal 
infections in 31 patients who received 
metronidazole intravenously and neomy­
cin orally. In a series of 27 patients who 
received only m etronidazole for 
prophylaxis,16 no anaerobic infections 
were reported but there were four infec-
T a b le  1— P a t ie n t  C h a r a c te r is t ic s
G ro u p  1 G ro u p  2
C h a ra c te r is t ic (n -  4 6 ) (n  =  4 6 )
A g e , y r
M e a n 4 3 4 4
R a n g e 1 6 - 7 5 1 5 - 8 6
M a le i fe m a le 2 5 : 2 1 2 4 : 2 2
D ia g n o s is
U lc e ra t iv e  c o litis 1 6 1 8
C ro h n 's  d is e a s e 7 1 0
C a n c e r 1 7 1 4
O th e r 6 4
S u rg ic a l p ro c e d u re
C o le c to m y 1 6 1 9
P ro c to c o le c to m y 0 1
R e s to r a t iv e  p ro c to c o le c to m y 7 3
A n te r io r  re s e c t io n 2 3
A b d o m in o p e r in e a l re s e c t io n 1 2
S m a ll -b o w e l re s e c t io n 4 2
O s to m y  c lo s u re 1 2 1 6
O th e r 4 0
T a b le  I I — C o m p lic a t io n s
G ro u p  1 , G ro u p  2 ,
C o m p lic a t io n n o . (% ) n o . (% )
W o u n d  in fe c tio n 3 ( 6 . 5 ) 5 ( 1 0 . 9 )
In tra -a b d o m in a l a b s c e s s 1 ( 2 .2 ) 0 ( 0 )
U r in a r y  t r a c t  in fe c t io n 1 ( 2 .2 ) 5 ( 1 0 . 9 )
F e v e r -  u n k n o w n  e tio lo g y 1 ( 2 .2 ) 1 ( 2 .2 )
A n a s to m o t ic  d e h is c e n c e 1 1 2 .2 ) 1 ( 2 .2 )
S m a ll -b o w e l o b s tru c t io n 1 ( 2 .2 ) 2  ( 4 .3 )
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tions due to aerobic organisms. A wound 
infection rate of 25% was observed in a 
tria l conducted by C unliffe and 
colleagues,12 in which patients received 
metronidazole alone. Thus, it would 
appear that an agent which is effective 
against gram-negative aerobic organisms 
should be given in combination with the 
metronidazole. Our standard regimen has 
been metronidazole and an aminoglyco­
side, netilmicin.
Ticarcillin/clavulanic acid appears to 
be equally effective in preventing septic 
complications after elective colorectal sur­
gery. It has two potential benefits over the 
metronidazole and netilmicin combina­
tion . F irst, although the risk of 
nephrotoxicity associated with short-term 
use of an aminoglycoside is low, this risk 
is avoided by using ticarcillin/clavulanic 
acid. Also, because of Timentin’s broad 
spectrum, only one drug is administered, 
thus reducing the time spent by nursing 
and pharmacy staff and decreasing the 
potential risk of drug error. This drug was 
well tolerated by patients in our study. No 
drug-related complications were detected.
The Birmingham group18 has advo­
cated a 5-day perioperative course of 
antibiotics for patients with inflammatory 
bowel disease who undergo elective 
colorectal surgery. In a randomized con­
trolled trial (57 patients) comparing three 
doses of metronidazole and gentamicin to 
placebo, they reported abdominal wound 
infection rates of 37% in the control 
group and 23% in the treatment group, 
not a significant difference. In a later 
study, 30 patients were given metronida­
zole and gentamicin for 5 days and results 
were compared with those obtained in the 
randomized controlled trial. The abdomi­
nal wound infection rate in the patients 
treated with the 5-day course was 13%, 
significantly (p <  0.05) lower than that 
of the placebo group but not significantly 
different from that of the group treated 
with only three doses of antibiotics. Simi­
lar results were found when the total 
infection rates (i.e., abdominal, perineal 
and intra-abdominal abscess and septice­
mia) were compared. In this study, 
patients with inflammatory bowel disease 
had more septic complications (eight in 
51 patients with inflammatory bowel dis­
ease versus one in 41 patients with other 
indications for surgery [p <  0.05]). We 
attribute this increased infection rate to 
those patients with ulcerative colitis who 
had a restorative proctocolectomy (ileal 
reservoir and ileoanal anastomosis). Five 
of 11 patients (2 of 7 in group 1 and 3 of 
4 in group 2) who had this procedure sub­
sequently had septic complications. At 
our institution, the average time for these 
operations is 6 hours, which may account 
for the increase in wound infection rate. 
If these 11 patients are excluded from the 
study, then the overall septic complica­
tion rate was 7.5% in patients with
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inflammatory bowel disease and 2.4% in 
patients with other conditions necessitat­
ing colorectal surgery (p > 0.05). Fur­
thermore, the wound infection rate in 
patients with Crohn’s disease was only 
5.9%. Thus, we do not routinely use 
prolonged perioperative antibiotic cover­
age for patients with inflammatory bowel 
disease except those who undergo recon­
structive procedures (i.e., continent 
ileostomy or restorative proc­
tocolectomy).
Conclusion
This study demonstrates that ticarcil­
lin/clavulanic acid (Timentin) and 
metronidazole/netilmicin are equally 
effective in preventing septic complica­
tions after elective colorectal surgery.
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ANTIBIOTIC
ACTION
In vitro  studies demonstrate that the 
bactericidal action of cefoxitin, a cephamycin 
derived from cephamycin C, results from the 
inhibition of bacterial cell wall synthesis. 
Evidence suggests that the methoxy group in 
the 7a position is responsible for the 
resistance of cefoxitin to degradation by 
bacterial beta-lactamases.
INDICATIONS AND CLINICAL USES 
TREATMENT
The treatment of the following infections when 
due to susceptible organisms:
1 - Intra-abdominal infections such as
peritonitis and intra-abdominal abscess
2 - Gynecological in fections such as
endometritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia marcescens and 
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and joint infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections 
Appropriate culture and susceptibility studies 
should be performed to determine the 
susceptibility of the causative organism(s) to 
MEFOXIN*. Therapy may be started while 
awaiting the results of these tests, however, 
modification of the treatment may be required 
once these results become available. 
Organisms particularly appropriate for 
therapy with MEFOXIN* are:
Gram positive
Staphylococci, penicillinase producing and 
non-producing
Streptococci excluding enterococci 
Gram negative (beta-lactamase producing 
and non-producing strains)
E. coli
Kl ebs i e l l a  species ( in c lu d in g  K. 
pneumoniae)
Proteus, indole positive and negative 
Haemophilus influenzae 
Providencia species 
Anaerobes 
Bacteroides Iragilis
MEFOXIN* may also be appropriate for the 
treatment of infections involving susceptible 
strains of both aerobic and anaerobic bacteria. 
Clinical experience has demonstrated that 
MEFOXIN* can be administered to patients 
who are also receiving carben ic illin , 
gentamicin, tobramycin, or amikacin (see 
PRECAUTIONS and ADMINISTRATION). 
Intravenous Administration 
The intravenous route is preferable for 
pa tien ts  w ith  bacterem ia, bacte ria l 
septicemia, or other severe or life-threatening 
infections, or for patients who may be poor 
risks because of lowered resistance resulting 
from such deb ilita ting  conditions as 
malnutrition, trauma, surgery, diabetes, heart 
failure, or malignancy, particularly if shock is 
present or impending.
PROPHYLACTIC USE
MEFOXIN* may be administered periopera- 
tively (preoperatively, intraoperatively and 
postoperatively) to patients undergoing 
vaginal or abdominal hysterectomy and 
abdominal surgery when there is a significant 
risk of postoperative infection or where the 
occurrence of postoperative infection is 
considered to be especially serious.
In patients undergoing cesarean section, 
intraoperative (after clamping the umbilical 
cord) and postoperative use of MEFOXIN* 
may reduce the incidence of surgery related 
postoperative infections.
Effective prophylactic use depends on the 
time of administration. MEFOXIN* usually 
should be given one-half to one hour before 
the operation. Prophylactic administration 
should usually be stopped within 12 hours. It 
has been generally reported that continuing 
administration of any antibiotic beyond 
*®T rademark
24 hours follow ing surgery increases the 
possibility of adverse reactions but, in the 
majority of surgical procedures, does not 
reduce the incidence of subsequent infection. 
If signs of postsurgical infection should 
appear, specimens for culture should be 
obtained for identification of the causative 
organism(s) so that appropriate therapy may 
be instituted.
CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who 
have shown hypersensitivity to cefoxitin or to 
the cephalosporin group of antibiotics.
WARNINGS
Before therapy with MEFOXIN* is instituted, 
careful inquiry should be made to determine 
whether the patient has had previous hyper­
s e n s it iv ity  re a c tio n s  to  M EFO X IN *, 
cephalosporins, penicillins or other drugs. 
MEFOXIN* should be given with caution to 
penicillin-sensitive patients.
There is some clinical and laboratory evidence 
of p a rtia l c ro s s -a lle rg e n ic ity  between 
cephamycins and the other beta-lactam 
antibiotics, penicillins and cephalosporins. 
Severe reactions (including anaphylaxis) have 
been reported  w ith  most beta-lactam  
antibiotics.
Pseudomembranouscolitis has been reported 
with virtually all antibiotics. This colitis can 
range from mild to life threatening in severity. 
Antibiotics should therefore be prescribed 
with caution in individuals with a history of 
gastrointestinal disease, particularly colitis. It 
is im portant to consider a diagnosis of 
pseudomembranous colitis in patients who 
develop diarrhea in association with antibiotic 
use. While studies indicate that a toxin 
produced by Clostridium d iffic ile  is one 
primary cause of antibiotic-associated colitis, 
other causes should also be considered.
Any patient who has demonstrated some form 
of allergy, particularly to drugs, should receive 
antibiotics including MEFOXIN* with caution. 
If an allergic reaction to MEFOXIN* occurs, 
a d m in is tra tio n  o f the drug shou ld  be 
d iscon tinued . Serious hypersensitiv ity  
reactions may requ ire  trea tm ent with 
epinephrine and other emergency measures. 
PRECAUTIONS
The total daily dosage should be reduced 
when MEFOXIN* is administered to patients 
with transient or persistent reduction of 
urinary output due to renal insufficiency (see 
DOSAGE AND ADMINISTRATION) because 
h igh and p ro longed  serum a n tib io tic  
concentrations can occur from usual doses 
In patients treated with MEFOXIN* a false­
positive reaction to glucose in the urine may 
occur with Benedict's or Fehling's solutions 
but not with the use of specific glucose 
oxidase methods.
Using the Jaffe Method, falsely high creatinine 
values in serum  may o ccu r if serum 
concentrations of cefoxitin exceed 100 pg/mL. 
Serum samples from patients treated with 
MEFOXIN* should not be analyzed for 
creatinine if withdrawn within two hours of 
drug administration.
Increased nephrotoxicity has been reported 
fo llow ing concomitant adm inistration of 
c e p h a lo s p o r in s  and a m in o g ly c o s id e  
antibiotics.
The safety of MEFOXIN* in the treatment of 
infections during pregnancy has not been 
e s ta b lish e d . If the a d m in is tra tio n  of 
MEFOXIN* to pregnant patients is considered 
necessary, its use requires that the anticipated 
benefits be weighed against possible hazards 
to the fetus. Reproductive and teratogenic 
studies have been performed in mice and rats 
and have revealed no evidence of impaired 
fertility or harm to the fetus due to MEFOXIN*. 
Cefoxitin has been observed in the milk of 
nursing mothers receiving the drug. 
Prolonged use of MEFOXIN* may result in the 
overgrowth of non-susceptible organisms. 
Repeated evaluation of the patient's condition 
is essential and if super-infection occurs 
during therapy, appropriate measures should 
be taken. Should an organism become 
resistant during antibiotic therapy, another 
antibiotic should be substituted.
In children 3 months of age or older, higher 
doses of MEFOXIN* (100 m g/kg/day and 
above) have been associated w ith  an 
increased incidence of eosinophilia and 
elevated SGOT.
ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse 
reactions rare ly requ ired cessation of 
treatment and usually have been mild and 
transient.
Local Reactions
T h ro m b o p h le b it is  has occu rre d  w ith  
intravenous administration. Some degree of 
pain and tenderness is usually experienced 
after intramuscular injections using water. 
Induration has occasionally been reported. 
Allergic
M aculopapular rash, urticaria, p ru ritus , 
eosinophilia, fever and other allergic reactions 
have been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can 
appear during or after antibiotic treatment. 
Nausea and vomiting have been reported 
rarely.
Blood
T ra n s ie n t e o s in o p h ilia ,  le u k o p e n ia , 
neutropenia, hemolytic anemia, and thrombo- 
cy to p e n ia  have been reported. Some 
individuals, particularly those with azotemia, 
may develop positive direct Coombs tests 
during therapy with MEFOXIN*.
Liver Function
Transient elevations in SGOT, SGPT, serum 
LDFI, and serum alkaline phosphatase have 
been reported.
Kidney
Elevations in serum creatinine and/or blood 
urea nitrogen levels have been observed. As 
with the cephalosporins, acute renal failure 
has been reported rare ly. The ro le  of 
MEFOXIN* in changes in renal function tests 
is d i f f ic u l t  to  assess, since fa c to rs  
predisposing to prerenal azotemia or to 
impaired renal function have often been 
present.
TREATMENT OF OVERDOSE
Other than general supportive treatment, no 
specific antidote is known. MEFOXIN* can be 
eliminated by dialysis in patients with renal 
insufficiency.
DOSAGE AND ADMINISTRATION
MEFOXIN* may be administered in tra ­
venously or intramuscularly when required. 
(See complete monograph for full details on 
ADMINISTRATION and RECONSTITUTION.) 
TREATMENT DOSAGE 
Adults
The usual adult dosage is 1 g o r 2g  of 
MEFOXIN* every 6 to 8 hours. Dosage and 
route of administration should be determined 
by severity of infection, susceptibility of the 
causative organisms, and condition of the 
patient. The usual adult dosages are shown in 
the Table below.
Usual Adult Dosage
Type of Daily 
of infection Dosage
Frequency 
and Route
Uncomplicated 
form s* o f in­
fections such as 
pneumonia, 
urinary tract 
infection, soft 
tissue infection
3-4 g 1 g every 6-8 h 
I.V. o r  I.M.
Moderately 
severe or severe 
infections
6-8 g 1 g every 4 h 
o r
2 g every 6-8 h I.V.
Infections 
com monly 
needing anti­
biotics in higher 
dosage (e.g. gas 
gangrene)
12 g 2 g every 4 h
or
3 g every 6 h I.V.
'Including patients 
absent or unlikely
in whom bacteremia is
Therapy may be started while awaiting the 
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic 
streptococcal infections should be maintained 
for at least 10 days to guard against the risk of 
rheumatic fever or glomerulonephritis. In 
staphylococcal and other infections involving 
a collection of pus, surgical drainage should 
be carried out where indicated.
Adults with Impaired Renal Function
MEFOXIN* may be used in patients with 
reduced renal function but a reduced dosage
should be employed and it is advisable to 
monitor serum levels in patients with severe 
impairment.
In adults with renal insufficiency, an initial 
loading dose of 1 g to 2 g should be given. 
A fte r  a lo a d in g  dose, th e  fo l lo w in g  
recommendations for maintenance dosage 
may be used as a guide:
RENAL CREATININE
FUNCTION CLEARANCE D O SE F R E Q U E N C Y
mL/mln
Mild
im pairment
Moderate
50-30 1-2 g every 8-12 h
im pairment
Severe
29-10 1-2 g every 12-24 h
im pairment 9-5 0.5-1 g every 12-24 h
Essentially 
no function <5 0.5-1 g every 24-48 h
In the patient undergoing hemodialysis, the 
loading dose of 1 - 2g should be given after 
each hemodialysis, and the maintenance dose 
should be given as indicated in the Table 
above.
Neonates (Including Premature Infants), 
Infants and Children (See WARNINGS for 
Neonates under ADMINISTRATION in the 
complete monograph.)
Premature Infants 
with Body Weights 
Above 1500 g 20-40 mg/kg every 12 h I.V.
Neonates
0- 1 week of age
1- 4 weeks of age
20-40 mg/kg every 12 h I.V. 
20-40 mg/kg every 8 h I.V.
Infants
1 month to 2 years 
of age
20-40 mg/kg every 6 h or 
every 8 h I.M. or I.V.
Children 20-40 mg/kg every 6 h or 
every 8 h I.M. or I.V.
In severe infections, the total daily dosage in 
infants and children may be increased to 
200 mg/kg, but not to exceed 12 g per day. 
MEFOXIN* is not recommended for the ther­
apy of meningitis. If meningitis is suspected, 
an appropriate antibiotic should be used.
At present there is in su ffic ie n t data to 
recommend a specific dosage for children 
with impaired renal function."However, if the 
administration of MEFOXIN* is deemed to be 
essential the dosage should be modified 
consistent with the recommendations for 
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of 
MEFOXIN is recommended as follows: 
Vaginal or abdominal hysterectom y and 
abdominal surgery
2 g  a d m in is te re d  in tra m u s c u la r ly  o r 
in tra v e n o u s ly  ju s t p r io r  to  s u rg e ry  
(approximately one-half to one hour before 
initial incision).
The second and third 2g doses should be 
administered at 2-6hour intervals after the 
initial dose.
Cesarean Section
The first dose of 2 g should be administered 
intravenously as soon as the umbilical cord 
has been clamped. The second and third 
2g doses should be given intravenously or 
intramuscularly four hours and eight hours 
after the first dose.
AVAILABILITY
MEFOXIN* (sterile cefoxitin sodium, Frosst 
Std.) is supplied as sterile powder in boxes of 
10 vials:
No. 3356 1 g cefoxitin as sodium salt 
No. 3357 2 g cefoxitin as sodium salt
Storage
MEFOXIN* in the dry state should be stored 
below 30° C.
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Hazards of Epidural Anesthesia in Patients With 
Previous Vascular Grafts
Two cases are described in which throm­
bosis of both limbs of an aortobifemoral 
bypass occurred after epidural anesthesia 
for a nonvascular operation. This has not 
previously been reported, and possible 
reasons for its occurrence are discussed. 
It seems likely that the hypotension 
associated with epidural anesthesia, par­
ticularly in patients already hypotensive 
or volume depleted, may precipitate this 
phenomenon. In addition, the sensory 
loss produced by the anesthetic may 
mask the signs and symptoms of acute 
vascular occlusion. Epidural anesthesia is 
not recommended in heparinized patients 
because of the risk of an epidural 
hematoma.
On fait ici la description de deux cas ou 
une thrombose des deux branches d’un 
pontage aortobifemoral est apparue con- 
secutivement a une anesthesie epidurale 
lors d'une chirurgie non vasculaire. Ceci 
n'a pas ete signale jusqu'a maintenant. 
On en commente les raisons possibles. II 
apparait vraisemblable que I'hypotension 
qui accompagne I'anesthesie epidurale 
puisse precipiter ce phenomene, particu- 
lierement chez des patients deja hypo- 
tendus ou hypovoldmiques. De plus, la 
perte sensorielle produite par I'anesthesi- 
que peut masquer les signes et symptd- 
mes d'une occlusion vasculaire aigue. 
L'anesthesie epidurale n'est pas recom- 
mandee chez les patients traitds b 
I'heparine a cause du risque d'hematome 
epidural.
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Epidural anesthesia provides an effective 
method of pain control. In addition to its 
use in obstetrics it may benefit patients 
with chronic obstructive pulmonary dis­
ease or other problems that make general 
anesthesia inadvisable because o f  
postoperative respiratory depression. 
Instead of traditional narcotics it may be 
used for postoperative pain control to 
facilitate chest physiotherapy and ambu­
lation.1 It is not recommended for 
patients who require high abdominal inci­
sions, and some2 believe it is contraindi­
cated when heparin has been given 
prophylactically before operation or in 
patients who will be com pletely  
heparinized intraoperatively, because 
there is a risk of producing an epidural 
hematoma.
Despite occasional local neurologic 
complications due to injection and inser­
tion of the catheter, this form of anesthe­
sia is generally considered safe if the 
appropriate indications and contraindica­
tions are observed.3 The purpose o f this 
report is to describe two patients who 
received epidural anesthesia intra- and 
postoperatively and in whom thrombosis 
o f both limbs of a previously placed aor­
tobifemoral graft subsequently deve­
loped. The usual signs were masked by 
the epidural anesthesia, leading to a 
marked delay in diagnosis in each case.
Case Reports
Case 1
In 1973, this 60-year-old man underwent 
aortobifemoral bypass grafting. Subsequently 
he was well until January 1984 when he 
required resection of the sigmoid colon for car­
cinoma. Postoperatively, an epidural catheter 
was inserted to control pain. During chat night 
his lotVer limbs became cool and mottled and 
he complained of pain, which subsided with 
further injections through the epidural 
catheter. The following morning he had severe 
ischemia of both feet and loss of pulsation in 
the bypass graft. Bilateral thrombectomies and 
right fasciotomy were attempted, but adequate 
flow was established only to the left leg. A sub­
sequent digital subtraction angiogram revealed
total occlusion of the right limb of his graft 
and a stenosis of the aorta proximal to the take­
off of the graft. Renal failure developed with 
myoglobinuria. He was transferred to The 
Wellesley Hospital for treatment.
Upon arrival he was dyspneic and 
diaphoretic, with a pulse rate of 120 beats/min 
and a blood pressure of 130/80 mm Hg. Find­
ings on examination of his respiratory and 
cardiac systems were otherwise within normal 
limits. He had fresh scars on his abdomen and 
both groins. No pulsation could be felt in the 
right limb of the aortic graft, but it was ade­
quate in the left limb. On the right lower limb 
there was mottling of the skin with no sensa­
tion or movement distal to the buttock. There 
was diminished sensation in the toes on the left 
with some limitation of movement. The mus­
cles visible at the fasciotomy site were doubt­
fully viable although the fat bled well. After 
hemodialysis he was taken to the operating 
room where a Fogarty catheter could be passed 
from the right common femoral artery to the 
foot with the return of a small amount of 
liquefied thrombus. A right axillofemoral graft 
was constructed. With re-establishment of 
blood flow there was considerable swelling of 
the leg requiring a full four-compartment fas­
ciotomy of the lower leg. Postoperatively, 
although the graft remained patent, the lower 
limb was not revascularized and demarcated 
at the level of the middle thigh. A high above­
knee amputation was subsequently carried out 
and many of the major muscle groups at this 
level were found to be necrotic. Following 
operation he did poorly. He had no return of 
renal function and remained confused until his 
death 3 weeks later.
Comment.—The actual cause of graft occlu­
sion in this patient is debatable. Although there 
was no major blood loss during the operation, 
it is possible that hypotension associated with 
the postoperative epidural block may have led 
to thrombosis, particularly in the presence of 
the aortic stenosis above the graft. With the 
epidural anesthesia for pain control, the diag­
nosis of acute lower limb ischemia was delayed 
so the ischemic muscle was not revascularized. 
If the graft occlusion had been diagnosed 
earlier, corrective surgery might have preserved 
the viability of the limbs and subsequently the 
patient’s life.
Case 2
A 62-year-old woman was transferred from 
another hospital for treatment of bowel
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obstruction. In 1978 she had undergone aor- 
tobifemoral bypass grafting for claudication. 
The graft had since functioned well. In 1981, 
a left modified radical mastectomy was per­
formed for carcinoma of the breast. One of 
three nodes in the specimen contained tumour. 
Three years later she had bowel obstruction 
that failed to improve with conservative 
treatment.
On examination at The Wellesley Hospital, 
the pulse rate was 80 beats/min and regular and 
the blood pressure was 120/80 mm Hg. The 
abdomen was grossly distended with ascites, 
and a mobile central abdominal mass could be 
felt. All peripheral pulses were present.
At operation for relief of her small-bowel 
obstruction, multiple metastases were found in 
the liver, spleen, omentum and ovary. Approx­
imately 5 L of ascitic fluid were present in the 
abdominal cavity. The anesthetic for the 
laparotomy consisted of high epidural anesthe­
sia with a general anesthetic. One additional 
injection was given into the epidural catheter 
in the recovery room. Throughout the opera­
tion and in the recovery room she was hypoten­
sive with a systolic pressure of 60 mm Hg, 
probably due to a combination of hypovole­
mia and the loss of vasomotor control secon­
dary to the epidural block.
The next day she had profound weakness in 
her lower limbs, which progressed over the next 
24 hours, with decreased tone in the hips, knees 
and ankles, worse on the left than the right. 
She had a lax anal sphincter. The neurologic 
defect was thought to be compatible with a 
lesion at the level of L I-2. An emergency 
myelogram appeared normal but computerized 
tomography revealed a spinal cord infarct. It 
was not until 48 hours later that the previously 
felt femoral pulses were noted to be absent. On 
examination of the lower limbs at this time 
there was some movement in the right but not 
the left foot. Her position sense was maintained 
in both feet but the limbs were areflexic. Capil­
lary refill was sluggish and no femoral or dis­
tal pulses were palpable. After occlusion of the 
aortobifemoral bypass graft and thrombosis of 
the anterior spinal artery were diagnosed, we 
attempted to restore blood flow to her lower 
limbs. Multiple thrombectomies were required 
on both sides due to repeated clotting of the 
grafts. Over the next week both limbs of the 
graft remained patent but there was no neu­
rologic improvement. Subsequently she 
suffered from an acute psychosis for which no 
cause could be found. During this episode she 
became hypotensive and her right foot again 
became cold and mottled. As she was now a 
formidable operative risk no attempt was made 
to revascularize the leg. A high above-knee 
amputation was carried out. Postoperatively 
the stump healed, her confusion cleared and 
she was discharged home. There was little neu­
rologic recovery of the left leg.
Comment.—The only apparent etiologic fac­
tor for the graft thrombosis was the hypoten­
sion that was noted both intra- and postoper­
atively. Although this could have been 
secondary to fluid shifts associated with 
drainage of the ascites it might have been made 
worse by the loss of vasomotor control secon­
dary to the epidural block. Although throm­
bectomy of her graft would probably not have 
altered the outcome neurologically, the diag­
nosis of graft occlusion was delayed because 
of the effects of the epidural anesthesia. Had 
the diagnosis of graft occlusion been made in
the recovery room, an earlier thrombectomy 
could have been carried out.
Discussion
Thrombosis of a previously placed aor­
tobifemoral graft in conjunction with 
epidural anesthesia has not been reported 
previously. In both our patients the diag­
nosis of graft occlusion was delayed due 
to masking of the signs and symptoms of 
ischemia by this particular form of 
anesthesia. The unlikely event of throm­
bosis of both limbs of both aortic grafts, 
which was noted only once in 40 acute 
occlusions of 364 aortic grafts surveyed 
by Ameli and associates,4 suggests that 
hypotension may have played a part, as 
was noted in case 2. Since hypotension is 
sometimes seen with epidural anesthesia 
associated with high block or hypovole­
mia, or both, there is a possible connec­
tion between the use of epidural anesthe­
sia and the graft thrombosis in both of 
our patients. The cardiovascular effects 
of extradural anesthesia have been 
reviewed by Stanton-Hicks.5 He noted 
that there was a linear relationship to the 
height of the block and the degree of 
hypotension but also commented that a 
normovolemic man could compensate for 
vasodilatation due to segmental blockade 
of the sympathetic outflow up to the T5 
level, by vasoconstriction in the upper 
part of the body. Presumably, when the 
patient is hypovolemic this compensatory 
mechanism is impaired. Neurologic 
deficits associated with epidural or spinal 
anesthesia were reviewed by Kane3 in 
1981, but of the 36 patients with severe 
neurologic deficit after epidural block, 
only 4 were noted to have hypotension as 
a causative factor. In three cases an 
epidural hematoma was blamed.
Late occlusion of vascular grafts is 
usually due to neointimal hyperplasia or 
progression of atherosclerotic arterial dis­
ease. However, patients requiring an 
operation for other reasons may be pre­
disposed to occlusion of these grafts 
because of altered coagulation secondary 
to hypercoagulability caused by cancer, 
dehydration or by hypotension and low 
flow states. The cardinal signs and symp­
toms of graft occlusion are the disappear­
ance of a pulse in the graft and a cool, 
painful, pale limb that becomes paralysed 
and anesthetic as the limb becomes non- 
viable. Since epidural anesthesia alters 
pain sensation and because paralysis will 
be difficult to assess, vascular occlusion 
and a nonviable extremity may not be 
diagnosed. It is of paramount importance 
that the diagnosis of vascular occlusion 
be made early so that treatment can be 
instituted. The tolerance of resting skele­
tal muscle to ischemia has been reported6 
to be as little as 6 to 8 hours depending 
upon the degree and acuteness of the 
episode.
When the warning signs of early graft 
occlusion may be masked by epidural 
anesthesia, it is essential to evaluate the 
pulses in the limb frequently. This may 
give early evidence of acute limb ische­
mia and thus permit urgent revasculari­
zation. Epidural anesthesia may not be 
the technique of choice in patients with 
previous vascular grafts as these grafts are 
particularly vulnerable to thrombosis dur­
ing the periods of hypotension that may 
be associated with this form of analgesia 
and anesthesia, and neither medical nor 
nursing staff are likely to be attuned to 
the possibility of acute graft occlusion 
under the circumstances. Fuchs and 
colleagues7 have recommended continu­
ous epidural anesthesia for patients with 
vascular disease, both for arteriography 
and for aortobifemoral or femoral-distal 
bypass grafting. They noted profound 
pain relief with minimal depression of 
pulmonary and myocardial performance 
and no epidural complications in 193 
patients. However, they suggested that 
epidural anesthesia should not be used if 
blood is obtained when the needle is 
introduced into the epidural space, 
because of the risk of epidural hematoma 
in patients who require anticoagulation 
during their operative procedure. They 
also mentioned that hypotension can 
occur with the use of this anesthetic. In 
their series, hypotension usually respond­
ed to fluid administration but in some 
cases vasopressors were required.
The two cases we describe indicate that 
epidural anesthesia may be hazardous 
when used for intraoperative anesthesia 
or postoperative analgesia in patients who 
have had a previously placed vascular 
bypass graft, unless the risks of associated 
hypotension are recognized by the 
anesthetists. The nursing staff and medi­
cal attendants should also be aware of the 
increased risks of thrombosis of the grafts 
under these circumstances.
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Dalacin C Phosphate S.S.
(clindamycin phosphate)
Rocommtnded Applications
Action: Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis and also by 
causing a reduction in the rate of synthesis of nucleic acids.
Indications: Dalacin C Phosphate (clindamycin phosphate) is indicated for the treatment of infections 
where the oral route is not indicated or feasible.
Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic 
bacteria, such as Bacteroides species, peptostreptococcus, anaerobic streptococci, Clostridium 
species and microaerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms 
(staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci) when 
the patient is intolerant of, or the organism resistant to other appropriate antibiotics. 
Contnlndlcitlons: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated in 
patients previously found to be hypersensitive to this compound, the parent compound, clindamycin, or 
clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride) has 
not been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have 
demonstrated lincomycin sensitivity.
Until further clinical experience is obtained. Dalacin C Phosphate is not indicated in the newborn 
(infants below 30 days of age), or in pregnant women.
Mhrnings: Some cases of severe and persistent dianhea have been reported during or after therapy with 
Dalacin C Phosphate (clindamycin phosphate). This diarrhea has been occasionally associated with 
blood and mucus in the stools and has at times resulted in acute colitis. When endoscopy has been 
performed, some of these cases have shown pseudomembrane formation.
If significant dianhea occurs during therapy, this drug should be discontinued or, if necessary, 
continued only with close observation. Significant diarrhea occurring up to several weeks post-therapy 
should be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing minimal mucosal changes may 
respond to simple drug discontinuance. Moderate to severe cases, including those showing ulceration 
or pseudomembrane formation, should be managed with fluid, electrolyte, and protein supplementa­
tion as indicated. Corticoid retention enemas and systemic corticoids may be of help in persistent 
cases. Anticholinergics and antiperistaltic agents may worsen the condition. Other causes of colitis 
should be considered.
Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a principal 
cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this 
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg of vanco­
mycin were administered orally four times a day for 5 -10  or more days, there was a rapid observed 
disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea 
Is should be noted that serious relapses have occuned up to one month after apparently successful 
treatment. A relatively prolonged period of continuing observation is therefore recommended. 
Precautions: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed with 
caution in atopic individuals.
Dalacin C Phosphate must be diluted for intravenous administration. (See Dosage and Administration) 
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly 
yeasts. Should superinfections occur, appropriate measures should be taken as indicated by the 
clinical situation.
As with all antibiotics, perform culture and sensitivity studies in conjunction with drug therapy. 
Since abnormalities of liver function tests have been noted occasionally in animals and man, periodic 
liver function tests should be performed during prolonged therapy. Blood counts should also be 
monitored during extended therapy.
Dalacin C Phosphate may be used in anuretic patients. Since the serum half-life of clindamycin in 
patients with impaired hepatic function is greater than that found in normal patients, the dose of 
Dalacin C Phosphate should be appropriately decreased. Hemodialysis and peritoneal dialysis are not 
effective means of removing the compound from the blood. Periodic serum levels should be determined 
in patients with severe hepatic and renal insufficiency.
Advarsa Reactions: Local.
(a) Intramuscular Injections: Of 404 patients treated with Dalacin C Phosphate (clindamycin phos­
phate) intramuscularly (with a solution containing 150 mg/mL). six (1.5%) demonstrated local 
reactions as follows: Two complained of pain at the injection site, two demonstrated induration at the 
injection site and two developed sterile abscesses.
(b) Intravenous Infusions: Of 192 patients treated with Dalacin C Phosphate by intravenous infusion, 
14 (7.3%) demonstrated local reactions. Eleven patients developed superficial thrombophlebitis and 
one patient developed both superficial and deep thrombophlebitis. The majority of these cases 
developed in conjunction with the use of indwelling I V. catheters and it is difficult to know how much 
the drug contributed to the irritation. Two patients developed localized erythema, swelling and pain at 
the site of the infusion.
Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin 
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as 
follows:
Number of Patients
Rash........................................................................................................................................................ 7
U rticaria................................................................................................................................................. 1
Pruritus................................................................................................................................................... 1
Fever, Leucocytosis ............................................................................................................................  1
Nausea, with or without vom iting.......................................................................................................  1
Diarrhea (See also under "Warnings")............................................................................................... 4
Hypotension ..........................................................................................................................................  1
Hypertension..........................................................................................................................................  1
Shortness of Breath ............................................................................................................................  1
Superinfection*.....................................................................................................................................  4
Cardiac arrest** ...................................................................................................................................  1
Bad and bitter taste in m outh.............................................................................................................. 5
* Superinfection is a complication of antibiotic therapy in general and is not necessarily a true 
side effect of clindamycin phosphate.
'* Due to underlying myocarditis in this patient.________________________________________
Clinical and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphate 
(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology, 
urinalysis and liver and kidney function tests. Some of these tests were abnormal initially and returned 
to normal during therapy with Dalacin C Phosphate, while others were normal initially and became 
abnormal during therapy. Overall evaluation of clinical laboratory values in these patients does not 
indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic or renal 
systems. Transient elevations of serum transaminases have occurred in some patients, but other liver 
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and 
there have not been clinical signs of drug-induced hepatic toxicity.
Symptoms and Treatment of Ovordosage: No cases of overdosage have been reported. No specific antidote 
is known. Doses as high as 1200 mg every six hours (4800 mg/day) by infusion for five days have been 
given without adverse effects.
DOSAGE AND ADMINISTRATION 
Adults
Intramuscular Injection: 600 mg/day in 2 equal doses.
Moderately severe infections: 600 to 1200 mg/day in 2 or 3 equal doses.
Severe infections: 1200 to 2400 mg/day in 2,3 or 4 equal doses. Intramuscular injections of more than 
600 mg into a single site are not recommended.
Intravenous Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted prior to I V. 
administration to a dilution of 300 mg in 50 ml of diluent (6 mg/ml) or more, and infused in not less 
than 10 minutes. Administration of more than 1200 mg in a single 1 hour infusion is not recommended. 
Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.
Moderately severe infections: 900 to 1800 mg/day by continuous drip or in 2 or 3 equal doses, each 
infused over 20 minutes or longer.
Severe infections: 1800 to 2700 mg/day by continuous drip or in 3 or 4 equal doses, each infused over 
20 minutes or longer. In life-threatening infections, doses of 2700 to 4800 mg/day by continuous drip 
or in 3 or 4 equal doses each infused over 20 minutes or longer may be given.
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Dilution and Infusion rates:
Dose Diluent Time
300 mg 50 ml 10 min.
600 mg 100 ml 20 min.
900 mg 150 ml 30 min.
1200 mg 200 ml 45 min.
Alternatively, drug may be administered in the form of a single rapid infusion of thefirst dose followed 
by continuous I V. infusion as follows:
To maintain serum Rapid Maintenance
clindamycin levels infusion rate infusion rate
Above 4 mcg/ml 10 mg/min. for 30 min. 0.75 mg/min.
Above 5 mcg/ml 15 mg/min. for 30 min. 1.00 mg/min.
Above 6 mcg/ml 20 mg/min. for 30 min. 1.25 mg/min.
Children: (Over one month of age)
Intramuscular injection: 10 to 15 mg/kg/day in 2, 3 or 4 equal doses.
Moderately severe infections: 15 to 20 mg/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 30 mg/kg/day in 3 or 4 equal doses.
Intravenous Administration:
Moderately severe infections: 15 to 25 mg/kg/day by continuous drip or in 3 or 4 equal doses, each 
infused over 20 minutes or longer. In severe infections, it is recommended that children be given no less 
than 300 mg/day regardless of body weight. (Dilute Dalacin C Phosphate Sterile Solution in the same 
manner as for adults.)
Dilution and Compatibility:
4 ml (600 mg) Dalacin C Phosphate when diluted with 1000 ml of the following commonly used in­
fusion solutions was found to be physically compatible and demonstrated no significant change in pH 
or antimicrobial potency over a period of 24 hours:
Sodium chloride injection 
Dextrose 5% in water 
Dextrose 5% in saline 
Dextrose 5% in Ringer’s Solution
Dextrose 5% in half-strength saline plus 40 mEq potassium chloride 
Dextrose 2Vz% in Lactated Ringer's Solution (Hartmann's Solution)
Dalacin C Phosphate was not stable when added to Dextrose 5% in water plus vitamins. Therefore it is 
not recommended that Dalacin C Phosphate be mixed with any infusion solution containing B vitamins. 
Supplied:
Dalacin C Phosphate contains the following per ml of sterile solution:
Clindamycin phosphate equivalent to clindamycin base 150 mg 
Benzyl alcohol 5 mg 
Disodium edetate 0.5 mg 
Water for injection q.s.
When necessary the pH is adjusted with sodium hydroxide and/or hydrochloric acid to maintain a pH 
range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 ml and 4 ml ampoules.
NOTE: Do not store below 15°C.
4.
*
^  ■1
r
-4  -
*  ♦
-4
t-
1 -
1
Product Monograph available upon request. CE 1377.1C
4
8401 REGISTERED TRADEMARKS DALACIN 
TRADEMARK DALACIN C CE 3950.1LB
Upjohn
ANTIBIOTIC THE UPJOHN COMPANY OF CANADA 
RESEARCH 865 YORK MILLS ROAD/DON MILLS, ONTARIO
DENIER
PAAB
CCPP
Yves E. L eclerc, m d ; A ntoine L outfi, md
Implantable Device for Venous Access
This paper reports the experience at the 
Royal V ictoria  Hospital in M ontreal w ith  
the firs t 50 Port-A-Cath devices 
implanted fo r venous access in patients 
requiring long-term  chem otherapy. There 
were 25 women and 22 men. ranging in 
age from  18 to  85  years. T w en ty -tw o  
devices were implanted fo r hematologic 
malignant disease, 26 fo r solid tumours 
and 2 fo r benign disease. The mean 
operative tim e was 4 6 .3  m inutes, using 
a percutaneous subclavian s tick tech­
nique in 94%  o f insertions. Blood sam­
pling and in fusions were easy in 88%  
and 92%  respectively. Seventy-e ight per­
cent of the patients accepted the device 
well. Nine devices were removed, four at 
the end o f therapy (median function ing 
time o f 2 0 8 .5  days) and five  because of 
sepsis (median tim e 18 days). The 
median tim e o f the s till-function ing  
devices in live patients is 141 .5  days. 
Septic com plications w ere seen in 12%, 
blockage in 6%  and skin necrosis in 2% . 
One death occurred from  sepsis in a 
poor-performance patient w ith  stage IV 
breast cancer and hypercalcem ia. We 
believe tha t the Port-A-Cath is effic ient, 
safe and easily accessible fo r patients on 
long-term  chemotherapy.
Cet article fa it le bilan des 50 premieres 
im plantations d 'instrum ents Port-A-Cath 
a etre pratiquees ii I'hop ita l Royal V icto­
ria de M ontreal pour etablir un acces vei- 
neux chez des patients ayant besoin 
d'une chim iotherapie a long term e. On 
com ptait 25 femmes et 22  hommes dont 
I'age varia it de 18 d 85  ans. V ingt-deux 
instrum ents ont etd im p la n ts  pour des 
affections hematologiques malignes, 26 
pour des tumeurs solides et 2 pour des 
maladies non cancdreuses. Le temps
From the Department o f  Surgery, Royal 
Victoria Hospital, McGill University, Mon­
treal, PQ
Accepted for publication Sept. 10, 1986
Reprint requests to: Dr. A. Loutfi, Depart­
ment o f  Surgery, Royal Victoria Hospital, 
687 Pine Ave. W, Montreal, PQ H3A 1A1
operatoire moyen a ete de 4 6 .3  m inutes; 
une technique d 'insertion  sous-claviere a 
ete utilisee dans 9 4 %  des cas. Les prele- 
vem ents sanguins et les perfusions ont 
dtd facilites dans respectivem ent 88%  et 
92 %  des cas. So ixante-d ix-huit pourcent 
des patients on t bien accepte ('instru­
m ent. Neuf appareils on t dte retires, qua- 
tre  a la fin  du tra item ent (apres un temps 
median de fonctionnem ent de 208 .5  
jours) et cinq pour cause d 'in fection  
(temps median de 18 jours). Chez les 
patients qui surv ivent, la mddiane du 
tem ps de fonctionnem ent est de 141 .5  
jours. Des com plications infectieuses on t 
etd observees dans 12%  des cas, un 
blocage dans 6% , et une necrose cuta- 
nee dans 2% . Un d£c6s est attribuable a 
I'in fec tion ; il s 'a g it d 'une patiente souf- 
fra n t d 'un  cancer du sein au stade IV et 
d 'hypercalcem ie, et qui a mal evolue. 
Selon les auteurs, le Port-A-Cath est e ffi- 
cace, sur et h la portee des patients 
devant recevoir une chim iotherapie au 
long cours.
Suitable venous access in cancer patients 
receiving chemotherapy is often a major 
problem. Peripheral veins may be inade­
quate from the outset or progressively 
occlude. The frequently used central 
venous catheters require a certain amount 
of care from the patient. Recently, a com­
pletely implantable device has been 
introduced, and we report on the first 50 
cases of implantation of these devices for 
venous access.
Patients and Methods
From March 1984 to January 1986, 47 
patients had 50 insertions of implantable 
devices for venous access (3 patients had 
a second device inserted after removal o f  
the first). There were 22 men and 25 
women; the median age was 48.5 years 
(range from 18 to 85 years) (Fig. 1). The 
types of tumours encountered are shown 
in Table I. Two patients with benign dis­
ease had the device inserted because of 
poor venous access and the necessity for 
frequent blood transfusion.
The drug delivery system used was the 
totally implantable Port-A-Cath (Phar­
macia [Canada] Inc., Dorval, PQ). It 
consists o f a stainless steel portal with a 
silicone catheter that self-seals by means 
of a stainless steel lock. The reservoir is 
entered through a self-sealing silicone 
rubber septum that will accept without 
leakage at least 1000 punctures with an 
atraumatic 22-gauge Huber-point needle 
or a 22-gauge Yale hypodermic needle 
(see this issue page 75). The external 
diameter of the catheter is 2.79 mm, the 
internal diameter 1.02 mm and the inter­
nal volume o f the reservoir 0.4 ml.
Surgical Procedure
Under sterile conditions in the operat­
ing room and with local anesthesia in 
most cases, the catheter is introduced by 
puncturing the subclavian vein percutane- 
ously, using a modified Seldinger tech­
nique and a special peel-away introducer 
used for pacemaker introductions. With 
the patient in the Trendelenburg position 
the subclavian vein is entered with a
FIG. 1—Age and sex distribution. White 
bars = men, black bars = women.
Table 1—Types of Tumour
Type No.
Hematologic 22
Lymphoma 16
Leukemia 6
Solid tumours 26
Gastrointestinal 2
Breast 9
Lung 5
Gynecologic 5
Genitourinary 4
Mediastinal paraganglioma 1
Benign 2
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16-gauge needle. A steel J guide wire is 
introduced and its position checked by 
fluoroscopy with the C arm. An oblique 
incision 5 cm long is made parallel to the 
deltopectoral groove, incorporating the 
puncture site at its upper end. A pocket 
is fashioned medially over the pectoralis 
major fascia. In obese patients, the sub­
cutaneous fat is thinned to a thickness of 
5 to 7 mm. The vessel dilator and sheath 
introducer are positioned using the guide 
wire. The dilator is removed and the 
catheter slipped into the peel-away sheath 
which in turn is removed leaving only the 
catheter in place. The catheter position is 
checked by fluoroscopy; its length is 
adjusted and it is connected to the reser­
voir. The reservoir is then sutured to the 
fascia and the incision closed. The system 
is flushed with 5 ml of heparinized saline 
at a concentration of 100 units/ml. We 
do not tunnel a catheter.
Method o f  Use
After the skin has been disinfected with 
iodine solution and alcohol, the septum 
is punctured percutaneously with an L- 
shaped 90° bent Huber-point needle con­
nected to an extension tube that has been 
flushed with saline. If blood return is 
good the system is connected to an 
intravenous solution and the infusion is 
carried out. Blood sampling follows the 
same procedure, after initial flushing of 
the reservoir. First, 10 ml of blood is aspi­
rated, discarded and the sample is then 
taken. After infusion or blood sampling, 
the system is flushed with 5 ml of heparin- 
saline solution containing 100 units/ml of 
heparin. Heparinization is initially carried 
out in the operating room, and then every
4 weeks, or less in patients who have 
chemotherapy more frequently. No dress­
ing is applied over the injection site.
Results
The mean operating time was 46.3 
minutes (range from 15 to 180 minutes). 
Forty-seven (94%) implantations were 
done using a percutaneous subclavian 
stick technique. Three (6%) were done by 
cephalic cut-down, one after failure of the 
percutaneous technique. Thirty-eight 
(76%) were placed in the left side; 12 
(24%) in the right side.
Of the 50 implanted devices only 9 were 
removed — 4 at the end of therapy and
5 because of sepsis. Fourteen patients died 
with the device in place. The median time
T a b le  II-- C o m p lic a t io n s
C o m p lic a t io n N o . %
S e p s is 6 12
B lo c k a g e 3 6
S k in  n e c ro s is 1 2
P n e u m o th o ra x 0 —
H e m a to m a 0 —
of function was 67.5 days (range from 17 
to 353 days). The respective median times 
of the functioning devices were 115.5 days 
(range from 12 to 400 days) for the 41 left 
implanted, 208.5 days (range from 89 to 
553 days) for the ones removed at the end 
of therapy and 18 days (range from 14 to 
63 days) for the ones removed because of 
sepsis.
Infusion was easy in 46 cases and 
difficult, requiring a change in the 
patient’s position, in 4. Blood sampling 
was easy in 44, difficult in 3 and impos­
sible in another 3 cases. Of 42 patients 
assessed, tolerance and acceptance of the 
device were good to excellent in 33 (79%) 
and acceptable in 9.
Complications
Sepsis occurred in six (12%) cases, 
blockage in three (6%) and skin necrosis 
one (2%). Pneumothorax or hematuria 
were not encountered (Table II). There 
was one death, thought to be caused by 
sepsis in a poor-performance patient with 
breast cancer who had widespread 
metastases, hypercalcemia, and in whom 
the insertion was done under general 
anesthesia.
Five of the six patients had their 
catheters removed. Blood cultures from 
the Port-A-Cath were positive for 
Staphylococcus aureus in two, 
Staphylococcus epidermidis in three and 
Escherichia coli in one (Table III). After 
intensive chemotherapy, 50% of the 
patients were neutropenic at the time of 
sepsis, which developed twice in one 
patient, and the device had to be removed 
each time. In the other three, the leuko­
cyte count ranged from 3.0 x 109/L  to 
12.1 x 109/L . Three catheters blocked, 
two at 21 and 31 days respectively after 
implantation. Patency was restored in 
these two by streptokinase infusion but 
the third had to be repositioned.
Discussion
The Port-A-Cath venous access system
was well accepted by 78% of the patients; 
blood sampling was easy in 88% and 
infusion in 92% of the cases, thus reduc­
ing patient anxiety and improving their 
general well-being. The failure of blood 
sampling in three patients is difficult to 
explain especially since infusion was ade­
quate. We placed the catheters laterally 
in order to avoid compression between 
the clavicle and first rib, as described by 
Aitken and Minton.1
Catheter-related sepsis has been a 
major problem in other angioaccess 
methods. Sepsis with the Hickman 
catheter is reported to be from 3% to 
13%.2-4 Slater and colleagues5 reported a 
13% sepsis rate in 140 patients receiving 
chemotherapy, using a silicone elastomer 
catheter placed percutaneously without 
tunnelling. We encountered sepsis in 12% 
of our cases. We did not routinely use 
prophylactic antibiotics perioperatively. 
In only three instances was the leukocyte 
count lower than 1.0 x 109/L  when sep­
sis developed and two of these occurred 
in the same patient with acute leukemia. 
In five of the six septic patients, the 
catheter was removed after persistent 
fever, with positive blood cultures and 
adequate administration of broad- 
spectrum antibiotics. The median time at 
removal was 18 days. Early sepsis might 
suggest that contamination occurred in 
the peri-implantation period rather than 
after prolonged use so perioperative 
administration of antibiotics might be 
helpful in decreasing the incidence of 
infection. Our results are not in keeping 
with those reported by Brincker and 
Saeter,6 who reported no cases of sep­
ticemia in 78 implantations.
The duration of function compares 
favourably with that of the Hickman 
catheter, where the median duration of 
function was 91 days,7 compared to 
115.5 days overall when the device was 
in place and functioning.
Conclusions
The implantable Port-A-Cath system
T a b le  III - S e p t i c  C o m p lic a t io n s
E ven t
D a y
p o s to p
L e u k o c y te  
c o u n t , X  1 0 9/L C a n c e r  ty p e
In fe c t in g
o rg a n ism O utcom e
1* 2 6 .0 B re a s t ,  s ta g e  IV S t a p h y lo c o c c u s D ied
a u r e u s
2 6 3 3 .0 B re a s t ,  s ta g e  IV S t a p h y lo c o c c u s D ev ice
e p id e r m id is rem oved
3 4 5 12 .1 Lym p ho m a S .  a u r e u s D ev ice
rem oved
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5 t 1 8 0 .7 Leu kem ia E s c h e r ic h ia D ev ice
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6 1 4 0 .2 Lym p h o m a S .  e p id e r m id is D ev ice
rem oved
'G e n e r a l a n e s th e s ia .
tS a m e  p a t ie n t.
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offers important advantages over previ­
ous methods of venous access: operating 
time is relatively short, the implantation 
technique is easy and patient acceptance 
has been good. It provides easy and relia­
ble venous access and the complication 
rate is low. We believe that the Port-A- 
Cath is a good implantable device for 
patients on chemotherapy with poor 
venous access.
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Innovative Palliative Surgical Procedure for Hypoplastic
Left-Heart Syndrome
A novel surgical procedure was per­
formed on a 2-day-old infant with 
hypoplastic left-heart syndrome. It con­
sisted of partitioning the pulmonary trunk 
thereby creating two channels, one lead­
ing to the pulmonary arterial system and 
the other to the aorta, and atrial septec­
tomy to relieve left atrial pressure and 
facilitate mixing of blood. The technique 
avoids the use of conduits.
Une nouvelle operation chirurgicale fut 
tentee chez un nourisson de 2 jours de 
vie qui presentait un hypoplasie du coeur
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gauche. Cette intervention comprend: a) 
la diviser de I'art&re pulmonaire, creant 
deux canals, I'un vers le systeme arteriel 
pulmonaire et I'autre vers I'aorte et b) 
une septectomie auriculaire visant a 
diminuer la pression dans I'oreillette 
gauche et faciliter la melange du sang. 
Cette technique n'utilise pas les conduits 
artificielles.
The generic term hypoplastic left-heart 
syndrome1 or, as earlier described, 
hypoplasia of aortic tract complex2'3 
includes aortic atresia or severe aortic ste­
nosis with mitral stenosis and coexistent 
aortic and mitral atresia.4 Neonates with 
hypoplastic left-heart syndrome usually 
die during the first week of life. The 
problem is especially important because 
most of these infants are born at term and 
are otherwise normal.
So far the methods of treatment have 
been futile, highly controversial or 
promising but risky. We describe and 
illustrate a first-stage palliative surgical 
procedure that was performed with satis­
factory early results in one case.
Case Report
A male infant weighed 2.8 kg when born at 
term. Cyanosis, tachypnea and metabolic aci­
dosis were noted soon after birth. Two dimen­
sional echocardiography demonstrated the fea­
tures of hypoplastic left-heart syndrome. 
Preoperative management included continuous 
infusion of prostaglandin Ej and administra­
tion of sodium bicarbonate as required. Two 
days after birth, the following procedure was 
performed.
The anterior mediastinum was exposed 
through a median sternotomy. The thymus was 
partially excised and the innominate vein 
ligated and divided. The major branches of the 
aorta and the right and left pulmonary arter­
ies were encircled with silk ligatures. Deep 
hypothermic (13°C) extracorporeal circulation 
was instituted after cannulating the pulmonary 
trunk with a no. 10 cannula for arterial inflow 
and the right atrium with a no. 18 cannula for 
venous return. The right and left pulmonary 
arteries were occluded. Subsequently, the atrial 
septum was excised through a right atriotomy, 
taking care to avoid damage to conductive tis­
sue. Total circulatory arrest was initiated with 
occlusion of major branches of the aorta. 
Additional cephalic surface cooling was 
provided by ice bags. The coronary circulation 
was perfused intermittently with slightly cooled 
blood (34°C) injected through a no. 8 French 
catheter inserted in the proximal aortic arch. 
The ductus arteriosus was excised. The orifice 
created in the aorta was enlarged in the form 
of a tear drop with the tapered end pointing 
toward the descending aorta. The pulmonary 
trunk was opened longitudinally by parallel 
incisions along its lateral borders. The roof of 
the pulmonary trunk was tipped forward to 
expose the floor of the artery and orifices of 
the two main branches. A calibrated Hegar 
dilator (4 mm) was used as a guide to construct 
a narrowed pulmonary trunk from this 
posterior portion of artery. A 3 x 1-cm lan- 
ceolated patch, fashioned from autologous 
pericardium, formed the floor of the anterior 
portion of the artery, thus creating a second 
augmented channel originating at the bifur­
cated pulmonary trunk. The distal end of the 
augmented tube was connected to the descend­
ing aorta at the site of the transected ductus 
arteriosus. The right atriotomy was closed. 
Coronary artery perfusion was discontinued. 
Cardiopulmonary bypass was resumed with 
gradual rewarming and when it was discon-
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tinued there was good contraction and ejection 
with normal sinus rhythm and a systolic pres­
sure of 80 mm Hg. Bypass time was 3 hours, 
systemic circulatory arrest was 80 minutes and 
intermittent coronary perfusion was main­
tained for 50 of the 80 minutes of total arrest.
Postoperatively, the infant spent 6 days in 
the pediatric intensive care unit. His condition 
was monitored with a radial artery line, cen­
tral venous pressure catheter, cerebral function 
monitor and a pulse oximeter. He was mechan­
ically ventilated using a Servo 900C ventilator 
(Siemens Corp., Iselin, NJ) and paralysed with 
pancuronium bromide. Cardiogenic shock 
required dopamine, dobutamine and dextrose- 
calcium-insulin infusions. A 20-second episode 
of asystole following suctioning occurred on 
postoperative day 2. This responded to a 1-ml 
bolus of epinephrine and 5 ml sodium bicar­
bonate and was attributed to a vagal or hypoxic 
response to suctioning. Periods of ectopic atrial 
tachycardia not requiring therapy were noted. 
Hemodynamic and ventilator support were 
withdrawn 5 days after operation. Oral feed­
ing and digitalis were begun on day 6, and the 
infant was transferred to the neonatal unit. 
Cardiopulmonary function was excellent — an 
oxygen saturation of 85% to 90% on 30% oxy­
gen by face mask, normal serum creatinine 
level, no neurologic deficit and a normal elec-
FIG. 1—Surgical approach to hypoplastic left-heart syndrome. (A) Operative findings. Huge pulmonary trunk (12 mm diameter) and markedly narrowed ascending aorta (4 mm diameter); diameter of left main pulmonary artery was 5 mm and that of right main pulmonary artery 6 mm. Left atrium was small and tense. (B) Cardiopulmonary bypass was conducted at deep hypothermia (13°C). Ice bags were used for surface cooling of head. Dashed lines indicate sites of incisions. (C) Atrial septum was cut away with scissors. Ductus arteriosus was dis­sected and transected at its aortic and pulmonary ends. Pulmonary trunk was divided longitudinally along lateral borders. Parallel incisions were extended proximal  ^to orifices of two main branches. Direct closure of posterior portion of artery created narrowed (4 mm diameter) pul­monary trunk. Pericardial patch was inserted to form floor of anterior channel, with special caution to increase calibre at its origin from pulmo­nary artery. (D) Anterior channel was connected to descending aorta. (E) After surgery, mixed blood was ejected through only ventricular outlet into short common artery where it must detour preferentially towards aorta through channel of almost same calibre as descending aorta and to main pulmonary arteries through calibrated trunk.
FIG. 2—Postoperative angiogram. Oblique view after injection of contrast in right ventri­cle showing retrograde flow into ascending aorta (common coronary), adequate passage into thoracic aorta and branches, and symmetric filling of pulmonary arteries.
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troencephalogram. Premature atrial beats and 
episodes of moderately rapid supraventricular 
tachycardia were controlled with digoxin and 
Inderal. Cardiac catheterization was carried out 
1 month postoperatively. The mean pressure 
in each atrium was 3 mm Hg. The right ven­
tricular pressure was 104 mm Hg systolic with 
an end-diastolic pressure of 4 mm Hg. Left 
atrial saturation was 91%. Right ventricular 
saturation was 73%. It was not possible to 
guide a catheter into the reconstructed main 
pulmonary artery. Contrast medium injected 
into the right ventricle demonstrated unob­
structed, balanced flow through both systems. 
A pulmonary perfusion study done 1 month 
after surgery gave normal results. Seven weeks 
after the operation the baby weighed 3.7 kg. 
Blood pressure was 78/45 mm Hg. At 53 days 
of age the infant was discharged and treatment 
with digoxin and Inderal was continued. At 
3 months of age his weight was 4.6 kg.
Discussion
Although relatively infrequent among 
congenital heart defects, hypoplastic left- 
heart syndrome accounts for almost one 
in four cardiac deaths occurring in infants 
during the first week of life.5
Because of the generally good condi­
tion of these infants at birth and their 
rapid deterioration once the ductus arteri­
osus starts to close, surgeons have become 
interested in finding an operative proce­
dure that offers some hope for long-term 
survival.6' 12 Prompt clinical recognition, 
echocardiographic confirmation and 
adjunctive pharmacologic intervention to 
arrest the closure of the ductus13 and to 
maintain acid-base balance are crucial in 
preparation for surgery.
The initial stage in the surgical pallia­
tion described here (Fig. 1) establishes 
unobstructed pulmonary venous return 
and assures mixing of blood. A morpho­
logic right ventricle supports both the pul­
monary and the systemic circulations. The 
former is restricted by partitioning the 
pulmonary trunk and the latter is restored 
by anastomosing a diverted segment of 
the pulmonary trunk to the descending 
aorta (Fig. 2). The procedure bridges the 
frequently encountered obstruction of 
coarctation of the aorta.14-16 Eventually, 
one anticipates that separation of the two 
circulations can be accomplished by 
applying the Fontan concept.17
The procedure described here was con­
ceived about 2 years ago. We tried it on 
cadavers and attempted it clinically once, 
unsuccessfully. The result of the opera­
tion in our second case led us to present 
this preliminary report with the confi­
dence that it can be done successfully by 
others.
We are indebted to Dr. B.E. Favara, (Direc­
tor of Laboratories) for support and critical 
review of the manuscript. We thank Drs. J. 
Morrison and E.P. Rees and the nursing staff 
for participation in the care of this patient. We 
are grateful to Mr. B. Lamb for the illustra­
tions and Miss V. Jennings for typing the 
manuscript.
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SESAP V  Critique
ITEM 3
For small pulp defects without exposed bone, simple occlusive dressings 
minimize the loss of time from work, preserve length, avoid immobilization 
of the digit, and provide both satisfactory appearance and good two-point dis­
crimination. Skin grafting is not necessary for such defects. While useful for 
more severe defects, cross-finger flap procedures require immobilization, and 
may result in ankylosis of the donor finger and excessive scarring or diminished 
sensation in the recipient digit. Removal of the distal portion of the distal 
phalanx shortens the finger and is not necessary for this type of injury.
D
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COUMADIN
(Warfarin sodium) ANTICOAGULANT
INDICATIONS COUMADIN®. Prophylaxis and treatment of venous throm bosis and its extension, treat­
ment o f atrial fibrillation w ith embolization, prophylaxis and treatm ent of pulmonary embolism, and 
as an adjunct in the treatment of coronary occlusion.
The following are some of the more common clinical disorders which may be associated w ith or 
predispose patients to the above indications: 1. Thrombophlebitis 2. Congestive heart failure 3, Surgical 
procedure or trauma associated with a high risk of thromboembolism 4. Myocardial infarction 5. Cerebral 
em bolism . It may also be useful as an adjunct in the treatment of transient cerebral ischemic attacks 
due to intravascular clotting.
CONTRAINDICATIONS Any localized o r general physical condition o r personal circumstance in which 
the hazard o f hemorrhage m ight be greater than its potential clinical benefits, such as:
Pregnancy: COUMADIN® is contraindicated in pregnancy because the drug passes through the 
placental barrier and may cause fatal hemorrhage to the fetus in utero. Furthermore, there have been 
reports o f b irth malformations in children born to mothers who have been treated with warfarin during 
pregnancy. Women of childbearing potential who are candidates fo r anticoagulant therapy should be 
carefully evaluated and the indications critica lly reviewed w ith the patient. If the patient becomes preg­
nant while taking this drug, she should be apprised of the potential risks to the fetus, and the possibility 
of term ination of the pregnancy should be discussed in light of those risks. Hemorrhagic tendencies 
or blood dyscrasias. Recent o r contemplated surgery of: 1. central nervous system 2. eye a traum atic  
surgery resulting in large open surfaces. Bleeding tendencies associated with active ulceration or overt 
bleeding of: 1. gastrointestinal, genitourinary or respiratory tracts 2. cerebrovascular hemorrhage 3. 
aneurysms -  cerebral, dissecting aorta 4. pericarditis and pericardial effusions 5. subacute bacterial 
endocarditis. Threatened abortion, eclampsia and preeclampsia. Inadequate laboratory facilities or un­
supervised senility, alcoholism, psychosis, or lack of patient cooperation. Spinal puncture and other 
diagnostic o r therapeutic procedures w ith potential fo r uncontrollable bleeding. Miscellaneous: major 
regional, lum bar block anesthesia and malignant hypertension.
WARNINGS The m ost serious risks are hemorrhage in any tissue or organ and, less frequently, necrosis 
and/or gangrene of skin and other tissues. The risk of hemorrhage is related to the level o f intensity 
and the duration of anticoagulanttherapy. Hemorrhage and necrosis have in some cases been reported 
to result in death or permanent disability. Necrosis appears to be associated w ith local thrombosis and 
usually appears within a few days of the start of anticoagulant therapy. In severe cases of necrosis, treat­
ment through debridement or amputation of the affected tissue, limb, breast or penis has been reported. 
Careful diagnosis is required to determine whether necrosis is caused by an underlying disease. War­
farin therapy should be discontinued when warfarin is suspected to be the cause of developing necrosis 
and heparin therapy may be considered for anticoagulation. Although various treatments have been 
attempted, no treatment for necrosis has been considered uniform ly effective. See below fo r informa­
tion on predisposing conditions. These and other risks associated w ith anticoagulant therapy must be 
weighed against the risk of throm bosis or embolization in untreated cases.
Warfarin sodium is a potent drug w ith a half-life o f 2.5 days: therefore, its effects may become more 
pronounced as daily maintenance doses overlap. It cannot be emphasized too strongly that treatment 
of each patient is a highly individualized matter. Dosage should be controlled by periodic determina­
tions of prothrom bin time or other suitable coagulation tests. Determinations o f whole blood clotting 
and bleeding tim es are not effective measures for control of therapy. Heparin prolongs the one-stage 
prothrombin time. Therefore, to obtain a valid prothrombin time when heparin and COUMADIN® are 
given together, a period of at least 5 hours should elapse after the last intravenous dose and 24 hours 
after the last subcutaneous dose of heparin, before blood is drawn. Caution should be observed when 
administered in any situation or in the presence of any predisposing condition where added risk of hemor­
rhage o r necrosis is present. Administration of anticoagulants in the follow ing conditions w ill be based 
upon c linical judgement in which the risks of anticoagulant therapy are weighed against the risk of throm­
bosis o r embolization in untreated cases. The following may be associated w ith these increased risks:
•  Lactation -  Coumarins may pass into the m ilk of mothers and cause a prothrombinopenic state in 
the nursing infant. •  Severe to moderate hepatic o r renal insufficiency. •  Infectious diseases or distur­
bances o f intestinal flora -  sprue, antibiotic therapy. •  Trauma which may result in internal bleeding.
•  Surgery or trauma resulting in large exposed raw surfaces. •  Indwelling catheters. •  Severe to moderate 
hypertension.
Known or suspected heredity, familial or clinical deficiency in protein C: This condition, which should 
be suspected if  there is a history of recurrent episodes of throm boem bolic disorders in the patient or 
in the family, has been associated w ith an increased risk o f developing necrosis following warfarin ad­
m inistration. Skin necrosis may occur in the absence of protein C deficiency. It has been reported that 
in itiation of anticoagulation therapy w ith heparin for 4 to 5 days before initiation of therapy with 
COUMADIN® may minimize the incidence of this reaction. Warfarin therapy should be discontinued when 
warfarin is suspected to be cause of developing necrosis and heparin therapy may be considered for 
anticoagulation.
Miscellaneous: polycythemia vera, vasculitis, severe diabetes, severe allergic and anaphylactic 
disorders. Patients w ith congestive heart failure may become more sensitive to COUMADIN,® thereby 
requiring more frequent laboratory monitoring, and reduced doses o f COUMADIN.® Concurrent use 
of anticoagulants w ith streptokinase or urokinase is not recommended and may be hazardous. (Please 
note recommendations accompanying these preparations.) Abrupt cessation of anticoagulant therapy 
is not generally recommended; taper dose gradually over three to four weeks.
PRECAUTIONS Periodic determination o f prothrombin time or other suitable coagulation testis essential.
Numerous factors, alone or in combination, including travel, changes in diet, environment, physical 
state and medication may influence response o f the patient to anticoagulants. I t  is generally good prac­
tice to monitor the patient's response with additional prothrombin time determinations in the period 
immediately after discharge from the hospital, and whenever other medications are initiated, discon­
tinued or taken haphazardly. The following factors are listed for your reference: however, other factors 
may also affect the prothrombin response.
The following factors, alone in or combination, may be responsible for increased prothrombin time 
response: ENDOGENOUS FACTORS: Carcinoma; collagen disease; congestive heart failure; diarrhea; 
elevated temperature; hepatic disorders -  infectious hepatitis; hypothyroidism; jaundice; poor nutri­
tional state; vitam in K deficiency -  steatorrhea. EXOGENOUS FACTORS: A lcoholf; allopurinol; 
am inosalicylic acid; amiodarone; anabolic steroids; antibiotics; bromelains; chloral hydratet; chlor­
propamide; chymotrypsin; cimetidine; cinchophen; clofibrate; COUMADIN® overdosage; dextran; 
dextrothyroxine; diazoxide; dietary deficiencies; diflunisal; diuretics); disulfiram; drugs affecting blood 
elements; ethacrynic acid; fenoprofen; glucagon; hepatotoxic drugs; ibuprofen; indomethacin; influenza 
virus vaccine; inhalation anesthetics; mefenamic acid; methyldopa; methylphenidate; metronidazole; 
miconazole; monoamine oxidase inhibitors; nalidixic acid; naproxen; oxolin icacid; oxyphenbutazone; 
pentoxifylline; phenylbutazone; phenyramidol; phenytoin; prolonged hot weather; prolonged narcotics;
pyrazolones; quinidine; quinine; ranitidine); salicylates; sulfinpyrazone; long-acting sulfonamides; sulin- 
dac; thyroid drugs; tolbutamide; triclofos sodium; trimethoprim/sulfamethoxazole; unreliable prothrombin 
time determinations.
The following factors, alone or in combination, may be responsible for decreased prothrombin time 
response: ENDOGENOUS FACTORS: Edema, hereditary resistance to coumarin therapy, hyperlipemia, 
hypothyroidism. EXOGENOUS FACTORS: Adrenocortical steroids; alcohol); antacids; antihistamines; 
barbiturates; carbamazepine; chloral hydrate); chlordiazepoxide; cholestyramine; COUMADIN® under­
dosage; diet high in vitamin K; diuretics); ethchlorvynol; glutethimide; griseofulvin; haloperidol: 
meprobamate; oral contraceptives; paraldehyde; primidone; ranitidine); rifampin; unreliable prothrombin 
time determinations; vitamin C. A patient may be exposed to a combination of the above factors, some 
of which may increase and some decrease the patient's sensitivity to COUMADIN.' Because the net 
effect on prothrombin time response may be unpredictable under these circumstances, more frequent 
laboratory monitoring is advisable. Drugs not yet shown to interact or not to interact with coumarins 
are best regarded w ith suspicion, and when their adm inistration is started or stopped, the prothrombin 
time should be determined more often than usual. Coumarins also affect the action of other drugs. 
Hypoglycemic agents (chlorpropamide, tolbutamide and glyburide) and anticonvulsants (phenytoin and 
phenobarbital) may accumulate as a result o f interference w ith their metabolism or excretion. 
ADVERSE REACTIONS Potential side effects may include: •  Hemorrhage from any tissue or organ. This 
is a consequence of the anticoagulant effect. Signs and symptoms will vary according to location and 
degree or extent of bleeding. Therefore, the possibility of hemorrhage should be considered in evaluating 
the condition of any anticoagulated patient with complaints which do not indicate an obvious diagnosis. 
Bleeding during anticoagulant therapy does not always correlate w ith prothrombin activity. (See TREAT­
MENT FOR OVERDOSAGE.) Bleeding which occurs when the prothrombin time is within the therapeutic 
range warrants diagnostic investigation, since it may unmask a previously unsuspected lesion, e.g. tumor, 
ulcer, etc. •  Necrosis of skin and other tissues. (SEE WARNINGS). •  Other adverse reactions are infrequent 
and consist of alopecia, urticaria, dermatitis, fever, nausea, diarrhea, abdominal cramping, a syndrome 
called "purple toes," and hypersensitivity reactions. •  Priapism has been associated w ith anticoagulant 
administration, however, a causal relationship has not been established.
DOSAGE: Should be gauged according to prothrombin time determinations by a suitable method. Blood 
prothrombin time should be determined daily after the administration of the initial dose until prothrom ­
bin time results stabilize in the therapeutic range. Intervals between subsequent prothrombin time deter­
minations should be based upon judgement of the patient’s reliability and response to warfarin in order 
to maintain the individual within the therapeutic range. Acceptable intervals for prothrombin time deter­
minations have usually fallen w ithin the range of one to four weeks. Satisfactory levels for maintenance 
of therapeutic anticoagulation are 1.5 to 2.5 times the normal prothrombin time (e.g. 18 to 30 seconds, 
w ith a control of 12 seconds).
Induction -  Induction may be initiated w ith 10 to 15mg daily and thereafter (usually 2 or 3 days) 
adjusted according to prothrombin time response. The basis fo r the no-loading dose regimen is that 
the depression of Factors II, IX, and X is not accelerated by the administration of a loading dose. Avoidance 
of a large priming dose may minimize the possibility of excessive increases in prothrombin time.
Maintenance -  Most patients are satisfactorily maintained at a dose of 2 to 10mg daily. Flexibility 
is provided by breaking scored tablets in half. The individual dose and interval should be gauged by the 
patient’s prothrombin response. Alternatively, 40 to 60mg for average adult o r 20 to 30mg for elderly 
and/or debilitated patients for one dose only.
Duration o f therapy -  The duration of therapy in each patient should be individualized. In general, 
anticoagulant therapy should be continued until the danger o f thrombosis and embolism has passed.
Treatment during dentistry and surgery- Management o f patients requires close liaison between 
attending physicians, surgeons and dentists. Interruption of anticoagulant therapy may precipitate 
thromboembolism, conversely, at full doses, some patients may hemorrhage excessively. If it is elected 
to administer anticoagulants prior to, during, or immediately following dental or surgical procedures, 
it is recommended the dosage be adjusted to maintain the prothrombin time at approximately 1.5 to 
2.5 tim es the control level. The operative site should be lim ited to perm itthe effective use of local pro­
cedures for hemostasis including absorbable hemostatic agents, sutures, and pressure dressings if 
necessary. Under these conditions dental and surgical procedures may be performed without undue 
risk of hemorrhage.
COUMADIN^with heparin -  Since a delay intervenes between the administration of the initial dose 
and therapeutic prolongation of prothrombin time, it may be advisable in emergency situations to ad­
m inister sodium heparin in itially along with COUMADIN.® Heparin may affect the prothrombin time, 
and therefore, when patients are receiving both heparin and COUMADIN,® the blood sample for pro­
thrombin time determination should be drawn just prior to the next heparin dosage, at least 5 hours 
after the last intravenous injection or 24 hours after the last subcutaneous injection.
SYMPTOMS AND TREATMENT OF OVERDOSAGE Excessive prothrombinopenia, with or w ithout 
bleeding, is readily controlled by discontinuing COUMADIN,® and if necessary, by the oral or parenteral 
administration of vitamin K ,. The appearance of m icroscopic hematuria, excessive menstrual bleeding, 
melena, petechiae or oozing from nicks made while shaving are early manifestations of hypoprothrom- 
binemia beyond a safe and satisfactory level. In excessive prothrombinopenia w ith mild or no bleeding, 
om ission of one or more doses of COUMADIN® may suffice, and if necessary, small doses of vitamin 
K, orally, 2.5 to 10mg will usually correct the problem. If m inor bleeding persists, or progresses to frank 
bleeding, vitamin K, in doses of 5 to 25mg may be given parenterally (please note recommendations 
accompanying vitamin Kt preparations prior to use.) Fresh whole blood transfusions should be con­
sidered in cases of severe bleeding or prothrombinopenic states unresponsive to vitamin K ,. Resump­
tion of COUMADIN® administration reverses the effect of vitam in K, and a therapeutic hypoprothrom- 
binemia can again be obtained.
DOSAGE FORMS COUMADIN® TABLETS are single-scored, and are imprinted as follows:
SIZE: 2mg 2.5mg 5mg 10mg
CODE: 0101 0201 0301 0401
COLOR: lavender orange peach white
IMPRINT: 
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New Options in the Surgical Management 
of Crohn’s Disease
Conventional surgical treatment of 
Crohn's disease involves multiple or 
extensive resections or bypass proce­
dures. These contribute to the morbidity 
and mortality of the disease. Minimal 
resection with appropriate “ stric­
tureplasty" is proposed as an alternative 
approach. Strictureplasty is analogous to 
pyloroplasty. The authors performed 15 
strictureplasties in three patients, all of 
whom had previously undergone small- 
bowel resection for Crohn's disease.
They presented with symptoms of 
chronic bowel obstruction resistant to 
medical therapy. There were two minor 
postoperative complications. Two 
patients were asymptomatic 20 months 
postoperatively; the third required 
reoperation for recurrent enterovesicai 
fistula. The technique is safe. Its efficacy 
will be determined by long-term 
follow-up.
Le traitement chirurgical traditionnel de 
la maladie de Crohn comprend des resec­
tions larges ou multiples ou des opera­
tions de derivation. Ces interventions 
contribuent a la morbidity et a la morta­
lity rattachees a la maladie. On propose 
comme choix d'approche une resection 
minimale avec "stenoplastie" appropriee. 
La stenoplastie est analogue a la pyloro- 
plastie. Les auteurs ont effectue 15 ste- 
noplasties chez trois patients qui avaient 
tous subi prealablement une resection du 
grele pour maladie de Crohn. Ils presen- 
taient des symptomes d'obstruction 
intestinale chronique resistant au traite­
ment medical. Ils ont enregistre deux 
complications postopgratoires mineures.
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Deux patients demeuraient asymptomati- 
ques 20 mois apres ('intervention; le troi- 
sieme a du etre rdopere pour recidive 
d'une fistule enterovesicale. Cette tech­
nique est sure. Son efficacite sera ytablie 
par une surveillance h long terme.
The surgical treatment of Crohn’s disease 
has passed through several distinct stages 
since it was first considered in the 
1930s.1 Initially, bypass was favoured. 
Two methods were used. Bypass in con­
tinuity was popularized in the 1950s in the 
United States because it was so effective 
in the late President Eisenhower; 
however, the outcome was poor in the 
majority of patients. Not only did the dis­
ease fail to settle down, but the postoper­
ative course was often stormy and com­
plicated by fistulas and abscesses. It was 
recognized that diversion of the fecal 
stream away from the site of inflamma­
tion was critical to the success of such sur­
gery. Thus, bypass with exclusion became 
the procedure of choice. Later, as surgi­
cal technique and perioperative care 
improved, resection was preferred, except 
in patients with complicated inflamma­
tory masses. Physicians and surgeons then 
became preoccupied with the resection 
margins, some2 advocating wide resec­
tion, others3 dwelling on disease-free 
frozen sections. Such considerations 
proved to be irrelevant,4 giving early 
support to the concept of Crohn’s disease 
as a panenteric problem. Meanwhile, 
reports of the development of carcinoma 
in bypassed segments made it clear that 
exclusion surgery should not be consi­
dered further.5
The Present
The natural history of Crohn’s disease 
does not conform to a set pattern, but the 
majority of patients will eventually 
require laparotomy.6 Surgery should be 
undertaken only for complications resis­
tant to medical management, such as 
recurrent obstruction or extraintestinal 
fistulization. There are two groups of
patients with Crohn’s disease in whom 
surgical therapy may create at least as 
many problems as it solves: patients with 
at least one previous small-bowel resec­
tion, who require another and patients 
with extensive (more than 100 cm) small- 
bowel disease, having resection for the 
first time.
It is established that most patients who 
lose 100 cm or more of ileum will have 
steatorrhea,7 which is often difficult to 
manage. The resulting malnutrition adds 
to that inherent in the primary disease 
when it recurs clinically. The morbidity 
in this group is high.
It is because of these patients that the 
concept of minimal surgery has evolved.8 
Minimal surgery takes one of two forms 
— “ strictureplasty” and minimal resec­
tion. The former is analogous to 
pyloroplasty, from which the technique 
and nomenclature have been adapted. 
Strictureplasty was introduced in India,9 
in order to avoid extensive resection and 
relieve obstruction in patients with 
burned-out tuberculosis, which mimics 
Crohn’s disease of the small bowel. In 
fact, patients with Crohn’s disease were 
included and seemed to fare as well as the 
patients with tuberculosis. Within a short 
time the technique was introduced to the 
Western world by two British surgeons 
working independently.10’11
Alexander-W illiams11 has dem on­
strated this technique in many parts of the 
world and did so at our hospital in March 
1985 (case 1). We have since performed 
the procedure on two patients* and report 
our experience.
Patients and Methods
All three patients had previously under­
gone resection for Crohn’s disease of the 
small bowel. The total duration of symp­
toms from the time of original diagnosis 
was 8, 16 and 23 years, and the intervals 
between the resection and strictureplasty
*Since submission of the manuscript, six addi­
tional patients have undergone a total of 53 
strictureplasties.
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were 2, 4 and 21 years respectively, with 
recurrent symptoms having been present 
for 6 months, 3 years and 2 years. All 
were evaluated preoperatively by two of 
us (F.G.S. and A.W.H.). One patient 
(case 1) had been followed up for 7 years, 
and the other two were referred specifi­
cally for strictureplasty. All three had 
symptoms of chronic small-bowel 
obstruction, and multiple strictures were 
demonstrated on barium studies of the 
small bowel. An enterovesical fistula was 
present in case 1. Pancolonoscopy 
demonstrated a macroscopically normal 
large bowel in each case.
Because of a right paramedian scar in 
each case, our approach was through a 
midline incision. After exploration, the 
entire small bowel was mobilized. Each 
patient had more strictures than were 
identified radiologically. A longitudinal
FIG. 1—Strictureplasty for short strictures. 
Stricture is opened longitudinally on 
antimesenteric border (A). Running simple 
sutures are begun laterally at midpoint of 
enterotomy. Alignment for closure is demon­
strated by tension on these knots (B,C). 
Enterotomy is closed by tying sutures across 
apex (D).
enterotomy was performed through one 
of the strictures and others were identi­
fied by anterograde and retrograde pas­
sage of a Foley catheter, after the method 
of Alexander-Williams.12 As he re­
ported, this is necessary because areas of 
stenosis are not always evident on inspec­
tion of the serosal aspect of the gut. Stric­
tureplasties were then performed sequen­
tially, starting with the site of the initial 
enterotomy. Strictures were opened lon­
gitudinally on the antimesenteric border. 
Single strictures separated by more than 
3 cm, or two closely spaced strictures, 
were repaired after the method of 
Heineke-Mikulicz with a single layer of 
continuous 3-0 Maxon suture (Fig. 1). 
Areas of multiple (three or more), closely 
spaced strictures were repaired after the 
method of Finney, again using a continu­
ous suture (Fig. 2).
In case 1, an area of stricture was found 
just distal to a small abscess and fistulous 
tract into bladder. The induration around 
the fistula was broken down by blunt dis­
section. The opening into the bladder was 
closed with absorbable Lembert sutures. 
The opening into the small bowel was 
extended longitudinally through the stric­
ture and closed by the Finney technique.
No drains were left in the abdomen.
Nasogastric suction was maintained until 
the patients passed gas, and progress to 
a full diet was intentionally slow.
Case Reports
Case 1
This man first experienced symptoms of 
Crohn’s disease, with abdominal pain and 
fever, in 1969, at the age of 17 years. After 4 
years of intermittent therapy with steroids and 
sulfasalazine, he was hospitalized with a mid- 
small-bowel obstruction that failed to respond 
to medical management. Laparotomy was said 
to have revealed extensive segmental Crohn’s 
disease of the entire small bowel. An exclusion 
bypass was performed at the site of obstruc­
tion in the jejunum. He did well for several 
years, being maintained on sulfasalazine. In 
March 1981, an episode of partial small-bowel 
obstruction was treated by giving clear fluids 
only. In May 1981, barium studies of the small 
and large bowel gave normal findings; the 
excluded intestine was, of course, not 
visualized.
Because of intermittent left-sided abdomi­
nal pain, recurrent iron-deficiency anemia and 
concern about the possibility of carcinoma in 
the excluded loop, laparotomy was performed 
in April 1983. This revealed active disease 
within the bypassed segment and obstruction 
at the previous anastomosis. The bowel other-
FIG. 2—Strictureplasty for multiple or long strictures. Area is opened longitudinally and 
about 2 cm past strictures on each end (A). Bowel is folded at midline of enterotomy (B). Run­
ning simple suture is begun at angle of inner or posterior wall. First knot is inside lumen. This 
suture is brought outside lumen at apex (C). Running simple suture is begun at anterior angle 
and continued to meet first suture which has been continued onto anterior wall of strictureplasty 
to avoid tying at apex (D,E). Enterotomy is closed by tying these sutures across anterior wall (F).
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wise appeared normal, except for a short seg­
ment of “ burnt-out” terminal ileitis. He was 
well for 3 months and then complained of a 
variety of nonspecific symptoms suggestive of 
reactivation of his Crohn’s disease. In 1984, 
he had a severe exacerbation of the disease and 
an enterovesical fistula developed. He com­
plained of abdominal bloating, crampy pain 
after eating solid food and diarrhea. He 
required a course of total parenteral nutrition, 
and steroid therapy was begun. He responded 
to treatment but could not tolerate a reduction 
of prednisone below 20 mg/d. His obstructive 
and urinary tract symptoms progressed and 
anemia developed. The symptoms were totally 
controlled only when he was on a zero-residue 
liquid diet, consisting of Ensure and clear 
fluids.
In March 1985, he underwent laparotomy, 
having been maintained on the liquid diet for 
4 weeks. Three discrete strictures were identi­
fied in the last 20 cm of ileum. The distal stric­
ture was tightest and 1 cm proximal to this a 
fistula entered the bladder. Three Heineke- 
Mikulicz strictureplasties were performed. On 
postoperative day 5 the patient had symptoms 
and signs suggestive of a small intestinal leak; 
they settled with conservative management. He 
was discharged home 3 Vi weeks postopera- 
tively. He was weaned off prednisone and 
gained 3 kg eating a full diet. Two months after 
the operation he complained of marked 
fatigue, and very mild, occasional, right lower 
abdominal discomfort. One month later he was 
clearly having a flare-up of his ileitis, with right 
lower quadrant pain and anorexia. After 
another month, he was readmitted with a recur­
rent abscess between the ileum and the blad­
der. Excellent control of symptoms was 
achieved with total parenteral nutrition, 
steroids and antibiotics, and he was discharged. 
Five months after strictureplasty, he ex­
perienced an episode of gastrointestinal bleed­
ing, apparently due to Crohn’s disease.
During the next 5 months, he did reasona­
bly well on a gradually reduced dosage of pred­
nisone, in combination with 5-aminosalicylate 
(Salofalk tablets; Interfalk Canada, Inc., Mon­
treal, PQ). However, 10 months after his last 
surgery, the enterovesical fistula recurred and
FIG. 3—Case 3. Appearance of small bowel. 
At laparotomy, 17 discrete strictures were 
found.
12 months postoperatively he underwent 
laparotomy and ileocecal resection. The oper­
ative and pathological findings will be the sub­
ject of a separate report.
Case 2
A 49-year-old woman was well until, at the 
age of 26 years, she had her first symptoms of 
ileitis while pregnant. Eighteen months later, 
she suffered small-bowel obstruction which 
necessitated ileocecal resection, with removal 
of approximately 100 cm of terminal ileum. 
She was then well for 19 years, until 1983, when 
she experienced symptoms of recurrent disease 
in her small bowel. After 2 years of medical 
management, she was hospitalized again with 
small-bowel obstruction. An upper gastroin­
testinal and small-bowel series demonstrated 
at least four small-bowel strictures with dilated 
bowel proximally. One month later, she 
became intolerant of solid food, but was other­
wise well. This intolerance was not relieved by 
a period of bowel rest combined with total 
parenteral nutrition, so she was referred to us 
for strictureplasty.
Laparotomy in May 1985 revealed 120 cm 
of normal proximal small bowel. Distal to this 
was an inflammatory mass of diseased small- 
bowel loops. Within this segment, approxi­
mately 75 cm long, were five strictures. Dis- 
tally, an additional 120 cm of grossly normal 
small bowel was identified.
The inflamed segment contained dilated jeju­
num, two closely spaced short strictures, 
another area of dilatation, two more closely 
spaced strictures and one hard stricture about 
20 cm long which was opened with a Finney 
strictureplasty. The two pairs of short strictures 
were opened by the Heineke-Mikulicz tech­
nique. Apart from a slightly prolonged ileus, 
the postoperative course was uncomplicated 
and she was discharged on a full diet 14 days 
postoperatively. Currently, 21 months after 
operation, she has gained 6 kg and is on no 
medication or dietary restriction.
Case 3
This 25-year-old man was well until the age 
of 17 years when he presented with diarrhea, 
abdominal pain and an anal fissure. A short 
segment of ileitis was demonstrated radiolog- 
ically. He was managed medically until 1981, 
when laparotomy was performed because of 
intractable symptoms and an extensive 
jejunoileitis was found. Thirty centimetres of 
ileum and a small segment of right colon were 
resected. A stenotic lesion 200 cm from the liga­
ment of Treitz was bypassed by enteroen- 
terostomy and the remaining diseased portion 
left in situ. He was well for 1 year but then ane­
mia, pain and diarrhea not responsive to 
steroids developed. A small-bowel enema rev­
ealed numerous strictures (Fig. 3). Because of 
progressive symptoms of partial small-bowel 
obstruction, he was referred for strictureplasty.
At laparotomy there were 17 discrete stric­
tures, the most proximal being 100 cm from 
the ligament of Treitz. Seven Heineke-Mikulicz 
and two Finney strictureplasties were per­
formed. One of the latter included several stric­
tures in a 40-cm segment of bowel and the other 
included the previous bypass.
Postoperatively he had a prolonged ileus, but 
was discharged on a low-residue diet 3 weeks 
after operation. He was readmitted 1 week later
with what appeared to be a small-bowel 
obstruction. This resolved quickly with naso­
gastric suction, and he was discharged 6 days 
later. At the time of writing, 19 months after 
operation, he is on a full diet, has gained 15 
kg and is on no medication. In August 1986, 
he underwent an elective cholecystectomy after 
several attacks of biliary colic. His only medi­
cation is iron.
D iscu ssion
Strictureplasty is used to decrease the 
incidence o f short-bowel syndrome secon­
dary to multiple resections for Crohn’s 
disease. It may not, however, reduce the 
frequency of clinical recurrence.13 One 
must remember that the technique was 
developed not to reduce recurrence, but 
to reduce the frequency o f resection. In 
our patients, resection was delayed and 
may have been prevented. Long-term 
follow-up is required.
The technique contravenes conven­
tional surgical teaching. Areas of inflam­
mation are left in situ, opened and 
sutured. Contrary to popular belief, the 
inflamed bowel wall holds sutures well 
and complications are no more common 
than after any other procedure involving 
enterotom y.13 This durability o f  the 
inflamed bowel may be due to the fibro­
sis o f the bowel wall seen with long­
standing Crohn’s disease. It may be, 
therefore, that obstruction from early 
Crohn’s disease would be less amenable 
to strictureplasty, but some surgeons are 
now using this as a primary procedure.14
The patient in our first case has 
required reoperation for recurrent entero­
vesical fistula and obstructive symptoms. 
This may be the earliest reported recur­
rence of obstruction in an area o f previ­
ous strictureplasty (Alexander-Williams J: 
Personal communication, 1985). At 
present, we cannot tell what factors would 
have allowed us to predict this unfor­
tunate course. The patient did seem to 
have more active disease at operation, and 
was steroid-dependent preoperatively, but 
these factors have not been contraindica­
tions to strictureplasty in other series. The 
patient also had a suspected postopera­
tive intestinal leak, but thus far this has 
not been considered a prognostic factor. 
Most patients who undergo this proce­
dure have had chronic obstruction 
without other complications o f Crohn’s 
disease. It may be that abscess and fistula 
represent relative contraindications to the 
operation. In keeping with the concept o f  
minimal surgery, it would be reasonable 
to combine segmental resection with stric­
tureplasty in selected cases, as has been 
suggested.10
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Transient Focal Cerebral Ischemia Resulting From Digital 
Palpation of the Carotid Artery in the Neck
Complications of digital palpation of the 
carotid artery in the neck are uncommon. 
They include cardiac arrhythmias and 
cerebral ischemic events. A 65-year-old 
woman experienced transient paralysis of 
the left arm immediately after palpation 
of the right carotid artery; at surgery, a 
friable, atherosclerotic plaque was 
removed from the bifurcation of the 
artery. The most likely cause of a tran­
sient neurologic deficit after digital 
manipulation of the carotid artery in the 
neck is an embolus from an 
atherosclerotic carotid plaque. The 
authors review the literature on the fre­
quency and pathogenetic mechanism of 
this complication.
Les complications de la palpation digitale 
de I'artere carotidienne au niveau du cou 
sont frequentes. L'arythmie cardiaque et 
I'ischdmie cerebrale en font partie. Une 
femme de 65 ans a souffert d'une 
paralysie transitoire du bras gauche 
immediatement apres la palpation de la 
carotide droite; a la chirurgie, une plaque 
d'atherome friable a ete retiree de la
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bifurcation carotidienne. La cause la plus 
probable du deficit neurologique transi­
toire aprds manipulation de la carotide 
avec les doigts est une embolie originant 
de la plaque d'atherome. Les auteurs 
passent en revue des publications sur la 
frequence et le mecanisme pathogeneti- 
que de cette complication.
Although digital palpation of the carotid 
artery in the neck is commonly used for 
both diagnostic and therapeutic reasons, 
complications attributable to carotid 
manipulation are rare. They consist 
mainly of cerebral ischemic events and 
cardiac arrhythmias. This report describes 
a case of transient cerebral ischemia that 
followed digital palpation of the carotid 
artery. We review the appropriate litera­
ture regarding the frequency and possi­
ble pathogenesis o f this iatrogenic event.
Case Report
A 65-year-old right-handed woman was 
referred to an otolaryngologist because of dys­
phagia associated with a painful mass in the 
right side of the neck, present for 1 year. The 
patient was a cigarette smoker with no history 
of diabetes, hypertension, angina or leg clau­
dication. There was a family history of hyper­
tension and stroke. There were no episodes of 
amaurosis fugax or symptoms of transient 
cerebral ischemia. Oropharyngeal examination 
gave negative findings. A 2 x 2-cm firm, 
mobile, pulsatile mass was palpable in the right 
submandibular area, but no accompanying 
bruit was heard. Minutes after repeated digi­
tal examination of the region by a number of 
physicians, the patient experienced a dense 
monoparesis of the left arm that resolved com­
pletely in 2 hours. Cardiac examination rev­
ealed normal heart rate and rhythm and no 
murmurs; an electrocardiogram was normal.
Computerized tomography of the head rev­
ealed no abnormality. Transfemoral carotid 
arteriography demonstrated a 40% stenosis of 
the right internal carotid artery near its origin 
(Fig. 1). The left internal carotid artery 
appeared normal.
The patient underwent right carotid endar­
terectomy as prophylaxis against cerebral 
infarction. The carotid bifurcation was found 
to be quite bulbous and firm to palpation. 
Arteriotomy exposed a large, extremely fria­
ble plaque which was removed. Pathologically, 
the specimen consisted of an atheromatous 
plaque with no evidence of dissection (Fig. 2). 
The patient’s postoperative course was uncom­
plicated and she remains symptom-free 3 years 
later.
Discussion
The first neurologic complication 
attributable to carotid manipulation was 
reported in 1941 by Marmor and Sapir- 
stein.1 The patient, a 53-year-old man 
with generalized arteriosclerosis, 
experienced bilateral thrombosis of the 
anterior cerebral arteries shortly after 
serial compression of both carotid bifur­
cations. Total right hemiparesis occurred 
within minutes of the procedure, preceded 
by a syncopal episode, bradycardia and 
a generalized seizure. The largest series of 
hemiplegia following carotid manipula­
tion was reported by Askey2 in 1946,
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who described eight cases. Six patients 
suffered cerebral infarction, one had a 
deficit resolving within 24 hours and one
Fig. lb
FIG. 1—Right carotid angiogram — (a) 
lateral and (b) anteroposterior views — demon­
strating atherosclerotic plaque of internal 
carotid artery without hemodynamically sig­
nificant stenosis.
patient experienced two transient ischemic 
attacks, both occurring shortly after 
carotid sinus stimulation. Generalized 
vascular disease was clinically evident in 
six of these patients. In seven instances 
the hemiplegia followed routine diagnos­
tic testing for carotid hypersensitivity, and 
in one it followed compression of the 
neck during a chiropractic maneuver. The 
authors attributed the six cases of cerebral 
infarction to either thrombosis or small 
hemorrhage, and the transient events to 
reflex vasoconstriction of the ipsilateral 
cerebral circulation, a theory no longer 
in favour.3 No mention was made of the 
possibility of embolism. In a series of 188 
elderly patients tested for carotid sinus 
hypersensitivity, Zeman and Siegal4 
described an 83-year-old man who 
experienced fixed right-arm paralysis after 
serial bilateral carotid compressions. 
Webster and Gurdjian5 examined a 
group of patients with pre-existing 
hemiparesis or hemiplegia from a variety 
of causes. Of 100 patients exposed to 
carotid artery compression, worsening of 
an existing hemiparesis was observed in 
1. Others3-6'7 have reported hemiplegia 
related to carotid palpation.
In their series of four patients, Cal- 
verley and Millikan8 reported on a 
35-year-old man, the youngest such 
patient in the literature, who had con­
tralateral hemiplegia during neck massage 
to relieve muscle tension. The authors 
speculated that a hemodynamic cerebral 
infarction was caused by decreased flow 
to the ipsilateral cerebral circulation 
secondary to manual occlusion of the 
artery. Conversely, it was proposed that
FIG. 2—Photomicrograph of surgical speci­
men showing atherosclerotic plaque with subin- 
timal lipid-laden m acrophages (top), 
cholesterol clefts, and media (bottom) 
(hematoxylin and eosin, bar = 200 jtm).
another patient who suffered cerebral 
infarction after intraoperative manipula­
tion of the carotid artery suffered either 
an in-situ thrombosis or an embolism of 
atherosclerotic debris. More recent 
reports have implicated carotid compres­
sion ocular tonography9 and carotid 
massage for the termination of supraven­
tricular tachycardia10 in causing cerebral 
infarction. Several2-11 have described a 
delayed onset of hemiparesis, approxi­
mately 24 hours after initial carotid 
manipulation. This time lapse is compat­
ible with local arterial trauma producing 
delayed embolism, as opposed to immedi­
ate embolism or thrombosis, or cardiac 
dysfunction.
Pathological verification of cerebral 
ischemia precipitated by digital carotid 
artery compression has been reported 
infrequently. Marmor and Sapirstein’s 
original paper clearly described anterior 
cerebral artery thrombosis at autopsy. In 
one of Calverley and Millikan’s patients, 
exam ined post m ortem , m arked 
atherosclerotic changes were found in 
both carotid arteries associated with 
thrombosis of the previously palpated 
vessel. Nelson and M ahru12 confirmed a 
case of massive hemispheric infarction 
secondary to internal carotid artery 
thrombosis after digital occlusion of the 
carotid artery in the neck. Pathological 
evidence of an artery-to-artery embolism 
after carotid artery compression is 
documented by Beal and colleagues.13 A 
79-year-old man suffered right hemiple­
gia 1 minute after left carotid sinus pres­
sure was applied; autopsy disclosed an 
intraluminal mass of atherosclerotic 
material at the bifurcation of the left mid­
dle cerebral artery and an ulcerated 
atherosclerotic plaque in the left internal 
carotid artery in the neck. Further sup­
port for an embolic cause of transient 
cerebral ischemia after carotid artery 
compression is inferred by the report of 
Cohen and Jacobson.14 They described a 
50-year-old physician who experienced a 
transient ischemic attack while demon­
strating carotid massage to a patient with 
paroxysmal atrial tachycardia; at carotid 
endarterectomy an ulcerated plaque con­
taining loose fibrinous material was 
removed.
Despite the reported adverse conse­
quences, carotid artery palpation appears 
to carry a low morbidity. In an attempt 
to ascertain the relative frequency of neu­
rologic complications, it is worthwhile 
examining the cardiology and neurology 
literature pertaining to routine carotid 
massage or compression. Sigler15 evalu­
ated 1193 patients with carotid sinus mas­
sage and encountered no complications 
attributable to focal cerebral ischemia. 
Lown and Levine16 reported just one 
brief episode of transient facial weakness 
in several thousand such tests. Smiddy 
and colleagues17 confined their study to
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feilthy men over 65 years of age without 
e Jence of cardiac arrhythmia or 
raocardial infarction; in 58 instances of 
cs»tid sinus massage no neurologic 
evnts were observed. Deaths have been 
afcibuted to induced cardiac arrhythmias 
Wowing carotid sinus massage;18-19 
however, this occurrence is also rare. In 
the neurologic examination of patients, 
carotid compression to assess cerebrovas- 
culr insufficiency used to be routine;20 
Toole and Bevilacqua21 performed over 
250) carotid compressions and reported 
no oeurologic events. In another study, 
2  of 479 patients so tested suffered 
cerebral infarction.22 Janeway23 used 
carotid compression as a screening test to 
evaluate cerebral collateral reserve; of 
2800 compressions in 336 patients there 
was one cerebral infarction. Fieschi and 
colleagues24 performed carotid sinus 
massage in 274 patients who had previ­
ously experienced one or more transient 
ischemic attacks. No cerebral ischemic 
events were attributed to these maneuvers 
even though 148 of these patients had 
stenotic or complicated carotid plaques 
demonstrated on angiography. Precipita­
tio n  of hemiplegia ipsilateral to the 
carotid artery compressed has also been 
recorded25 and explained on the basis of 
hemodynamic ischemia of the con­
tralateral hemisphere due to impaired col­
lateral flow to the hemisphere above a 
totally blocked carotid artery.
Possible mechanisms to explain the 
occurrence of cerebral ischemia follow­
ing carotid artery palpation include the 
following: (a) embolism from an 
atheromatous plaque of the internal 
carotid artery, (b) local trauma to the 
arterial wall with resultant thrombosis or 
intimal dissection, (c) manual compres­
sive occlusion of the internal carotid 
artery with resultant decreased flow to the 
hemisphere, (d) decreased cardiac output 
from  an arrhythmia, causing thrombosis 
o f  the internal carotid artery or 
hemodynamic focal cerebral ischemia and 
(e) mural thrombus in the heart with dis­
tal embolization precipitated by cardiac 
arrhythmia. The likely cause of our 
patient’s transient ischemic attack was an 
atheromatous embolus dislodged from 
her friable internal carotid artery plaque 
by firm digital palpation. This theory is 
supported by the observation that bright 
retinal plaques indicative of cholesterol 
emboli have been seen immediately after 
carotid palpation and surgical manipula- 
tion.23-26-27 It is puzzling, however, that 
cerebral ischemic symptoms are infre­
quently reported after palpation of the 
carotid artery, a maneuver that is often 
done in older individuals. The friable 
nature of carotid artery atherosclerotic 
plaques seen at surgery or autopsy sug­
gest that traumatic dislodgement of 
emboli from firm digital manipulation 
should be more common. Perhaps this
does happen but the emboli are too small 
to cause clinically recognizable neurologic 
deficits. Alternatively, such deficits may 
be common but are infrequently reported.
Regarding the relative safety of digital 
manipulation of the carotid artery in the 
neck, most authors1-2’4-9-10-13 recommend 
caution when performing carotid sinus 
massage on elderly, atherosclerotic, 
hypertensive patients. However, the liter­
ature offers no firm predictors of the 
occurrence of cerebral ischemia as a result 
of carotid palpation.
In patients already experiencing tran­
sient ischemic symptoms (i.e., amaurosis 
fugax or a transient ischemic attack), dig­
ital palpation of the artery in the neck is 
contraindicated; it provides little clinically 
useful information that cannot be 
provided more anatom ically and 
accurately by carotid angiography or dig­
ital intravenous subtraction angiography. 
In asymptomatic older patients, routine 
digital palpation of the artery in the neck 
is also unlikely to give much information 
regarding the cerebrovascular status and 
therefore is not indicated. In younger 
patients with supraventricular tachyar­
rhythmias, carotid sinus massage remains 
an important therapeutic and diagnostic 
modality and the risk of precipitating 
artery-to-artery embolism in this popula­
tion is low. Carotid massage for 
supraventricular tachyarrhythmias in 
elderly patients would carry a higher risk, 
but the relative benefits of this procedure 
would outweigh the apparently small risk 
of precipitating neurologic problems. 
Perhaps auscultation of the neck for 
bruits would be a prudent screening test 
in these patients, although the relation of 
cervical bruits to the risk of embolic 
cerebral infarction is uncertain.28
When a transient ischemic attack is 
apparently precipitated by digital palpa­
tion of the neck for whatever reason, the 
clinician must investigate the patient 
thoroughly, and that includes a search for 
a surgically significant atherosclerotic 
lesion in the internal carotid artery in the 
neck.
We thank Dr. L. Resch for supplying the 
photomicrograph, Lynn Kovacs for preparing 
the manuscript and Dr. D. Borts for his cardi­
ologic critique.
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William Harvey, 1. That Incomparable Invention of Dr. Harvey’s
Harvey's discovery of the circulation had 
its roots far back in his early studies in 
medicine at the University of Padua 
where he was a pupil of the famed 
anatomist Fabricius, who was very 
interested in the valves of the veins. The 
difference between his teacher and Har­
vey was Harvey's dedication to the 
modern concept "scientific method". 
Other influences on his findings included 
the earlier work of Erasistratus and 
Galen. Harvey, after a long period of 
experimentation, published his findings 
on the circulation of the blood in his 
famous treatise De Motu Cordis in 1628. 
It is noteworthy that Harvey as a clinical 
practitioner failed thereafter to apply his 
discoveries to his work as a physician. 
The first of two articles on Harvey, this is 
concerned with his work as a scientist 
and discoverer. The second article is 
devoted to his work as a medical doctor.
La d£couverte de Harvey sur la circula­
tion prit naissance loin, dans ses premie­
res etudes medicales & I'Universite de 
Padoue oil il fut I'eleve du celebre anato- 
miste Fabricius, lequel s'interessait de 
pres aux valvules et aux veines. Contrai- 
rement a son maitre, Harvey s'en remet- 
tait au concept moderne de la "methode 
scientifique ". Parmi les autres influences 
sur ses recherches, on note les travaux 
anterieurs d'Erasistrate et de Galien. 
Apres une longue p£riode d'experimenta- 
tion, Harvey publia ses resultats sur la 
circulation du sang dans le traite bien 
connu De Motu Cordis en 1628. II faut 
remarquer que, tout praticien Clinique 
qu'il fut, Harvey negligea par la suite 
d'appliquer ses decouvertes a son travail
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The title of this article was suggested by a 
quote from Henry Power, a student of Glis- 
son’s at Cambridge and an interesting 
example of Harvey’s influence exerted at 
a distance. In the late 1640s, Power fol­
lowed his friend Thomas Browne’s advice 
to learn anatomy by autopsia, and most 
especially, to make himself master of Har­
vey’s De Motu Cordis. The tract he pub­
lished in 1652, Circulatio Sanguinis, 
brought to light over 50 experiments, both 
dissectional and vivisectional, to support 
“ our Reverend and Worthy Dr. Harvey” 
and “ that Incomparable Invention of his, 
the Circulation of the Blood” . (In the 17th 
century, the word “ invention” was used 
synonymously with our term “ discovery” .)
comme medecin. Le premier de deux 
articles sur Harvey est consacre a ses 
travaux en tant que scientifique et cher- 
cheur. Le second se penche sur son tra­
vail de medecin.
Through his discovery of the circula­
tion of the blood, William Harvey 
(1578-1657) laid the foundation of 
modern physiology and made possible the 
development of medicine as an applied 
science. In the 14th chapter of his famous 
treatise, De Motu Cordis (1628), Harvey 
gave a brief restatement or summary of 
the new doctrine, concluding that “ in 
animals the blood is driven round in a cir­
cuit with an unceasing, circular sort of 
movement, that this is an activity or func­
tion of the heart which it carries out by 
virtue of its pulsation, and that in sum it 
constitutes the sole reason for that heart’s 
pulsative movement” .
Nothing could be clearer and no scien­
tific treatise contains a more conclusive 
demonstration of the truth of the doctrine 
propounded in it. Yet Harvey’s great con­
tribution to our knowledge of anatomy 
and physiology does not represent the 
totality of his achievement. That is to be 
found in his sound empiricism, his mov­
ing from an idea, a premise, through dis­
section and experimentation, to establish 
“ scientific” proof of his hypothesis. In 
employing this approach, he not only
founded a branch of modern science and 
made possible its application to other 
sciences, in particular medicine, but he is 
now recognized as the true pioneer in the 
modern conception — the “ scientific 
method” . Argument from known facts, 
supported by experiments on living 
animals and autopsies on humans, had 
shown once and for all the validity of a 
fundamental physiological truth that had 
escaped every previous anatomist. “ Clear 
reasoning and perfect scientific method 
with quantitative measurements had set 
a pattern initiating advances in the bio­
logical sciences and was destined to 
influence all scientific investigation for 
the rest of time.” 1
Origins of the Circulation Doctrine 
From Plato to Galen
The doctrine of the circulation of the 
blood, it has been claimed, had been 
known to antiquity. Knowledge of it has 
been credited to ancient Chinese and 
Hindu civilizations. However, if there 
were any real foundation to these claims, 
it seems likely that Plato and Aristotle 
would have had a more accurate concep­
tion of the heart and its functions than 
can be found in their writings.2
Plato, writing in the fourth century, 
described the heart as protected by the 
lungs and as being the origin of the blood 
vessels. He made no distinction between 
arteries and veins. This distinction was 
first made by Praxagoras of Cos (circa 
320 BC), although he thought the func­
tion of the arteries was to carry air. 
P lato’s pupil Aristotle subscribed to this 
delusion and was responsible for perpetu­
ating it.
Erasistratus of Alexandria, a little later 
than Praxagoras, shared the belief that 
the arteries were designed to carry air, 
explaining the issue of blood from a 
severed artery as due to blood “ passing 
through free anastomoses from the veins” 
to fill the vacancy caused by the arterial 
lesion.
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Some 400 years after Erasistratus, in 
the second century AD, Galen, the last 
of the great Greeks, set about making a 
comprehensive synthesis of body struc­
ture and functions. Although Galen may 
not have anticipated the central truth of 
the movements of the blood, he believed 
implicitly in the value of experimentation 
in elucidating anatomical and physiolog­
ical problems. By dissections and experi­
ments on animals, he defined their 
organs, watched them work and thus 
arrived at a synthesis, combining his find­
ings with those of authorities of his day. 
These findings are summarized in a book 
on the uses of the parts (De Usu Partium). 
His conception of the movements of the 
blood is contained in scattered passages 
of his writings. His syncretic blend of ana­
tomical structure and function was so 
closely knit and authoritative that it 
remained unchallenged for the next 1400 
years. After Galen’s time, his teaching 
acquired an almost divine authority, so 
that things stood as he left them until 
Harvey’s remarkable discovery published 
in 1628. Galen is considered to be Har­
vey’s “ true father in science” , not so 
much for what he achieved, but for how 
he achieved it.3
Harvey at Padua and the Influence 
of Fabricius
Harvey was born in Kent, educated at 
Canterbury School and went on to hold 
the Parker scholarship at Gonville and 
Caius College, Cambridge. This college, 
originally known as Gonville Hall, was 
refounded by Dr. John Caius, sometimes 
regarded as the father of the study of 
anatomy in England, as a seat of learn­
ing for young men with a particular scien­
tific bent. Its reputation as a place where 
medical studies were encouraged was 
widely known. This college must have had 
a special attraction for Harvey, a youth 
with identifiable scientific and medical 
leanings. Probably he received a better 
medical education there than is generally 
conceded, for as we shall see, he spent lit­
tle more than 2 years at Padua before 
graduating with an MD degree, although 
there were no formal medical lectures 
during this time.
Following in the footsteps of Caius and 
Linacre, Harvey chose to complete his 
medical education at Padua, a medical 
school famous for its anatomical and clin­
ical training. A statute of 1558 at Gon­
ville and Caius College, proposed by 
Caius, recognized that the medical 
instruction then available at Cambridge 
was not adequate for full training as a 
doctor. Bachelors of arts wishing to pur­
sue a medical career were allowed to leave 
Cambridge and go to Padua, Bologna, 
Montpellier or Paris. It is thought that 
Harvey was attracted to Padua in the first
place by the celebrity of the medical 
school and the excellence of the teaching 
provided there. In anatomy the sequence 
of Vesalius, Columbus, Fallopius and 
Fabricius in the professorial chair had 
indeed given the school a quite dazzling 
distinction.4'5 Beginning with the 
influence of the physician Montanus 
(under whom John Caius had studied), 
the Clinical School of Padua for more 
than half a century had provided a unique 
form of teaching. In this milieu Harvey 
had the opportunity to study anatomy 
with the best teachers, and here he was 
also able to acquire clinical knowledge 
and bedside experience in the hospitals. 
Harvey was profoundly influenced, 
through his teachers at Padua, by Aristo­
tle. Many reasons can be listed to explain 
Harvey’s loyalty to Aristotle. Paduan 
Aristotelianism must have made a deep 
impression on him in his formative years, 
personified as it was in his teacher, 
Fabricius. Harvey calls him his guide next 
to Aristotle himself.6’7 His real teacher 
Fabricius of Aquapendente was at this 
time completing the work for his treatise 
on the valves of the veins (De Venarum 
Ostiolis). Although it has often been 
assumed that a fast friendship sprang up 
between master and pupil, this has never 
been firmly established, nor did Harvey 
ever serve as a special assistant to 
Fabricius. We can be sure, however, that 
the venal structures were demonstrated by 
the famous master to students in Padua’s 
anatomy theatre during Harvey’s first 
year of residence there. Fabricius was 
himself saturated in A ristotelian 
philosophy and scientific concepts. His 
example, in the wide range of his investi­
gations into the cardiovascular system 
and into the entire field of animal biol­
ogy and generation, had a profound 
effect on Harvey’s thinking and methods 
of work, more than any other teacher he 
is likely to have met at Padua or else­
where.
At the beginning of chapter 13 in De 
Motu Cordis, Harvey makes reference 
to “ the discovery of the valves” by 
Fabricius. This chapter and the two previ­
ous ones are of particular interest for they 
show how Harvey had come to appreci­
ate the true purpose of valves in veins. 
These chapters include observations 
describing Harvey’s dissections of the 
veins in the limbs and his attempt to pass 
a probe downwards. Invariably the valves 
provided a complete obstacle, though the 
probe passed easily in the other direc­
tion toward the heart. Then comes the 
celebrated demonstration of the valves in 
the veins of the forearm, for which Har­
vey used figures copied from the draw­
ings published by Fabricius in 1603 in his 
book De Venarum Ostiolis. These were 
the only illustrations Harvey included in 
the first edition of De Motu Cordis, and 
they appeared in virtually every subse­
quent edition of the book except the 
English version of 1653.
A glance back at Fabricius’s discovery 
in its relation to Harvey’s later findings 
is revealing. Hitherto, Fabricius claimed, 
the valves of the veins had escaped the 
notice of anatomists of his own and 
earlier generations. Never had they been 
mentioned. No one had even set eyes on 
them until 1574 when he first noticed 
them in the course of his dissection. In 
point of fact, they were known to 
Vesalius at Ferrara in 1545, and earlier 
still to Giambattista Canano (circa 1536). 
Neither of these two men, however, had 
ever published his observations. Both 
understood the function of the valves no 
better than Fabricius did.
The Latin word ostiolum, correctly 
translated, means little door. Translating 
it to mean valve is questionable. Whether 
or not Fabricius correctly named the 
valves, it is plain that he completely mis­
understood their function. He was aware 
that they opened upward and accepted the 
established idea that the function of the 
veins was to afford a passage of blood to 
the extremities, but he had no notion that 
the blood might be moving in the oppo­
sition direction, toward the heart. To his 
way of thinking, the ostiola were placed 
where he found them to delay the passage 
of blood downward in the lower limbs 
and not to act as valves preventing it. Lit­
tle doors they were, partly opened to per­
form their function, in his construct.8
In his dedication of De Motu Cordis, 
Harvey takes pains to profess his pro­
found faith in the philosophic love of 
truth and wisdom, from whomsoever it 
might come. At the same time he depre­
cates making attacks on the errors of his 
predecessors and teachers; he was loathe 
to provoke his contemporaries, anticipat­
ing how controversial his discoveries 
would be. And yet, he found it impossi­
ble entirely to avoid making these attacks. 
More than once he is found naming his 
old teacher, Fabricius, as the propagator 
of erroneous doctrines. It is pertinent to 
note that in chapter 13 he designated the 
valves by the Latin word valvula, not 
ostiola. He proceeded to point out that 
“ the discoverer of the valves did not 
rightly understand their real function, and 
others went no further” .
Evidence in the Lumleian Lectures
Evidence in Harvey’s early anatomy 
lecture notes suggests that even he did 
not, as early as 1616, fully understand the 
implications of the venous valves, or the 
fact that they gave free passage to the 
blood toward the heart, but opposed its 
passage the other way. The notes Harvey 
prepared for his lectures, now in the Brit­
ish Museum, were written on folded fool-
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scap paper. In the opinion of Keynes and 
other experts, folio 80, including the terse 
passage which at last clearly comprehends 
and explains the circulation of the blood, 
was inserted much later than 1616, the 
date at which it is arranged in chronologic 
order with the other folios. The rest of 
the lecture notes do not appear to have 
taken the discovery of the circulation into 
account. He certainly did not realize the 
point when he witnessed the demonstra­
tion by Fabricius, and a long interval, 
perhaps until 1627, elapsed before he 
dared to question his teacher’s interpre­
tation, at least in public discussions. Har­
vey waited to demonstrate the truth in his 
book published 25 years after the appear­
ance of the treatise by Fabricius.
In the seventh chapter of De Motu 
Cordis, Harvey argues closely, with the 
supporting passages from Galen, how the 
blood finds its way from the right ventri­
cle through the parenchyma of the lungs 
into the pulmonary vein and left ventri­
cle. He never did see the capillary vessels 
giving passage to the blood; lack of 
refined optical apparatus prevented him 
from seeing and demonstrating them. 
Galen’s errors are corrected, but Harvey 
credits him with having provided conclu­
sive evidence for a pulmonary circulation 
by his description of the valves of the 
heart and the passage of blood through 
the lungs. Nowhere in his writings did 
Galen provide a clear statement of it. 
Harvey provides his own arguments, 
using Galen, as far as he went, to support 
them. His interest was in demonstrating 
a general systemic circulation, not in 
proving the existence of the lesser circu­
lation.
Geoffrey Keynes, in his life of Harvey, 
has subjected De Motu Cordis, chapter 
by chapter, to a thorough textual analy­
sis. There is far too much of interest in 
his biography to discuss within the space 
of a short article.9 Strangely, however, 
his study does not mention Harvey’s 
failure to apply his discoveries to his clin­
ical practice. Harvey eventually came to 
realize many of the consequences that 
would follow from the illuminating truth 
he had revealed with his discovery of the 
circulation, affecting every part of medi­
cine — physiology, pathology, therapeu­
tics. It is surprising, therefore, that Har­
vey never made any direct application of 
his findings on the circulation to his clin­
ical practice of medicine, although he had 
examined closely and in full detail the 
structure of the heart and disclosed many 
new findings on its mechanical efficiency.
Harvey’s mind did not work like 
Francis Bacon’s. He was more like 
Galileo or Gilbert, engrossed in his par­
ticular problem, and sometimes unaware 
of the possible repercussions of what he 
was discovering. In spite of his advanced 
views on the circulation of the blood, 
Harvey was still Artistotelian in his prac­
tice of medicine. And yet his work had 
an influence on the development of the 
scientific method wide and universal 
enough to have satisfied even a mind like 
Bacon’s.
Conclusions
The continuing fascination with Har­
vey derives mainly from his work and 
influence as the discoverer of the circu­
lation of the blood. As a scientist he was 
sui generis. It is often overlooked, 
however, that he chiefly made his way in 
life by filling a more conventional role, 
that of the practising physician. It is not 
unnatural to think of Harvey as having 
devoted the bulk of his attention to anat­
omy, dissection and scientific experiment, 
but this view of him loses a sense of 
proportion. While still a student at 
Padua, he was studying medicine in its 
widest possible meaning. In 1662 Sir 
Charles Scarburgh characterized him as 
“ one not to be bound by the laws of a 
single discipline” . He had gathered 
professional knowledge from experience 
in hospital wards and autopsy chambers 
as well as in lecture theatres that would 
later be applied to a wide range of patients 
in private as well as public practice, and 
that would include two kings of the 
realm, James I and Charles I. Harvey in 
fact was to distinguish himself by busily 
developing an uncanny capacity for 
observation of everything that concerned 
him as a doctor.
NOTICES
continued from page 116
Progress in Vascular Surgery
“ Progress in Vascular Surgery” is the ti­
tle of a course being sponsored by the 
University of Minnesota Medical School. 
The course will be held June 17-19, 1987 
in Minneapolis. Write to Office of CME, 
University of Minnesota, Box 202 
UMHC, 420 Delaware St. SE, Minneapo­
lis MN 55455 for information or call (612) 
626-5525.
Institutional Program 
Guidelines
Health and Welfare Canada’s publication 
“ Cardiovascular Services in Hospitals” 
has been approved by the Feder- 
al/Provincial Advisory Committee on 
Institutional and Medical Services and is 
available for distribution. A copy of these 
guidelines may be obtained by writing to: 
Mr. D.F. Moffatt, Chairman, Sub- 
Committee on Institutional Program 
Guidelines, Health Services Directorate, 
Health Services and Promotion Branch, 
Department of National Health and Wel­
fare, Ottawa, Ont. K1A 1B4.
It is with that role as fellow of the Col­
lege of Physicians in London and as a 
medical practitioner during the years he 
worked at St. Bartholomew’s Hospital 
that a second article will be concerned. 
From 1609 onwards, Harvey’s time was 
divided between his hospital duties, his 
private practice, his anatomical and phys­
iological research, and his various duties 
at the College of Physicians, in which he 
held every office available to a fellow 
between 1607 and 1628 except that of 
president. In September 1654 the College 
of Physicians elected Harvey president, 
an honour he declined for reasons of old 
age and failing health. He was intensely 
loyal to its status and dignity for the 
remaining years of his life.
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American Back Society
A Symposium on Back Pain will be held 
in Anaheim, Calif., Apr. 29-May 2, 1987, 
sponsored by the American Back Socie­
ty and St. Rose Hospital. The program 
is approved for 18 hours Category I con­
tinuing medical education credit. Contact 
Dr. Rene Cailliet or Dr. Aubrey A. 
Swartz, American Back Society, 2647 
East 14th St., Ste. 401, Oakland, CA 
94601; (415) 536-9929 for information.
Applied Basic Science Course
“ Behaviour of the Growth Plate”  is the 
title of the title of the 14th annual applied 
basic science course sponsored by the Di­
vision of Orthopaedic Surgery of the 
University of Ottawa, together with the 
Pediatric Orthopaedic Society of North 
America. The course will be held May 
13-15, 1987 at the Health Sciences Com­
plex; more information can be obtained 
by contacting Dr. Hans K. Uhthoff, Di­
vision of Orthopaedics, Ottawa General 
Hospital, 501 Smyth Rd., Ottawa, Ont. 
K1H 8L6; (613) 737-8377.
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BOOK REVIEWS
GREENHILL’S SURGICAL GYNECOL­
OGY. 5th ed. Edited by Stephen L. Cor­
son, Thomas V. Sediacek and Jerome J. 
Hoffman. 376 pp. Illust. Year Book Med­
ical Publishers, Inc., Chicago, 1986. Price 
not stated. ISBN 0-8151-1863-5.
This edition of Greenhill's Surgical Gynecol­
ogy has been revised considerably from the last 
version which appeared 17 years ago. As with 
its predecessors, it is an atlas of monochro­
matic drawings and photographs with a mini­
mum of text. It attempts to describe and illus­
trate the majority of surgical gynecologic 
procedures.
Brief initial chapters are presented on the 
handling of surgical instruments, basic fluid 
and electrolyte metabolism, abdominal inci­
sions and wound healing and pre- versus 
postoperative care. The information contained 
in these chapters might be of use to a surgeon- 
to-be in the first days of training but is in no 
way comprehensive.
The following chapters are divided by topic 
into vulvar operations, urinary stress inconti­
nence, vaginal, abdominal and obstetric oper­
ations, sterilization and hysteroscopy. The 
illustrations are clear and easy to follow, but 
are necessarily limited by simplification of 
detail, two dimensional character and lack of 
colour. Normal anatomy is presumed and por­
trayed for the most part, and the accompany­
ing descriptive text is sparse.
The majority of the text is devoted to depict­
ing gynecologic procedures. This might be of 
use to a student, surgeon in training or “ old 
hand” who needs a quick reference illustration 
for teaching or personal review. Although the 
chapters on obstetrics and sterilization might 
interest a student, they are too brief and sim­
plified to benefit an experienced surgeon.
In summary, this reference text in its latest 
edition might be suitable for a university hospi­
tal or operating-room library. Whether or not 
it would be of value in one’s personal library 
is best left to individual preference.
Phillip F. Hall, md, frcsc
Assistant professor, 
Obstetrics and Gynecology, 
University of Ottawa, 
Ottawa General Hospital, 
501 Smyth Rd„
Ottawa, Ont.
K1H 8L6
INFECTION IN THE FEMALE. 2nd ed. Wil­
liam J. Ledger. 293 pp. Illust. Lea & 
Febiger, Philadelphia, 1986. $51.25. ISBN 
0-8121-0992-9.
Few aspects of obstetrics and gynecology have 
undergone more recent change than those con­
cerned with infections. Examples of such 
changes are the appreciation of the significance 
of organisms (papillomavirus, Chlamydia), the
improved technology that now allows routine 
culture of potentially virulent organisms 
(anaerobic bacteria), the necessity of using 
combinations of antibiotics (clindamycin and 
aminoglycosides) when treating postoperative 
soft-tissue infection and the augmentation of 
antibiotic choice (second and third generation 
cephalosporins, ureidopenicillins). There is a 
need to bring the whole subject together and 
to put the new information into perspective.
This book’s 12 chapters are arranged in a 
logical format. The first seven discuss such 
basic topics as microorganisms, their labora­
tory handling, the host response and antibiotic 
therapy; the clinical portion consists of four 
chapters that separately discuss obstetrical and 
gynecologic infections as acquired in either 
community or hospital; there is also a section 
on adverse fetal outcomes.
The first chapter is a brief historical outline, 
the second a perhaps too sketchy bacteriologic 
overview. The third chapter pertains to the col­
lection of specimens for microbiologic culture, 
and it was disappointing. Whereas I had hoped 
to find clear guidelines for the investigation of 
patients with postoperative fever, I found the 
advice to be confusing. For example, one page 
advocated culdocentesis, the next page sug­
gested that the procedure was of little value. 
The chapter on the laboratory testing of antibi­
otics is especially involved with measuring 
serum levels of aminoglycosides. Toxic levels 
of this drug are rarely reached in obstetrical 
and gynecologic patients because renal func­
tion of our more youthful patients is generally 
good. Ledger points out that the levels may not 
be therapeutic.
The chapter on the host response to infec­
tion was excellent. For a brief moment I under­
stood helper, suppressor and cytolytic T cells 
and the role of T cells in the secretion of lym- 
phokines (lymphokines stimulate monocyte 
phagocytosis). In acquired immune deficiency 
syndrome (AIDS) the T cell’s lymphokine 
secretion is suppressed; patients thus become 
subject to diseases that are controlled by mono­
cyte phagocytosis (i.e., fungi, viruses).
The chief interest in the chapter on a “ clin­
ical overview” was the evaluation of journal 
articles; although it was interesting, I am not 
certain why it was included. The prophylactic 
use of antibiotics is an important subject, but 
I thought the discussion was outdated. For 
instance, I examined all references cited in 
chapters 7 to 10 and found that 48% of them 
dated to 1977 or before.
There is a fine discussion on the animal 
model of mixed bacterial infection, which is 
the basis of our present understanding of soft- 
tissue infections and peritonitis. It was personal 
and the author’s long experience and familiar­
ity with the subject allowed a critical review. 
The chapter on community acquired gyneco­
logic infections was not up to expectations. 
There seemed to be undue emphasis on herpes 
infections. Clinical experience would suggest 
that more information on recurrent yeast infec­
tions is needed. Biopsy for condyloma of the 
vulva, culture of the vagina for ureaplasma
urealyticum or draining the peritoneal cavity 
through the vagina should rarely be required 
as opposed to the frequency recommended in 
this chapter. Further, the indifferent results 
that apparently follow subcuticular sutures 
with appendectomy are not reasons to discon­
tinue their use with abdominal hysterectomy, 
and the advocation of colpotomy was not con­
vincing. Much of the chapter on hospital- 
acquired gynecologic infections concerns 
postoperative fever but since no information 
was given of the relative importance of each 
etiologic factor, the chapter was not very help­
ful clinically.
Maternal infections with adverse fetal out­
comes would have been better served by includ­
ing AIDS and reducing the information related 
to syphilis; the whole chapter seemed strangely 
dated. The last two chapters were unsatisfac­
tory, much was unrelated to obstetrics and 
gynecology or was repetitive, with the excep­
tion perhaps of the sections on soft-tissue infec­
tions and endometritis.
There is certainly a need for a book of this 
sort. Should this be your first choice? I think 
not.
M.E. Boyd, md, frcsc
Vice-chairman,
Department of Obstetrics and Gynecology, 
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ 
H3A 1AI
PROGRESS IN PEDIATRIC SURGERY. 
Volume 19. Long-gap Esophageal Atresia. 
Prenatal Diagnosis of Congenital Malfor­
mations. Edited by P. Wurnig. 205 pp. 
Illust. Springer-Verlag New York, Inc., 
New York, 1986. $55.50 (US). ISBN 
0-387-15881-2.
This volume of Progress in Pediatric Surgery 
covers primarily the treatment of long-gap 
esophageal atresia and to a secondary degree 
the prenatal diagnosis of congenital malforma­
tions and their possible treatment.
The problems of long-gap esophageal atre­
sia for which primary anastomosis is difficult 
or impossible are dealt with in 12 papers that 
review the world literature fully. In most cases 
they also report the individual author’s per­
sonal experience. Earlier methods of bridging 
the gap between the two ends of the esopha­
gus are discussed, including colonic or jejunal 
grafts on a vascular pedicle. More recently, a 
reversed gastric tube has been used. The dic­
tum of Nathan Myers that the patient’s own 
esophagus is the best is generally held and there 
have been many attempts to find a method of 
repair that avoids the use of transplanted intes­
tine or stomach. Various stretching procedures 
that have been used in attempts to elongate 
both the upper and lower pouches are covered. 
The circular or spiral myotomy of Livadites, 
which has been used extensively, particularly
142 VOLUME 30, NO. 2, MARCH 1987 /  THE CANADIAN JOURNAL OF SURGERY
►A
«
*
(• *
*
*
■s
J
►
J
» - 4
4
*
4
in the upper pouch, is also described. These 
myotomies are generally considered to be of 
value in elongating the esophagus. Various ten­
sion methods of drawing the two ends of the 
esophagus together using variants on Rehbein’s 
Olive technique are described. So also are 
attempts to create a fistula between the two 
pouches using suture material to pass across 
the gap between them after high-tension 
approximation. There is still considerable dis­
cussion as to the efficacy of these methods. 
Although reconstruction of the thoracic 
esophagus using autotransplantation of small 
intestine has been carried out in an experimen­
tal model in piglets, it has not been used in 
humans. Moreover, it is unlikely to be used in 
the neonate because of problems in vascular 
anastomosis. Interesting experimental work in 
animals has been done using jejunal mucosa 
and submucosa alone. But, in general, exten­
sive dissection of the upper pouch combined 
with Livadites myotomy appears likely to offer 
the best chance of a primary anastomosis. 
Although gastric tube replacements have their 
own problems they are probably superior to 
colonic replacements. Interest in this section 
will be limited mainly to pediatric surgeons, 
although it may be of interest to thoracic sur­
geons working with caustic burns of the 
esophagus.
The second part of the volume concerns 
antenatal ultrasonographic diagnosis of con­
genital malformations. All the papers in this 
section originate from Europe. The advantages 
to the child include biochemical and genetic 
screening. If the diagnosis is accurate — and 
the accuracy rate for many abnormalities is 
really very high — the information may allow 
choices as to the best time for delivery, the best 
type of delivery, the possibility of intrauterine 
surgery and considerations as to whether the 
pregnancy should be terminated. The possibil­
ities for intrauterine surgery are extremely 
limited, and these articles clearly indicate that 
unreasonable expectations of success have been 
raised. The knowledge of an antenatal diag­
nosis can, however, be valuable. For example, 
gastroschisis, an abnormality of the abdomi­
nal wall, is commonly the only abnormality 
present, so the outlook for such children, if 
treated promptly at birth, is good. Primary 
closure of the abdomen in an otherwise healthy 
child can be successfully carried out in more 
than 80% of cases. On the other hand, a diag­
nosis of omphalocele suggests the likelihood 
of multiple congenital abnormalities, so the 
prognosis would be much more guarded. Chro­
mosomal examination of the amniotic fluid 
may give more information, allowing a more 
informed decision as to the treatment of the 
infant.
This second part is particularly valuable in 
that it raises in a most logical way the problems 
and advantages of being able to make an 
antenatal diagnosis of the congenital lesions. 
However, it often does not and cannot offer 
a life-saving solution for the individual child.
This book should be in the libraries of all 
major hospitals and medical schools.
Stanley Mercer, md, frcsc
Professor and chief of surgery,
Children’s Hospital of Eastern Ontario,
401 Smyth Rd.,
Ottawa, Ont.
K1H 8L1
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Surgeon
Required
An excellent opportunity exists for an 
experienced Fellowship General Sur­
geon to practice in a new 150-bed facility 
with expansion potential to 300 beds. 
Our facility boasts state-of-the-art tech­
nology with 4 O.R. theatres currently in 
use.
We are a young, affluent community of 
35,000 with outstanding recreational 
and cultural facilities.
For further information write in con­
fidence to: Mr. Grant Lemon, President, 
Fort McMurray Regional Hospital, #7 
Hospital Street, Fort McMurray, Alberta 
T9H 1P2 Phone (403) 791-6161
Fort McMurray 
Regional 
Hospital
-S87-40
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CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f  Surgery is pleased to accept suitable classified advertisements. The deadline is 1 month before issue 
date. Regular classified rates (for each insertion): $40.00 for the first 40 words or less, additional words 50C each (additional $16.00 for frame). Special Display 
under 75 words, 2XA" x 2" $100.00. $6.00 charge (first insertion only) for CJS box numbers. Display rates available on request.
Copy should be mailed to the Canadian Journal o f  Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.
HEAD, MULTI-ORGAN TRANSPLANTATION 
PROGRAM — The University of Toronto, Depart­
ment of Surgery is seeking Head of its Multi-Organ 
Transplantation Program. The incumbent w ill be 
expected to  integrate the existing renal, liver, lung 
and heart transplant program and to  develop a 
pancreas transplant program. He/she would be ex­
pected to  develop a training program in transplan­
tation and facilitate the development of research 
in parallel w ith  the clinical program. Applicants will 
be expected to have an established reputation in 
organ transplantation as well as in teaching and 
research. Applications and curriculum vitae should 
be sent to : Dr. B. Langer, Chairman, Department 
of Surgery, University of Toronto, 100 College St., 
Toronto, ON M5G 1L5. Closing date for receipt 
o f applications is May 30, 1987. Effective date 
o f appointment as early as September 1, 1987. 
In accordance with Canadian immigration require­
ments th is  advertisement is directed to Canadian 
citizens and permanent residents of Canada.
-S 8 7 -4 4
ADVERTISERS’ INDEX
Auto Suture Company Canada
Inside Front Cover
Bard Canada Inc.
Inside Back Cover
Davis & Geek
Outside Back Cover
Du Pont Pharmaceutical
Coumadin 90, 132
Frosst
Mefoxin 8 4 ,8 5 ,1 2 2 ,1 2 3
Glaxo Laboratories
Zantac 86,119
Johnson & Johnson
Nu-Gauze 76
Pharmaceutical Manufacturers 
Association of Canada 
113, 114
Rhone-Poulenc Pharma Inc.
Stemetil 78
Royal College of Physicians 
and Surgeons of Canada, The 
89
Searle Pharmaceuticals
Metamucil/Anucaine 102, 110
Upjohn Company of Canada, The
Dalacin C 100, 101, 126
GENERAL SURGEON: BC — locum required for the 
month of July in the Cariboo, for a full accredited 
80-bed active surgical hospital w ith  tw o  ORs and 
one endoscopy, drawing from a catchment area 
of approximately 40 000. Current medical staff 
includes one other general surgeon to share call 
w ith  three other specialists and more than 14 
general practitioners. The summer can be very 
busy. Apply to : Dr. P.A. Cullum, 203 — 143 
Fourth Ave. South, Williams Lake, BC V2G 1J8.
— S87-42
CLINICAL DAYS IN CRITICAL CARE 
PRESENTED BY THE INTENSIVE CARE UNITS 
OF TORONTO GENERAL HOSPITAL 
A P R IL 2 & 3, 1987 
D A Y  1 -  A P R IL  2nd.
INTENSIVE WORKSHOP IN CRITICAL CARE. 
Intensive review  of current topics w ith  hands on skill 
stations.
REGISTRATION IS RESTRICTED TO 16 PHYSICIANS. 
FEE FOR DAY 1: $150.00 (edn funds).
DAY 2 -  A p ril 3rd.
CLINICAL DAY.
Clinical presentation of current topics of in terest to 
internists, anaesthetists, surgeons and nurses manag­
ing patients in intensive care units. 
NON-RESTRICTED REGISTATION.
FEE FOR DAY 2: PHYSICIANS $50.00 
NURSES $25.00
For more information regarding registration, please con­
tact: Deborah J. Wilson; 416-595-4623. — S87-43
CLINICAL FELLOWSHIPS 
Ewart Angus Intensive Care Unit 
Wellesley Hospital 
Toronto
Available July 1, 1987 for a one year period 
in a Medical — Surgical Unit. Duties comprise 
clinical research in a strong academic and 
teaching unit. Present research includes the 
clinical epidemiology of ICU care, nutrition, 
and respiratory muscle physiology.
Reply to: Dr. I.M. Fraser, Director, EAICU 
Ste. 246, E.K. Jones Bldg 
160 Wellesley St.E 
Toronto, ON M4Y 1J3.
Tel. (416) 926-7747 -S 8 6 -3 5
HEAD, DIVISION OF ORTHOPEDIC SURGERY -
The Hospital for Sick Children (University of 
Toronto) a 587-bed teaching hospital is seeking 
a Head for the Division of Orthopedic Surgery. The 
division consists of six members who have been 
extremely productive in clinical and research ac­
tivities. The characteristics which will be consi­
dered in applicants include excellence in patient 
care, leadership in teaching, administrative capa­
bilities and demonstrated achievements which 
would foster research within the division. The ap­
plicant must be certified or eligible for certifica­
tion by The Royal College of Physicians and 
Surgeons of Canada. In accordance w ith  the im­
migration requirements, priority will be given to 
Canadian citizens and permanent residents of 
Canada. Please reply w ith curriculum vitae to: 
Robert M. Filler, MD, Surgeon In Chief, Depart­
ment of Surgery, University of Toronto, 555 
University Ave., Toronto, ON M5G 1X8. -S 87-41
ACADEMIC APPOINTMENT: ON -  Queen s 
University, Department of Surgery geographic full­
time position in general surgery. Applicants should 
be licensed to practise in Ontario and be Fellows 
o f The Royal College of Physicians and Surgeons 
o f Canada. The successful candidate will be ex­
pected to teach at undergraduate and postgradu­
ate levels and engage in research. He/She will be 
expected to  have specialized training and interest 
in critical care/trauma. The closing date for appli­
cation is March 31, 1987. In accordance w ith 
Canadian immigration requirements, this adver­
tisement is directed to  Canadian citizens and per­
manent residents. Candidates of both sexes will 
be given equal consideration. Applications w ith  a 
curriculum vitae and the names of three referees 
should be sent to: Dr. Charles Sorbie, Head, 
Department of Surgery, Queen's University, King­
ston, ON K7L 3N6. -S 8 7 -3 9
MICROSURGICAL COURSE: — The Department 
o f Surgery, McMaster University is now offering 
one week, on-going courses in microsurgery, us­
ing animal facilities and videotapes. These courses 
are for anyone interested in small vessel anasto­
mosis, nerve repairs, vas and fallopian tube recon­
structions. The laboratory is organized to guide 
you through the basic microsurgical techniques to 
more advanced tasks with the help of an assis­
tant on a one-to-one basis. Please call: Dr. A. Tho- 
ma at (416) 523-0019 for further information.
-S 8 6 -2 3
How do you spell 
truth in 
advertising?
PAAB
CCPP
This logo appearing on pharmaceutical advertisements In 
professional journals means that the advertisements have 
been reviewed—and cleared for publishing— by the Phar­
maceutical Advertising Advisory Board/Conseil Consuttatif 
de Publicity Pharmaceutique.
This unique screening system for pharmaceutical advertis­
ing is the first of its kind in North America. The Board of 
Directors is composed of individuals representing the fol­
lowing organizations: • Association des fabricants du 
Quebec de Produits Pharmaceutiques • Association des 
medecins de langue frangalse du Canada • Association of 
Medical Media • Canadian Advertising Advisory Board • 
Canadian Drug Manufacturers • Canadian Medical Associa­
tion • Canadian Pharmaceutical Association • Consumers' 
Association of Canada • Pharmaceutical Manufacturers 
Association of Canada.
The Health Protection Branch of Health and Welfare Canada 
acts as advisor and resource body to the board.
The program ensures the accuracy of pharmaceutical ad­
vertising to the health professions, so that It may continue 
to serve the ultimate best interest of the patient.
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Bard introduces the Harvard PCA  
Patient'Controlled Analgesia System.
Now, there’s a much better way to 
control pain. Because now there’s 
the Harvard PCA* System.
It’s far more effective than intra­
muscular injections. It infuses in­
travenous analgesics on patient 
demand.. .but only under physician- 
prescribed dosages and intervals.
By just pushing a button, patients 
can self-administer small doses of 
medication more frequently. Relief 
is immediate. Patient anxiety is 
reduced.
And because there’s optimal serum 
concentration, the cycles of pain 
and sedation are minimized.
Plus, research+ indicates that 
patients using a PCA pump may 
require less medication, experience 
faster recovery time and prefer PCA 
to I.M. injections.
NOW,
PAIN CONTROL 
IS RIGHT 
AT HAND...
Accuracy, to ±1%, special 
security, detailed recall.
The Harvard PCA* System is accu­
rate to ±1% to prevent overmedica­
tion. It’s safe, with a broad range of 
status alarms, and a locked narcotics 
compartment and access code.
For flexibility (and cost savings), 
the system can be used in a PCA 
mode, a PCA/Basil mode and a 
Continuous Infusion mode. All three 
modes use a 60 cc syringe that’s not 
prefilled. So you can choose your 
own medication and concentration.
And a detailed history recall 
provides hour-by-hour review of 
patient cumulative dose attempts,
injections, and prescribed dose and 
interval.
To evaluate the Harvard PCA* 
System in your hospital, call Bard 
Canada Inc. 1-800-268-2862.
Or just clip and return the coupon 
below.
Now, physician-prescribed, patient- 
controlled pain relief is right at 
hand.
Clip and mail to:
Bard Canada Inc.
2345 Stanfield Road 
Mississauga, Ontario 
L4Y 3Y3
Please send details on the Bard 
Harvard PCA* Patient-Controlled 
Analgesia System.
m/s\mro N am e_Address
Bard Canada Inc.
2345 Stanfield Road 
Mississauga, Ontario L4Y 3Y3
1-800-268-2862
"“Trademark
+ Bennett, R.L., Griffen, W.O.,: Patient Controlled Analgesia. 
Contemporary Surgery. 23:75-89; 1983.
City_____________ Prov.______ Postal Code
Hospital Affiliation______________________
Phone( )__________________________
Meet some members 
of our family
Mow a monofilament suture 
that is easy to handle and tie
• Soft, supple, flexible
• Resists kinking
• Yields secure knots 
•Strong
the manageable monofilament.
DEXON PLUS
Excellent knot security plus superior handling 
and smoother tissue passage.
FORA DIFFf 
YOU CAN]
n e w p r e [
IRENCE
FEEL.
■CYDE*
j (Ctdorlwxidine Gluconate)
TV Tew Pre-Cyde is the only 
IN germicidal antiseptic hand 
wash that combines all the 
effectiveness of chlorhexidine 
with a  gentle emollient to 
sooth the skin.
M i
Pre-Cyde's broad antibacterial 
spectrum makes it an excellent 
bactericidal and fungicidal 
antiseptic!2
Pre-Cyde is safe, virtually 
non-irritating,'and has a 
pleasant emollient...for a 
difference you can feeL
quality products from
DAVIS+GECK A TRADITION OF INNOVATION
Cyanamid Canada Inc. Atria North, 2255 Sheppard Avenue East, Willowdale, (Ontario) M2J 4Y5
•Registered Trademark of Cyanamid Canada Inc.
thecomesnow
Greater StaplerEven
■
ULC gfe,;.-
Ultra Light Compact 
disposable skin stapler 
Automatically released staples 
Improved staple visibility 
Proven reliability 
Allows for excellent accuracy 
Quality stapler supplied inexpensively
